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ABSTRACT 
In the face of rising morbidity and mortality due to HIV / AIDS epidemic in Sub-Saharan 
Africa, there has been an increasing pressure to provide life sustaining antiretroviral 
drugs to counbies in most urgent need of them. 
Antiretroviral Therapy (AR1) has been identified by policy-makers in Uganda as a 
potential programme aimed at mitigating the pervasive effect of HIV / AIDS on the social 
and economic life of the country. Since 2000, the country has shifted its focus from 
primarily HIV prevention to paying equal attention to care and treatment including 
ART. Provision of the ART programmes have been made possible through concerted 
efforts of international and national organizations such as the Global Fund to fight 
AIDS, Tuberculosis and Malaria (GFATM), the World Bank, Multi-country AIDS 
Programme (MAP), Great Lakes Initiative on AIDS (GLIA), the USA President's 
Emergency Plan for AIDS Relief (PEPFAR), UN agencies, Bi-lateral and.Government of 
Uganda inputs (UAC 2004). 
New and increased funding notwithstanding, the Ugandan population has continued to 
grow exponentially at a rate of 3.5% and even though the economy has been growing at 
a rate of 6 % per annum, there is a widening disparity in incomes attributed largely to 
high levels of unemployment in the country (Ministry of Finance 2002). These income 
disparities have also greatly conbibuted to health inequities in Uganda, thus affecting 
the equitable allocation of the limited health resources including ART. 
The main aim of the study was to establish the socioeconomic status of those individuals 
who benefit most from the provision of free ARV drugs and to explore factors that 
influence the distribution of such benefits. 
The study was carried out in Kampala district (Uganda's capital city) and Masaka 
disbict The study employed both qualitative and quantitative methods. Facility-exit 
interviews with patients accessing free ARVs formed the quantitative method, while 
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Focus Group discussions with community representatives and in-depth interviews with 
key informants formed the qualitative part of the study. Quantitative data was obtained 
by use of a questionnaire, which was structured to obtain information on socioeconomic 
characteristics, including asset possession as a measure of wealth. A principal 
component analysis was run for both the Uganda Demographic Health Survey (UDHS) 
and facility-exit asset data to determine utilization of ARV by wealth quintiles. A benefit 
incidence costing model was also employed to determine monetary benefit of free ARVs 
in Uganda. 
Major findings from this study indicate that 
• Women utilize free ARVs more than their male counterparts 
• Utilization of free ARVs is predominately among the productive age groups in 
Uganda. i.e. age groups 30-39 and 40-49 
• Those who utilize free ARVs have attained a primary or secondary level 
education but the majority of those are unemployed. However, those with 
secondary level education and more have greater access to free AR:Vs in Uganda 
than other educational levels. 
• On average, utilization of free ARVs is skewed mainly to the well off (those from 
the highest quintile) as compared to the rest of the quintiles. This pattern is more 
obvious in Masaka district than it is in Kampala district In Kampala district, 
ARV utilization is skewed to the lowest and highest quintiles while in Masaka, 
utilization of ARVs increases with wealth, with more utilization concentrated in 
the two topmost quintiles (high and highest). 
• The government ART subsidy is pro-rich. It is not well targeted to the poor. 
Indeed the ART subsidy favours the well -off in society and the poor seem to 
benefit only after the non-poor have benefited. 
• Distribution of free ARV use is not well targeted according to need. The 
socioeconomic groups that bear a relatively heavy burden of HIV / AIDS do not 
access the drugs in relation to their need. 
x 
The study therefore concludes that based on vertical equity and the 'maximin' principle 
of social justice, distribution of free ARV is not equitable because it benefits the rich 
more than it does for poor, who are both financially and socially marginalized. Further, 
according to the "priority view" of the egalitarian approach and horizontal equity, 
provision of free ARVs in Uganda is judged unfair because these drugs do not equally 
benefit those in need of them. Therefore it is suggested that policy makers develop 
strategies that are aimed at targeting the ART subsidy to those who are more likely to 
suffer exclusion due to economic, social, geographical or other barriers as well as to 
those with the greatest need of the service. 
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CHAPTER ONE: BACKGROUND TO TIlE SIUDY 
1.0 Overview 
This study attempts to ascertain the socioeconomic status of individuals accessing free 
Antiretroviral drugs (ARVs) as well the socioeconomic correlates of HIV infection in 
Uganda It focuses on establishing whether it is the poor or non-poor that benefit from 
the free ARV programme and whether disbibution of this programme is targeted 
according to need. This evaluation is useful in assessing whether the disbibution of such 
drugs has been equitable since the programme began. The study also seeks to establish 
reasons for any unusual disbibution if any exits. This chapter will offer background 
information as well as an overview of the study. The research question will be defined, 
objectives will be highlighted and the justification of the study will be discussed Finally, 
a brief description of the proceeding chapters will be outlined. 
1.1 Introduction 
Global HIV / AIDS prevalence rates have continued to escalate despite numerous efforts 
to combat the pandemic. Globally, it is estimated that 42 million people are infected with 
HN / AIDS. About 95% of these are in developing counbies of which 70% are in Sub-
Saharan Africa (SSA) (UNAIDS 2(03). Sub-Saharan Africa (SAA) has the highest HIV 
prevalence across the globe. In this region alone, it was estimated that the number of 
people who were HN positive was about 29.4 million in the year 2003 (UNAIDS 2(03). 
Uganda is one of the countries in Sub Saharan Africa that has been hit hardest by the 
HN / AIDS epidemic. In 1992, HIV / AIDS national prevalence rates were as high as 30% 
(UNAIDS 2000), making Uganda the country with the highest HIV / AIDS prevalence 
rates at that time. However, these rates have declined over time due to an open policy 
approach of a prevention intervention. The AIDS epidemic has had devastating social 
and economic effects on Uganda's population. AIDS-related mortality has been high 
such that by 2000 AIDS was the fourth leading cause of death among those under-five in 
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Uganda (UNICEF 20(0). It has also affected adults in their prime years that constitute 
the labour force as well as heads of households and leaders at large. This has had 
definite implications for natural life and development processes of the country. For 
instance, Uganda's health system has been affected in the sense that there is a lot of 
financial pressure in terms of providing health services and diversion of development 
resources into programmes aimed at mitigating the AIDS pandemic (Ministry of Health 
2003). 
1.2 Uganda's socio-economic Indicators 
Uganda is classified as one of the least developed country with a Gross Domestic 
Product (GDp) estimated at about USD $ 6.2 billion in 2003 (Ministry of Finance 2003). 
The GDP per capita is estimated at US$300-330 per annum and the average annual GDP 
growth is projected at 6% over the long term. Uganda's population at the last census was 
estimated at 24.7 million (Uganda Population and Housing Census, Ministry of Health 
2003). The country has the highest population growth rate in the world of 3.5% per 
annum (WHO 1997). More than 80% of the people live in rural areas and predominately 
depend on subsistence farming for a living. According to the Ministry of Finance (2003), 
the majority of Ugandan people live below the poverty line and survive on less than a 
dollar per day. 
The country has high mortality rates. The Infant Mortality Rate (IMR) is about 97 per 
1000 live births, while the Maternal Mortality Rate (MMR) is about 506 Per 100,000 live 
births. Life expectancy has declined from 52 years during the 1990s to 42 years due to 
the HIV / AIDS epidemic (Ministry of Health 2003). Physical access to health facilities is 
still low due to poor infrastructure, insurgency in the Northern part of the country and 
also health care financing mechanisms, which are predominately out of pocket 
payments. Most of the health facilities lack storage facilities, laboratory and clinical 
equipment and are in need of physical rehabilitation. The Ugandan health system also 
lacks both financial and human resource management capacity with no quality 
assurance systems (Ministry of Health 2003). 
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The current health care funding is about US $13 per capita per annum, of which US$ 8 is 
provided out of pocket and US$ 5 by the state (government, faith based mission services 
and donor funding consolidated) (Ministry of Health 2(03). Uganda's health system is 
decentralized to 56 districts. There are two referral hospitals, eleven regional hospitals, a 
number of district hospitals and below that, health center fours (IV). The health centers 
IV are at the sub-district level and are the equivalent of a primary care health clinic 
(Ministry of health 2003). 
1.3 HIV/AIDS and its Impact In Uganda. 
In Uganda, AIDS was first referred to as "SUM" due to its physical wasting 
characteristics. The epidemic began to spread on the shores of lake Victoria in the late 
1970's but the first AIDS case was diagnosed in 1982 (UNAIDS 2000). Around this time 
there was very little knowledge about the disease. Between 1982 and 1986, the AIDS 
epidemic spread quickly attacking a huge mass of Uganda's 'population HIV / AIDS 
was declared an epidemic in the country in 1986 with adult seroprevalence rates 
estimated at 37% (USAID 2(02). By that time Uganda had one of the highest HIV / AIDS 
rates in the world (Dyer 20(4). 
Due to the large impact of HIV / AIDS on the population and the economy of Uganda, 
the country became one of the first African countries to respond aggressively to the 
HIV / AIDS pandemic. The government together with international partners put in place 
strategic management systems, which were aimed mainly at prevention 
In 1986, when the National Resistance Movement (NRM) came into power, president 
Yoweri Kaguta Museveni realized that the AIDS scourge had not only affected a large 
number of civilians but his army too. He took it upon himself to address the problem by 
touring the whole country and telling people to avoid the disease. Museveni's approach 
of intervention against HIV / AIDS was mainly preventative. He taught the public about 
how to avoid catching AIDS and his message mainly emphasized three strategies known 
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as the ABC- the preventative approach that has been adopted by policy makers in 
Uganda. The president told the people that they should abstain from sex before they are 
married (A), Be faithful to one partner (B) and to always use a condom (q. This was the 
first major intervention in Uganda that helped in bringing down the HN / AIDS 
prevalence in the country. National HN / AIDS prevalence rates declined from higher 
than 30% in early 90's to about 8% in the late 90's in the adult age group (Dyer 2(04). 
At the end of 2003, the government and the UN say that only 4.1 % of adults had the 
virus. The country is seen as having implemented a well timed and successful public 
education campaign against indulging in casual sex as well as significantly cutting the 
HN prevalence rate (USAID 2002). 
Despite the tremendous progress achieved in fighting the epidemic, Uganda still 
remained vulnerable to negative impacts of the HN / AIDS pandemic. For instance, 
Uganda's population was estimated at about 21 million in 1999, of which an estimate of 
8.34% was living with HN/ AIDS (UNAIDS 2000). According fo the UNAIDS report, 
HN / AIDS prevalence among young people aged 15-24 years was estimated to be 
6.65%-8.99% for females and 256 - 5.12% for males. The 2000 HN / AIDS surveillance 
report from the Ministry of Health also showed that an estimate of about 1,438,000 
people were living with HN / AIDS by the end of December 1999. Of these 1,294,200 
were adults and 143,800 children aged 12 years and below. In the adult group 761,300 
were female adults while 532,900 were male (Ministry of Health 2000). 
Although. there has been a decline in the HN / AIDS prevalence rates from 8.34% in 
1999 to about 4.1 % by the end of 2003 (USAID 2002), as well as decline in new infections 
(incidence rates), those already living with HIV and progressing to AIDS are still many. 
AIDS is still a major cause of death, currently responsible for 12% of the total annual 
deaths in the country and a leading cause of death among people aged 19-45 years 
(Ministry of Health 2003). According to the UNAIDS epidemiological fact sheet 2002 
update, it is estimated that 230 people in Uganda die daily due to HN / AIDS related 
illnesses (UNAIDS 2003). The Ministry of Health has estimated that there are about 
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120,000 patients in need of ARVs if such high mortality rates are to decline (Ministry of 
Health 2003). 
1.4 The Antiretroviral Therapy (ART) programme in Uganda. 
In order to mitigate the impact of the HIV / AIDS epidemic in Uganda, there was a 
concerted effort to fight the scourge through an antiretroviral therapy programme. The 
UNAIDS / Ministry of Health HIV / AIDS Drug Access Initiative (OAI) was launched as 
a pilot project in Uganda in November 1997 and became operational in June 1998. The 
goal of the initiative was to improve the quality of life of persons living with HIV / AIDS 
by increasing access to HIV / AIDS drugs. 
Uganda was among the first countries to participate in the UNAIDS Access to Drugs 
Initiative. As a pilot country, Uganda benefited from negotiated prices for triple therapy 
with antiretroviral drugs (UNAIDS, 2003). However, this programme had been confined 
to Non- Governmental Organization (NGOs) as well as research arid pilot projects, and 
had not been available to the wider public through the public health system (Ministry of 
Health 2003). Antiretroviral drugs (ARV drugs) from the UNAIDS_ DAI initiative were 
subsidized therefore patients met the cost of their medical care, which included 
consultation fees, laboratory tests, and cost of the drugs, although the latter were at a 
lower than normal cost By the end of 2000, only about 1000 patients could access ART 
from the UNAIDS_DAI initiative programme (Ochola et al2000). 
After this pilot phase, the MOH took over the coordination of the ART programme in 
April 2000. An expansion plan to increase access to ARVs was developed with support 
from WHO, which is referred to as the "National Strategic Framework for expansion of 
HIV / AIDS care 2001/2002 to 2005/2006." The main focus of the new strategy was to 
provide free ARV s to the estimated 120,000 patients in urgent need of them, plus the 
costs of related services (Ministry of Health 2003). Since then, the government with the 
support of international partners has worked tirelessly to ensure that free ARVs are 
provided through the public health system. During Financial Year 2003/2004, 58 health 
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facilities in 20 districts from both public and private sectors were accredited to provide 
antiretroviral drugs. Forty-eight of these facilities are currently providing ART and an 
estimated 23,000 patients are currently accessing ART from the different public outlets 
(Ministry of Health 2004). 
The public sector ART programme was officially launched in June 2004 with drugs for 
treating 2,700 adults that were procured under the World Bank funded Uganda AIDS 
Control Project The drugs were distributed to 26 health facilities, including all the 11 
Regional Referral Hospital (Ministry of Health 2004). 
Some of the projects involved in providing free ARVS include: Medicine San Frontiers 
(MSF), Center for Disease Control and Prevention (CDC) and Uganda Business Coalition 
for HN / AIDS. (Ministry of Health 2000). The Ministry of Health in Uganda also intends 
providing free drugs on a large scale by the year 2005 through the Global Fund to Fight 
AIDS, Tuberculosis and Malaria. Currently, the projects under Ministry of Health 
involved in the provision of free ARVs are Presidential EmergencY Project Fund for 
AIDS Relief in Africa (PEPFAR) and Uganda AIDS control project (UACP) referred to as 
the Multicountry AIDS Programme in Africa (MAP) (Ministry of Health 2003). 
Despite the tremendous efforts to expand provision of free ARVs in Uganda, the 
majority of the people in need of these drugs have not been able to access them. 
1.5 Problem statement 
Officially 120,000 people in Uganda are in need of ARVs. Currently, however only about 
23,000 access the free drugs bought by the government through the Uganda AIDS 
Commissio~ the MAP (Multi-country AIDS programme in Africa) project funded by the 
World Bank, the French governments and from President Bush's grant for AIDS in 
Africa. The Global fund project is expected to procure more drugs and provision will be 
rolled out gradually on a universal basis (Ministry of Health 2003). It is not clear how 
many people access free ARVs from all NGOs consolidated. 
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While provision of free ARV s to those in need is still on a very small scale, the main 
question of who benefits from such an initiative in Uganda is still pending. The ART 
roll- out policy needs to address issues concerning the beneficiaries of the ARV drugs. 
The new health policy is that the government of Uganda provides free ARVs to all its 
population, however, the main problem that arises here is how to measure the benefit 
obtained by users of the service. Secondly, as the government of Uganda and some 
international projects have already started offering free ARVs to those in need, it is 
important to assess who currently benefits from the programme in terms of socio-
economic status, gender, or age group. This is important to evaluate equity of the 
gradual roll-out and to identify obstacles to accessing ARVs for particularly vulnerable 
groups. 
1.5.1: Research Question 
The major question to be answered here is II which groups of people in Uganda benefit 
from free ARV programmes in relation to socio-economic status, gender, age group and 
geographical location; what are the implications of such benefits; and is current 
provision of ARVs equitable?" 
1.5.2 Rationale: 
The purpose of the study is to establish who benefits from free ARV drugs particularly 
in relation to socio-economic status and also to establish reasons underlying any 
unusual distribution of ARVs, if it exists. These issues are important to understand 
because the ARV roll- out policy is increasingly considered as one of most important 
HIV / AIDS programmes aimed at mitigating the HIV / AIDS pandemic in Uganda. If 
access to free ARVs is skewed in favor of certain socio-economic groups, this will have 
implications for the equitable delivery of these services, a concern that policy makers 
should address. 
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1.5.3 Study objectives 
AIM 
The aim of the study is to establish which socio- economic groups benefit the most from 
provision of free ARV drugs in Uganda and to determine the factors that influence the 
distribution of such benefits. 
Specific objectives include: 
• To assess the participant's knowledge and attitude towards ARV drugs. 
• To understand the objectives underlying the provision of free ARVs in Uganda. 
• To establish the criteria considered for eligibility to access free ARV drugs. 
• To identify the type of ARV drugs provided free of charge. 
• To establish, the socio-economic and, demographic characteri$tics of those 
accessing free ARV drugs. ;,;c 
• To compare utilization of the ARV programmes between groups with different 
socio-economic and demographic characteristics such as age, gender, 
occupational history, education and geographical location 
• To compare the socio-economic and demographic characteristics of those 
accessing ARV drugs to those of the HIV positive population as well as those for 
the entire population (Uganda Demographic Health Survey) 
• To explore possible social, economic and supply factors that may be facilitating 
or constraining access for the disadvantaged groups. 
• To estimate the value of benefit derived from ARVs in terms of costs of services 
• To calculate the benefits (average) that accrue to various socio-economic groups. 
• To suggest tools for constant monitoring of the programmes' benefit incidenCe 
• To derive guidelines on how to reach disadvantaged groups more effectively. 
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1.5.4 Justification for the study 
Efforts to expand provision of free ARVs in resource poor settings have greatly 
improved. The WHO 3x5 initiative, increased financing available from the Global Fund 
to fight AIDS, Malaria and Tuberculosis (GFA TM), the Presidential Emergency Plan for 
AIDS Relief (PEPF AR) and national efforts to fight the AIDS scourge through a health 
policy known as the "National Strategic Framework for expansion of HIV / AIDS care 
2001/2002 to 2005/2006" has made it possible for Uganda to provide free access to 
antiretroviral drugs in particular institutions and facilities. Pilot studies have 
demonstrated that highly active antiretroviral therapy (HAAR1) has been feasible and 
effective in reducing the viral load and increasing CD4 counts in limited resource 
settings including Uganda. As a result, occurrence of opportunistic diseases has reduced 
and hospitalization rates have declined, translating into decreased morbidity and 
mortality rates (UNAIDS 2002). However, there is consistent evidence throughout the 
world that people at a socicreconomic disadvantage suffer a heavier burden of illness 
and have higher mortality rates than their better-off counterparts (Macken bach &:: Kunst 
1997). These soci<reconomic inequalities in health are a major challenge for health 
policy, not only because most of these inequalities can be considered unfair, but also 
because a reduction in the burden of health problems in disadvantaged groups offers 
great potential for improving the average health status of the population as a whole. In a 
limited resource setting like Uganda, where not everyone in need of ARVs can access 
them, provision of such services should be guided by equity and human rights 
principles of fair distribution. However, in Uganda, such policy decisions based on 
equity are just beginning to emerge and as a matter of fact no study on benefit incidence 
on subsidized public goods and services has been documented. Therefore, the 
motivation for undertaking this research is to assess which soci<reconomic groups 
benefit from free ARVs in Uganda and to what extent, in order to inform policy makers 
about equitable access in the ARV roll-out programme. This will help in looking for 
strategies to improve the system, not only for ARV programmes but also, for all 
HIV / AIDS related programmes as well other subsidized public goods and services. 
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1.6 Outline of the thesis structure 
Chapter 2: Theoretical and Empirical Literature reviews. The empirical literature review 
provides information on implication of the disease and socioeconomic correlates of 
HN / AIDS in most of the affected African countries. The chapter further goes on to 
discuss strategies that have been adopted to mitigate the pandemic, of which the 
antiretroviral therapy is one. It also looks at different literature on equity concepts and 
definitions, giving clear health equity judgments on which the study will be evaluated. 
The final section examines different approaches to benefit incidence studies of the health 
sector, emphasizing the micro benefit incidence study type. 
Chapter 3: Methodology. This chapter describes study design, sampling strategy, data 
sources and nature, the benefit incidence methodology and the costing methodology. 
Chapter 4: Key findings from quantitative and qualitative research are presented 
Chapter 5: Study results are analyzed and discussed in detail. 
Chapter 6: The final chapter presents the policy implications, recommendations and 
conclusions. 
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CHAYI'ER. 'IWO: LITERATURE REVIEW 
2.0 Overview 
This chapter provides a review of the extent of HIV / AIDS problem, the impact of the 
epidemic on Africa and the socioeconomic correlates of the disease. The chapter goes on 
to consider concepts on Antiretroviral drugs (ARVs) and debates pertaining to 
affordability and sustainability in the context of limited resource settings in Africa. 
Equity concepts as major indicators of benefit incidence are also explored. Finally the 
chapter gives a theoretical review on what benefit incidence is and the studies that have 
been done in this area 
2.1 Introduction 
HIV / AIDS is considered one of the most threatening.diseases in the world today (WHO 
1997). Empirical evidence shows that during 1999, over 5 million people became newly 
infected with HIV-bringing to over 34 million the number of people living with HIV / 
AIDS in the whole of Africa (i.e. Sub-Saharan Africa and North Africa) (WHO 1997). 
Sub-Saharan Africa is one of the regions that has been hit hardest by the HIV / AIDS 
epidemic. In this region alone, about 29.4 million people are estimated to be living with 
HIV and in 2004, apprOximately about 3.1 million new infections were anticipated to 
occur in the same region (USAID 20(4). 
In many countries of Sub-Saharan Africa, HIV / AIDS is impeding efforts to extend life 
expectancy. It is argued that millions of adults in this region are dying young or in early 
middle age. Average life expectancy in Sub-Saharan Africa is now 47 years, when it 
could have been 62 without the AIDS pandemic (Avert 20(4). 
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HIV / AIDS epidemic has claimed almost 19 million lives over the past two decades 
including 4 million children. The epidemic is one of the major contributing factors to 
orphaned children because studies indicate that HN / AIDS has left over 13 million 
children orphaned in its wake (WHO 1997). 
The disease is today having a major impact on social and economic development not 
only in health but also in education, agriculture, transport, industry, human resources 
and the economy in general. 
AIDS is different from other diseases because it strikes people in the most productive 
age. Studies have revealed that a high proportion of people living with HIV / AIDS in 
Africa are in the 19 - 49 year age group, i.e. their prime working lives (World Bank 
2002). 
In specific terms, Stover and Bollinger (1999) argue that HIV / AIDS has severe economic 
iIi:\pacts on agriculture, finils and households. The tWo major economic effectS are a 
reduction in the labour supply and increased costs. 
2.2 Economic Impact of AIDS on Agriculture 
Agriculture is the largest sector in most African economies responsible for a big 
percentage of production and employment (Stover and Bollinger 1999). Studies done in 
Tanzania and other African countries have revealed that AIDS will have adverse effects 
on agriculture, including loss of labor supply and remittance income. The loss of a few 
workers at crucial stages of planting and harvesting can significantly reduce the size of 
harvest and in countries where food security is a continuous issue due to drought, any 
declines in food production will have adverse consequences for households. In addition, 
a loss of agricultural labor is likely to cause farmers to switch to less labor-intensive 
crops. In many instances, this will mean switching from export crops to food crops. Thus 
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AIDS could affect the production of cash crops as well as food crops (llinigumugabo 
1996). 
In Gwanda, a village in the Rakai district in Uganda, the FAO found that many 
previously cultivated areas were lying fallow due to labour shortages. Furthermore, 
within four years, the crops cultivated had changed entirely from coffee and bananas, 
two profitable crops, to cassava and sweet potato, which are subsistence crops. This 
switch was due to labor shortages as well. In addition, households had also switched 
from cattle raising to pig raising which is less labor-intensive (FAO 1997). Data collected 
in Uganda also indicate that agricultural tasks were frequently disrupted when women 
needed to care for household members ill with AIDS-related conditions (Taylor, Seeley 
and Kajura 1996). 
Loss of labour in the agriculture sector not only erodes the livelihood of small-scale and 
subsistence farmers, it also has serious consequences for Uganda's economy since the 
agiicultural sector accounts for 43 percent of GDP, 85 percent of export earnings imd 80 
percent of employment (UAC 20(4). In addition, 85 percent of the total population of 
Uganda live in rural areas and depend mainly on agriculture for livelihood (Asingwire 
2001) 
2.3 Economic Impact of AIDS on Firms 
Stover and Bollinger (1999) argue that AIDS may have a significant impact on firms, in 
the sense that AIDS-related illnesses and deaths to employees affect a firm by increasing 
expenditures and reducing revenues. Expenditures are increased for health care costs, 
burial fees and training and recruitment of replacement employees. Revenues may be 
decreased because of absenteeism due to illness, caregiver duties or attendance at 
funerals and time spent on training. Moreover labor turnover can lead to a less 
experienced labor force that is less productive. 
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The loss of professionals as well as managerial expertise and experienced workers due 
to HIV / AIDS has had a significant impact on businesses in Uganda. For instance, in one 
banking institution in Kampala, five senior staff died from AIDS in one year, and 
between 1989-93, out of 250 government officials sent abroad for further studies, 12 died. 
At least ten of these deaths were reported to have been AIDS-related (Nabalonzi, 
Kaddumukasa and Mulumba 1995). The Uganda Railway Corporation has been hard hit 
by AIDS among its employees, experiencing a labor turnover rate of 15 percent per year 
in recent years (Southern African Economist 1997). This represents a substantial loss of 
investment in human capital by the government 
2.4 Economic Impact of AIDS on Households. 
The household level impacts begin as soon as a member of the household starts to suffer 
from HIV-related illnesses. This results in loss of income particularly if the patient is the 
main breadwinner. Household expenditure substantially increases due to medical bills. 
There are also indirect costs due to time off work or absenteeism in school especially as 
women or daughters stay home to care for the sick. Death also results in permanent loss 
of income. This can contribute to a household declining into poverty because as savings 
go into funeral and mourning expenses. For instance, studies in Tanzania, Cote d'Ivoire, 
Uganda and Ethiopia have documented the tremendous burden of loss of income, large 
health care expenditures and consumption of savings to pay for funeral and mourning 
costs (Over 1992). 
Permanent loss of income usually forces households to take children out of school to 
save on educational expenses. This perpetuates household labor, resulting in a severe 
loss of future earning potential. Studies in Tanzania by Over and Ainsworth (1996) and 
in Uganda by Topouzis (1994) reveal that increased expenditures and reductions in 
income led to withdrawal of children from school in order to reduce education-related 
expenditures and to have children help with household chores. 
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The effects of HIV / AIDS on households in Uganda have been severe. Financial costs of 
caring for patients with HIV / AIDS are enormous, relative to the household's total 
income. One study revealed that households in Rakai district, spent one third of their 
total annual income on medical care for one month or for one funeral in 1996 (UNAIDS 
1996). Another survey found that burial expenses and expenditures on treatment for 
terminal AIDS patients were greater than average monthly income, causing many 
households to sell property in order to pay for these costs (Konde etal1996). 
Women in informal sector business are unable to continue with their trading activities 
because of caregiver responsibilities. In some instances, businesses have collapsed due 
to the needs of the AIDS patients (!LO EAMA T 1995). 
2.4.1 Coping with HIV and AIDS 
From the above section, it is clear that individuals, families and communities are 
impoverished by their experience of HIV and AIDS. There is thus enormous strain on 
the capacity of families to cope with psycho-social and economic consequences of AIDS 
related illnesses. The magnitude of the HIV impact depends on the capacity to cope with 
the effects of the disease. Poor families have reduced capacity to deal with the effects of 
morbidity and mortality than do richer ones for very obvious reasons. The poor lack 
savings and other assets, which cushion the impact of illnesses and death as compared 
to their rich counterparts. As Cohen (1996) argues the poor are already on the margins of 
survival and thus unable to deal with consequent health and other costs. In fact many 
poor families never recover to their initial standard of living, especially when productive 
household members fall sick or die and when assets once possessed are sold to meet 
health related expenses and funeral costs. 
Policy makers should thus understand the relationship between poverty and HIV 
infection in order to put in place programmes that assist the poor to cope with the AIDS 
epidemic. 
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2. 5 Socio economic correlates of HIVIAIDS 
Studies in industrialized countries have revealed that poverty and illiteracy raise the 
probability of HIV infection. This is due to the fact that people with low income and 
little education are less able to afford condoms and may also have less access to 
information about dangers of high-risk behaviour (Cowan etall994; Krueger etall990; 
McCoy et.al 1996) However, at least in the first decade of the HIV / AIDS epidemic in 
Africa, HIV infection did not follow this pattern (Ainsworth and Semali 1998). 
Many studies that have analysed the socioeconomic correlates of HIV infection in the 
general population of many developing countries tend to support the hypothesis that 
HIV infection tends to be associated with higher socioeconomic status for both men and 
women. (Barongo etal1992; Gross Kurth etall995; Serwadda et.all992; Menon etal 
1998). For instance, a study of urban areas of Butare, Rwanda, found that HIV incidence 
is lower among women in low-income households (Burtely et all994). This argument is 
reinforced by results from the DHS of early 1990s and surveys of sexual behaviour 
which revealed that the probability of having a non regular sexual partner (or 
commercial partner) rises with education, potentially raising their exposure to 
contracting STDs, including HIV (Filmer 1998; Deheneffe et.all998). Further, men and 
women with more education are probably more likely to travel and thus have more 
opportunities for casual sexual contacts (Ainsworth and Semali 1998). Although none of 
the surveys measured income, it is reasonable to expect that demand for commercial sex 
and/ or the ability to support multiple partners would rise with income. 
The probable explanation to the above arguments is that, early in the HIV epidemic, it 
was not known how HIV was spread. The knowledge of and access to means of 
prevention such as condoms was low. Thus a disproportionate share of people infected 
early in the epidemic had higher education and income. Since HIV has a long 
asymptomatic period and cannot be cured, current patterns of infection are likely to 
reflect the correlates of new infections in the past (Ainsworth and Semali 1998). 
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However, as HIV / AIDS becomes an endemic disease in many African countries, the 
positive relationship between economic status and HIV infection may disappear. 1bis 
will mean that the more educated may have greater access to information on how HIV is 
spread and may be able to act on this information. The DHS and WHO/ GPA data show 
for example that in virtually every country studied, those with more education are more 
likely to use a condom in casual and commercial sex (Filmer 1998; Deheneffe etal1998). 
Limited evidence on the characteristics of those with new HIV infection (incidence) 
indicate that a shift in the pattern of infection to those with lower socioeconomic status 
is already under way in some countries (Ainsworth and Semali 1998). Consistent to this 
argument is personal communication from Uganda AIDS Commission public relations 
officer who said that "HIV infection was associated with higher socioeconomic group at 
the start of the epidemic. Today HIV infection has cut across all socioeconomic groups" 
(Mr. James Kigozi, UAC 2(05). 1bis pattern is confirmed by the experience of Brazil, 
where there has been a shift in the socioeconomic distribution of AIDS cases. In the early 
1980's, three quarters of those newly diagnosed with AIDS had a secondary or 
university education; by early 19908 this share had fallen to a th:ifd (parker 1996). 
Thus, there is not clear evidence on the distribution of HlV / AIDS across socioeconomic 
groups at present However, the evidence suggests that it may be more evenly 
distributed now than the initial concentration among higher income groups. In view of 
this, provision of antiretroviral therapy should be guided by fair distribution especially 
in a limited-resource country like Uganda 
2.6 What is HIV antiretroviral drug treatment? 
Antiretroviral drugs (ARVs) have been defined as the main treatment but are not a cure, 
for HIV / AIDS. ARVs have the capacity to suppress the virus in the body, hence 
preventing its reproduction. ARVs therefore reduce the rate of occurrence of 
opportunistic infections thereby enabling people to live longer. The treatment consists of 
drugs that have to be taken every day for the rest of someone's life (Avert 2004). 
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The World Health Organization (WHO) recommends that a particular combination of 
drugs be provided for everyone to take when they start treatment. This is sometimes 
called the " first line regimen". These include four possible combinations listed below. 
d4T+3TC+NVP 
ZDV+3TC+NVP 
d4T+ 3TC+ EFZ 
ZDV+3TC+EFZ 
The alternative names for the components in the drug combinations listed above are : 
d4T - Stavudine, 
NVP- Nevirapine, 
ZDV - Zidovudine or AZf, 
3TC- Lamivudine 
EFZ - Efavirenz 
If treatment failure has occurred then WHO recommends that the entire drug 
combination is changed from first to a second line regimen. WHO recommends 
switching from first line regimens to second line regimens as follows: 
Failure on: Change to: 
d4t or ZDV+ TDF or ABC 
3TC+ ddI 
NVP or EFV LPV or SQV 
The alternative names for the drug components listed above are: 
TDF- Tenofovir LPV - Lopinavir 
SQV- Saquinavir 
ABC - Abacavir 
ddI - Didanosine 
WHO recommends that if one needs to change from second line, they should then be 
referred to a specialist physician for individualized care (WHO 2000). 
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2.6.1 Key Issues on ARVs and their Impact 
The prospects for expanded access to antiretroviral therapy (AR1) in resource-poor 
settings have greatly improved as a result of global and national efforts to reduce the 
cost of antiretroviral (ARV) drugs, growing availability of cheaper generics, and 
increased financing available from the Global Fund to Fight AIDS, Tuberculosis and 
Malaria (GF A TM), private foundations, corporate initiatives, government budgetary 
resources, and multilateral and bilateral donors. In addition, there is the prospect of 
additional financing for ARVs through the US Millennium Challenge Account 
The increase in the affordability of, and financing for, ARVs has resulted in a rapid 
expansion of programmes providing ARVs and of countries planning to introduce or 
scale-up access to ART (Picazo 2003). Whilst global organizations, such as World Health 
organization (WHO) and the International Human Immunodeficiency Virus (HIV) 
Treatment Access Coalition are supporting country efforts to increase access to 
treatment through a series of regional consultations exploring opportunities for scale-up 
and lessons learned from pilot initiatives (Kapp 2002), there is a lack of clear evidence-
based information to guide policy makers and planners in resource-poor countries. 
Pilot studies have demonstrated the clinical feasibility and effectiveness of highly active 
antiretroviral therapy (HAAR1) in a range of resource-poor settings, including 
Cameroon, Cote d'lvoire, India, Kenya, Malawi, Senegal, South Africa and Uganda 
(Attawell and Mundy 2003). These pilots have achieved positive outcomes for patients 
that compare with those found in patients in rich countries, in terms of decrease in viral 
load, increase in CD4 cell count, decrease in morbidity associated with opportunistic 
infections (Ols), and similar rates of side effects, thus prolonging lives. Patients have 
demonstrated good adherence, and there is limited evidence of the development of 
resistance (Attawell and Mundy 2003). Mascoloni (2002), in an article summarizing 
findings presented at the Barcelona Conference, identified factors contributing to 
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effectiveness as careful preparation and counseling of patients prior to starting 
treatment, training family members to support patients, local government and 
community support, and recovery from AIDS illnesses, which strengthens patient 
commitment (Mascoloni 2002). 
2.6.2 Health Systems and other Impacts of ARY programmes 
Universal provision of ART in Brazil has had a positive impact on health service 
expenditure. An estimated 358,000 hospital admissions were avoided between 1996 and 
2002, saving $2.2 billion (Attawe11 and Mundy 2003). Private sector companies, such as 
the Electricity Company of Cote d'Ivoire (OE), have reported both health benefits and 
cost savings as a result of providing ART to employees. In the 2 years following the 
introduction of comprehensive HIV / AIDS care with ART there was a five-fold increase 
in company based voluntary counseling and testing (VCI), 94 percent decrease in 
absenteeism, 81 percent decrease in HIV-related hospitalizations, 78 percent decrease in 
new AIDS cases, and a 58 percent decrease in HIV-related mortality. During this period, 
the company saved $287,000 from reduced absenteeism, $294,000 in health care costs 
and $194,000 in funeral costs (Eholie 2002; Eholie et al 2002). Evidence is also emerging 
of the positive social and economic impact of ART on households and communities. 
2.7 Equity and priority target groups 
Scale-up of ART programmes should be informed by equity issues. Policy decisions 
around equity are just starting to emerge in countries currently planning for scale-up. 
When not all persons in need of HIV treatment can be served, distribution of HIV 
treatment services should be guided by principles of equity or fair distribution and 
consideration of human rights, including the right of everyone to the enjoyment of the 
highest standard of physical and mental health (Universal declaration of human rights; 
Article 25). Ideally the WHO principle of reaching 3 billion people by the end of 2005 
(3x5 initiative) would provide free ARVs to all in need through public health care 
institutions. This would ensure that not only will the poor not be excluded from scaling 
20 
up of ART but also priority will be given to the large numbers of people in developing 
countries for whom existing health care services have not been affordable and who 
would continue to be excluded if they were to pay for ART treabnent (Macklin 20(4). 
Consideration needs to be given to coverage of the poor, of different geographical areas, 
of rural versus urban populations, and of specific population groups (Attawe11 and 
Mundy 2003). More attention also needs to be paid to gender, to ensure that clinical or 
socio-economic criteria do not for example disproportionately exclude women with HN 
who are not pregnant from accessing treatment. In addition, WHO has expressed 
concerns at the exclusion of children from many ARV access programmes (WHO 1997). 
Socio-economic criteria for determining which patients receive free or subsidized ARVs 
need to be carefully defined, to ensure equitable access. Even at subsidized cost, 
treabnent may not be affordable for the poorest Experience outside of large-scale 
national programmes indicates that the poor are the least likely to access ART (Attawe11 
and Mundy 20(3)~ For example, in the Ortig Access Initiative (DAI) in Cote d'lvoire, 
despite efforts to ensure equitable access, poorer people were less likely to access 
treabnent than those who were better off (Attawell and Mundy 2003). 
The design of a fair system for ARV distribution might be very difficult to define but the 
underlying assumption is that, every country and community should ensure that high 
priority to access free or subsidized ART is given to lowest socioeconomic classes and 
the poorest individuals, in conjunction with other eligibility criteria for treabnent. This is 
because these groups of people are disadvantaged both in terms of health status and 
socio-economic status and they are also least able to pay for ARVs and other health 
services. This idea is in accordance with the guiding principle of equity as stipulated in 
the 3x5 initiative: 1/ The initiative will make special efforts to ensure access to 
antiretroviral therapy for people who risk exclusion because of economic, social, 
geographical or other barriers" (WHOjUNAIDS 2005 pg 10) 
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2.7.1 Equity concepts and definitions 
Equity is a broad concept that captures the notion of fairness. It is also related in some 
way to the idea of a fair distribution of something or the other across different 
individuals and/or groups in society (Mooney 1983). The two concepts that need to be 
distinguished and clearly clarified are II equity and equality". It is important to note 
therefore that II equity and equality" are not always interchangeable. The dictionary 
definitions of both terms are: equity is "a system of justice based on conscience and 
fairness" while equality is " the state of being equal" (Longman New Universal 
Dictionary 1982). Equality is, thus, a particular interpretation of equity. It is concerned 
only with equal shares. Donaldson and Gerald (1993), argue that equity, however, is 
about fairness, and it may be judged fair to be unequal in some instances. For example, 
in health care it may be judged equitable to have unequal access to services in a sense 
that groups who are more likely to be ill should perhaps be given greater access. Thus, 
equity can only be achieved if resources are allocated in a fair/just way within each 
society (Wagstaff and Van Doorslaer 1993). However, it should be noted that fairness is 
a value judgment issue. This therefore implies that an equity goal adopted in one health 
system may not necessarily be the same in another health system. 
Another question that is posed here is whether equity sets out to achieve fair health or 
fair health care. Realistically, equality of health is not viable considering the fact that 
there are so many factors that influence health. For example genetically inherited 
conditions, natural deterioration in health over time, age, gender and the ability to 
ensure that individuals adhere to principles of II good health". These factors make it 
impossible to have equal health for all. Moreover it is not known exactly what is meant 
by "good health". Donaldson & Gerald (1993) argue that attempting to achieve good 
health may be seen as elitist in the sense that informed individuals are prevented from 
choosing their own level of health which may be somewhere below II good health". For 
example a person may choose not to give up smoking. Such a goal would necessarily 
impose a level of quality of life on a community. The objective for equity should be 
provision of opportunity, which is about health care rather than health itself. 
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Equity in health care can be evaluated in two dimensions: Horizontal equity and Vertical 
equity. Horizontal equity is concerned with equal treatment of equals. Following the 
explanations of Mooney (1983), equal treatment for equals is about equal treatment for 
equal need. This term would therefore imply that those with similar health conditions 
get the same treatment in all aspects. 
In terms of ART treatment this could mean that those patients with a CD4 below a 
certain threshold be given the same equal opportunity to access similar health care. This 
can be evaluated in terms of equal expenditure for equal need; such as equal nurse cost 
per patient or equity can be evaluated according to equal utilization for equal need. For 
example this may require that individuals living in different geographical areas of the 
country receive the same treatment regimes for the ART programmes and also use the 
same services equally. Horizontal equity can also be evaluated according to equal access 
for equal need. In terms of ART programmes, this would provide individuals an 
opportunity to use needed health services in a fair way. For example equal'waiting time 
for distribution of ARVs to patients with a particular CD4 count (Donaldson & Gerald 
1993). 
Vertical equity is defined as unequal treatment for unequals (Mooney 1983). Vertical 
equity can be evaluated as unequal treatment for unequal need. In terms of HN / AIDS 
this principle would mean that patients who are in stage 1 of their disease would not be 
given the same measure of treatment and care as those ones in stage 4 of AIDS disease as 
long as they have different symptoms of the disease. The second concept of vertical 
equity is based on progressive financing according to ability to pay. H ART was funded 
by the government through taxation, this would imply that the rich pay a high 
proportion of their income in order to cross-subsidize the poor. This would enable the 
government to buy the ARV drugs and provide them free to the poor through public 
funded institutions. Vertical equity also implies taking additional measures to promote 
use by the worst off. For instance if two individuals both in stage 4 of HN / AIDS 
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presented themselves for treatment, priority to access free ARVs should be based on the 
severity of the condition as well as ability to pay issues. 
Equity requires that II equals be treated equally and unequals be treated unequally". 
Barry (1990) identifies two fundamental types of judgments to identify what is equitable. 
The first is to identify existing standards of distribution, which define in what ways 
people should be viewed as equals or unequals, and then analyze whether these 
standards are applied consistently. The second encompasses the development of 
standards where none exist Addressing the first scenario, if for example the standard is 
universal provision of ARVs to all people with CD4 below 200, then inequity exists if 
certain groups with that criteria are not receiving the drugs. Similarly, standards for 
equity may involve identifying a minimum or basic level of health attainment, for 
example, all regions of a country achieve a life expectancy at birth of at least 65 years. 
Equity is achieved if all regions get to this minimum. 
Often, however, there are no clear standards agaillst which to assess eqUity. In most 
comparisons of social groups ( rural Vs urban" men Vs women, rich Vs poor ) there may 
not be an obvious criterion for when and how people count as equal and what 
inequalities are appropriate and/or required. The standards themselves need to be 
developed first For example in comparing men and women, one may question how to 
weigh the fact that women often tend to have longer life expectancy but higher 
morbidity. Furthermore, even if standards exit, one may still argue that the norms of 
health that were developed for men do not apply to women (Evans etal2001) . In the 
assessment of health equity of this second type, broader considerations of social justice 
and of the social good have to be taken into account so that the judgments of equity 
become interlinked with judgments of social justice and fairness. 
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2.7.2 Equity principles for fair distribution of ART 
As indicated previously, one of the guiding principles of the 3x5 initiative is equity 
(WHO/UNAIDS 2005). Several general ethical principles in addition to specific equity 
principles can potentially guide decisions in choosing one or another scheme for fair 
access to ART. However, these principles can conflict, therefore there is concern to 
balance competing issues to ensure that a fair decision is reached. For these reasons, 
leading commentators have urged that emphasis be placed on fair processes (Daniels 
and Sabin 2002). To the extent that decision makers in each country can agree on 
principled ways to set priorities among the various individuals and groups eligible for 
ART, the following principles of social justice can be used to justify their decisions. 
2.7.2.1 Utilitarian ethical principle 
.The utilitarian principle. calls for maximizing overall societal benefits.. Applied 
specifically to health policy, the utilitarian principle aims at maximizing the overall 
health benefits of the society as a whole. This will therefore embrace a mix of health 
services that produces the greatest overall health effects (Mill 1863). The philosophical 
doctrine of utilitarianism states that we should maximize the sum of individual well 
being. Under the assumption that everybody'S capacity to achieve health is equal, 
maximizing population health entails bringing everybody up to the highest possible 
level of health. Although the utilitarian principle has been understood to embrace 
considerations of justice, it does not provide a basis for choosing among the eligible 
groups in the most equitable manner. A common critique of utilitarianism is its inability 
to address issues of distributive justice (McGuire, Henderson & Mooney 1988). 
Utilitarianism is much more related to efficiency as opposed to equity. Efficiency deals 
with the optimum allocation of resources so as to maximize utility, while equity is about 
a fair distribution of resources and not necessarily maximization of utility. For instance, 
in the context of scaling up ART, a utilitarian approach could call for treating those 
patients where health improvement/ benefits would be maximized. This notion can 
therefore be more widely accepted and interpreted as giving priority to people whose 
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medical condition is such that they respond better to treatment and have greater chances 
to survive and live longest. Adhering to this interpretation would mean excluding 
patients who have advanced stage of HN disease and whose benefit from ART 
treatment would only be minimal. This is the best example of "fair chances versus best 
outcome" problem (Brock 2(02). Yet many people would argue that equity requires 
giving a fair chance of treatment to everyone regardless of the overall health outcome. 
Although the utilitarian principle of equity is widely accepted in the public health 
literature, there are disagreements and uncertainties that need to be addressed. Such 
controversies could have implications for policy issues. For instance, one may question 
what benefits are to be considered? Is it only the medical benefits to the individual or 
other benefits as well? For example, treating health care personnel and teachers has the 
additional benefit of ensuring that needed personnel are available to administer 
treatment and health promotion and this would have additional health benefits to the 
society as a whole. Similarly treating factory workers rather than the children or the 
unemployed would have economic benefits to the country, which would in turn De used 
to increase treatment access (Macklin 2004). However, giving priority to the more 
productive members of society would perpetuate exclusion of those individuals in 
society who have lacked access to health care - a principle that would contradict the 
guiding principle of equity in the 3x5 initiative. According to ethical principles, social 
worth measured in terms of financial wealth should not be an acceptable criterion in 
giving priority to individuals or groups; instead if certain groups are to be given priority 
of treatment, it should be based on the anticipated secondary health or social health 
goods that are produced, and not the inherent worth of the chosen groups (UN 2002). 
Implications of the utilitarian principle of equity could be that exclusive use of this 
principle could result in ignoring specific claims for priority of access on the part of 
vulnerable or marginalized groups (Macklin 2004). 
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2.7.2.2 Egalitarian principle of equity 
Egalitarian theories take different forms of interpretations depending on what 
egalitarian is perceived to entail. Some egalitarian theories emphasize equality of 
outcomes, which in the context of health would translate into equality of health status 
(Evans etal200l). An application to this interpretation would be to argue that it is more 
just if everyone in a population has a life expectancy of 60 years rather than having an 
average life expectancy of 70 years but when half the population can only expect to live 
to 50 years while the others half can expect to live to 90 years. Veatch (1991) argues that 
egalitarianism. in the context of health requires that persons be given an opportunity to 
have equal health status. Thus he stresses the equality of opportunities, which entail 
equal access to health care. Dworkin (1993) yet argues that justice in health requires 
equality of health care resources. This would call for distributing resources equally 
among persons or distributing goods, such as health care services, equally among 
different groups. The principle underlying this theory'is one that emphasizes health 
equity over health maximization. 
Within this approach, there are also disagreements and controversial issues. For instance 
one may ask, what should be equalized? Resources for health, health care or access to 
health services. This theory would apply only if people had the same health needs. In 
reality however, giving everyone the same resources will produce different health 
outcomes because health needs vary. This may thus result in inequitable provision of 
health services. For example, groups that have TB or malaria in addition to HN / AIDS 
have greater health needs than people living with HN / AIDS (PLWHAs) without other 
diseases. 
Aiming at equalizing health care would potentially divert resources to interventions that 
produce very small benefits for people who require enormous resources to obtain any 
benefit at all (Macklin 2004). 
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Partii (1997) also criticizes egalitarian theories described above, arguing that it is 
misleading to treat equality as in itself valuable. He stresses the fact that.. it is need that 
matters most and not equality, thus this view termed as "priority view" constitutes a 
third approach to egalitarianism. This requires that health benefits be allocated 
according to need. Put another way, such an approach emphasizes those with the 
poorest health who have enormous need for health care. This view corresponds with 
arguments being put forward by the World Health Organization for an inter- individual 
assessment of health distribution that is independent of social groups (Gakidou etal 
2000). 
Since the "priority view" emphasizes those with the poorest health and not necessarily 
the health status of the poorest, it may have more relevance within the health care 
system than a broader" society and health" perspective but considered exclusively, it 
does not clearly spell out which groups of people should have priority over the others. 
This is because everyone who needs ARVs should have equal access to them but they 
should not have priority over those with the same medical needs. Additional 
considerations are needed to make the case for determining priority of access. 
2.7.2.3 The Maximin principle (concern for the worst off or the least advantaged) 
This theory calls for giving preference to those who are worst off in some sense 
(Marchand, Wilker and Landesman 1998). However this principle is open to debate as 
far as the term "worst off" is conceptualized. In the context of health care delivery, this is 
usually understood to refer to those who are worst off in terms of health status, but it 
could also apply to a) the poorest in terms of income and consumption; b) the lowest 
socioeconomic class in terms of wealth or asset possessions; c) the most vulnerable (for 
example, children especially orphans); d) groups that are marginalized or most 
discriminated against or e) those who live in remote areas with poor access to any type 
of health services or t) even the sickest (Macklin 20(4). In general terms, highest priority 
should be given to the least economically advantaged individuals and groups because 
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they are more likely to have poor health status and yet they are the same group of 
people who cannot afford access to health care services. 
Under one interpretation, one can consider the least advantaged to be those who are the 
sickest, irrespective of how much they would benefit from the ART. This would mean 
that if people in their clinically advanced stage can benefit from ART, they should be 
given priority. The disadvantage with this interpretation would be to divert resources 
from those patients who could potentially benefit more from the treatment. This would 
thus conflict with the health maximization principle of utilitarianism. 
Under another interpretation, concern for the "worst off" could mean giving priority to 
those most in need, where need is understood as how badly off people would be if not 
treated (urgent need). According to this view, priority should be given to those patients 
who are in urgent need of ART. This has the disadvantage of treating comparatively 
fewer patients who may even be the better off in financial terms in the society. 
As seen from the above theories, it is now clear that a health care eqUity goal adopted. by 
a particular health care system is dependent on an ideology. It is highly unlikely to find 
only one theory of social justice prevailing in one particular health care system in a 
particular country. 
It is not clear which ethical and equity principles govern the distnbution of free ARVs in 
Uganda, however the health minister in Uganda was quoted as saying that priority of 
the first batch of medicines would be given to the poor as well as some civil servants 
lhttp://allafrica.com/stories/200405170504.html). Such a statement however, does not 
give a clear indication of whether access to free ARVs is equitable or not. The gap to 
assess who benefits from such services still remains and the question posed here is: Do 
the poor benefit more or less than the non-poor from provision of free ARV drugs in 
Uganda? 
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2.8 An overview of equity in practice 
In practice, equity takes two forms; namely equity in financing and equity in the 
delivery of health services (Wagstaff and Doorslaer 1993). According to Wagstaff and 
Van Doorslaer (1993), financing of health care should be a function of the ability to pay 
i.e. vertical equity; and that persons of families of the same ability to pay, should make 
the same contributions i.e. horizontal equity. 
Equity in health service provision can be evaluated on a geographic and socioeconomic 
basis. Equity on a geographic basis implies that people with equal capacity to benefit 
from health care should receive equal treatment despite personal characteristics such as 
their place of residence that are not related to capacity to benefit, and equity on a 
socioeconomic basis implies that citizens from different socioeconomic status when ill, 
should receive the same treatment regardless of their influence in society or access to 
resources (Wagstaff and Doorslaer 1993). 
2.8.1 Basis for equity evaluation In the study 
This study will examine equity in terms of delivery of ARV drugs and equity in 
financing will be left out because the study is concerned with distribution of free ARVs, 
therefore ability to pay may not necessarily be applicable to this kind of study. In terms 
of health service delivery, the study will focus on evaluating equity on a geographical 
and socioeconomic basis. 
Equity in the delivery of free ARV will be evaluated in terms of vertical and horizontal 
equity. Evaluation of vertical equity will require that persons with unequal need be 
treated in an appropriately dissimilar way. For example it could be judged to be fair if 
groups which are more socio-economically vulnerable and have ill health to have 
greater access than their counter parts. Evaluation of horizontal equity will be based on 
the notion that persons with equal need be treated equally. Equal need will be evaluated 
against a standard measure for eligibility of free ARVs. Horizontal equity will be 
evaluated according to equal utilization for equal need. Equal expenditure for equal 
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need, equal access for equal need and equality of health will be left out as they require 
that medical practice and compliance be standardized, a situation which may not be 
viable (Donaldson and Gerald 1993). They also involve a lot of data and value 
judgments. 
Considering the principles of social justice given above, my evaluation of health equity 
will be based on theories that emphasize distributive considerations independently of 
aggregate population health. In this case, the utilitarianism approach will be left out as it 
ignores distributional aspects and instead focuses on efficiency aspects. As much as 
other theories should not be used exclusively in making clear judgments about health 
equity, in my view, they are better suited and they could have more relevance in 
informing health policy about equity than the utilitarianism, particularly, the /I priority 
view" of egalitarianism and the maximin principle of social justice. This is because both 
theories are concerned with equity as opposed to efficiency. They also lay a firm 
foundation based on fairness that one can use to make sound judgments about 
distribution of a commodity or service. The main challenge is ~, how can one ascertain 
the extent to which the existing allocation of free ARVs in Uganda is reaching the poor 
and the most disadvantaged?" Benefit incidence is a tool that addresses this question. 
2.9 Benefit incidence: What it is and why it is important 
Benefit Incidence analysis has been defined as analysis that estimates the impact of 
public transfers, taxes, subsidies, or policy changes that affect prices (World Bank 2004). 
Benefit Incidence Analysis (BIA) measures the distributional incidence of benefits for 
different groups of interest, for instance households at different income levels or in 
different geographical locations. BIA can measure average/ aggregate benefit or 
marginal benefit-the incidence of the last (or next) unit of benefit (World Bank 2004). It 
brings together elements of the supply of and demand for public services and can 
provide valuable information on inefficiencies and inequities in government allocation 
of resources for social services and on the public utilization of these services. 
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Benefit incidence analysis is most commonly used to examine the impact of public 
expenditures and public expenditure reforms. It is also applicable to other policy 
reforms, including reforms affecting prices that change household income or 
expenditure and tax reforms. BIA studies can be applied to direct transfers as well as to 
transfers obtained by subsidized goods or services (World Bank 2(04). 
Three kinds of information are needed for the calculation of the incidence of government 
spending on the service it provides: Government spending on a service, public 
utilization of the service and the socioeconomic characteristics of the population using 
the service (Davoodi, Tiongson & Asawanuchit 20(3). 
BIA involves a five-step process methodology and these are: 
1.0btain the average unit cost of providing a public service by dividing government 
spending on the service by the total number of users of the service. 
2. Define the average benefit from government spending on a service as the average unit 
cost of providing the service. 
3. Rank the population of users from the poorest to richest using a welfare measure and 
aggregate them into groups with equal number of potential users. 
4.Derive the distribution of benefits by multiplying the average benefit by the number of 
users of the service in each income or consumption group. 
S.Compare the resulting distribution of benefits with a number of benchmark 
distributions. 
Benefit Incidence is important because it tells us who benefits from services, transfers or 
price changes. BIA tells us who is benefiting from public services, and it also describes 
the welfare impact on different groups of people or individual households of 
government spending. This is done by combining information about the unit costs of 
providing those services (usually obtained from government or service provider data) 
with information on the use of these services (usually obtained from the households 
themselves through a sample survey) (Demery 2000). 
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While BIA is widely used and very useful in evaluating public subsidies, it suffers from 
a number of limitations. Firstly, a BIA has a weak conceptual framework, due to the fact 
that it represents an "equilibrium" outcome of government and household decisions 
(Davoodi, Tiongson & Asawanuchit 2003). Put differently, BIA does not specify a model 
underlying the behavior of either government or households. BIA studies do not give 
specific reasons as to whether an inequitable health system is due to government's 
failure to distribute health services in an equitable manner or whether it is due to the 
public's negative response to health services. By contrast, studies of demand functions 
for public services (especially micro studies such as one by Thiede, Palmer & Mbatsha 
2(02) address this shortcOming. However, these studies are rare and methods used to 
obtain information on barriers to access are not one of the usual components for BIA. 
Secondly, BIA uses the cost of providing public services as a measure of the value 
attributed to such services. BIA thus makes an assumption that the costs of provision are 
a good approximation of the benefit that users attach to government services. As usually 
implemented, BIA does not cover the entire cost of providing public services. For 
example it does not cover tax adminiStration including pecuniaiy and nonpecuniary 
costs (Davoodi, Tiongson & Asawanuchit 2(03). Thirdly, BIA captures at best benefit 
incidence of government spending at a point in time. To get a dynamic picture, BIA has 
to be conducted for different years. Lastly, estimates of benefit incidence often represent 
average incidence. This means that BIA does not typically prOvide information on who 
benefits from an expansion or contraction in government spending which are important 
issues to policymakers (Davoodi, Tiongson & Asawanuchit 2003). 
2.9.1 Types of Benefit Incidence Studies and what they have shown 
Most of the studies on benefit incidence have been done at a macro level and the main 
emphasis has been placed on the benefit incidence of spending of the social sector 
including health, education and basic infrastructure. BIA has been carried out for a 
number of countries: Some transition economies, middle-income countries and even 
some advanced economies (Davooru.. Tiongson & Asawanuchit 2003). However, within 
the scope of this paper, a few countries will be considered. 
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Some of the studies done on benefit incidence at a macro level include: benefit incidence 
of education in Indonesia, and health in Ghana by Demery (2000), effectiveness of public 
spending on education and health in Cote d'Ivoire, Kenya, Madagascar, South Africa 
and Tanzania by Castro-Leal etal (1999), benefit incidence of education and health 
spending in eight countries in Africa by Sahn and Younger (1992, 2000) and a general 
benefit incidence of public services as a whole including education, health and access to 
basic infrastructure such as roads and sanitation facilities in Bolivia and Paraguay by 
Ajwad and Wodon (2002). 
Results from all of these studies revealed similar patterns, which were that government 
resource allocation is presently pro-rich. Results suggested that government / public 
subsidies of the social sector were not well targeted to the poor and indeed favoured 
those who were better off. Based on the Maximin principle of social justice, these results 
suggest that the distribution of public goods and services in most of these health systems 
are not equitable because the worst-off in' society are not given priority and in fact are 
disadvantaged in accessing them. This is not a good sign because if such a pattern is not 
altered, then those who risk exclusion from accessing public subsidies and who are 
mainly the poor will continue being excluded. This is a violation of human rights 
principles, which emphasize the right of everyone to enjoyment of the highest standard 
of physical and mental health. 
Whereas macro benefit incidence studies give a wide overview of the country's 
distributional aspects of public subsidies, they use aggregate data that is often crude and 
thus not very accurate. Government spending data are typically obtained from budget 
execution data as reported by the Ministry of Finance, the relevant line ministry, or the 
central statistical agency. The data used in macro benefit incidence analyses are typically 
reported on an aggregate basis. As such, the analyses cannot reflect the variation in the 
quality of services provided to different groups of users. For instance, health clinics in 
rural or low-income areas may not be as well staffed or equipped as clinics in urban or 
high-income areas. Lacking information on such quality variation, macro benefit 
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incidence studies are forced to maintain the hypothesis that quality is invariant 
(Davoodi, Tiongson & Asawanuchit 20(3). Furthermore, because macro benefit 
incidence studies deal with aggregate data on public subsidies in general, they cannot 
inform policy makers about specific programmes that a country may be interested in 
evaluating. For instance studies on benefit incidence of health services as a whole do not 
specifically indicate how public funds are spent on different health services, for 
example, immunization programmes or HIV / AIDS programmes independently. As a 
result aggregate data on health will give a misleading picture on the distribution of 
government spending on particular programmes. 
Another point to consider, is that macro benefit incidence studies will just inform policy 
makers that there is a problem with the distribution of the public subsidy but does not 
tell you specifically how to address such a problem. This is because these studies do not 
deal directly with the users of the service. For instance there are no focus group 
discussions conducted to ascertain factors that might influence or constrain accessibility 
of services, hence they cannot give a clear indication of what needs to be done to 
improve the situation. 
It is important therefore to note that more studies on benefit incidence of specific health 
services are required to address such issues. Unfortunately, studies in this area have not 
yet been greatly explored. Having said that. below is an example on benefit incidence of 
a specific health service. 
A study on the benefit incidence of a specific health service was done by Thiede, Palmer 
and Mbatsha (2002). The study covered three public clinics in the township areas of 
Cape Town, South Africa. The study was specifically addressing the question of 'who 
goes to the public sector for voluntary counseling and testing (VCf) for HN / AIDS in 
South Africa'. A comparative benefit incidence analysis of vcr programmes was done 
in the light of two strategies to increase awareness - "ProTFST" and "LoveUfe". The 
objective of the study was to establish the socio-economic status of those accessing vcr 
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at the public sector clinics in South Africa as well as to establish the reasons that could 
have influenced distribution or accessibility of such services. 
The methods employed followed this approach: Facility-based exit interviews with 
patients were conducted to assess utilization of vcr services as well as general public 
clinic services by different socioeconomic groups. To establish socio-economic status of 
the respondents, the facility-based questionnaire asked a series of brief, closed-ended 
questions about gender, race, education, employment status, sanitary and living 
conditions and household assets. Many of the household asset questions were taken 
from the South African Demographic and Health Survey (DHS) in order to allow 
comparison with the DHS data set during the analysis phase of the study. 
Data form the South African DHS on socioeconomic status of urban households was 
compared to data from the facility based questionnaire data to assess any differences in 
socioeconomic status between those attending the clinic and having vcr and those 
withln the catchment area of the clinic. This was obtained by generating an asset index 
from South Africa's 1998 DHS for households in townships around Cape Town and 
Johannesburg using principal component analysis methods. Household characteristics 
and assets included in the generation of the index were household's main source of 
drinking water, type of toilet facility, flooring and wall material of the dwelling, access 
to electricity and a range of household valuables such as a radio, TV, car. The 
socioeconomic status of individuals attending services (including VeT) was then 
compared to the reference population of township households. This comparison group 
was ranked into quintiles based on the asset scores generated from the whole DHS 
urban sample. (Thiede, Palmer and Mbatsha 2(02). 
In-depth interviews and focus group discussions with staff, clinic users and local 
community groups were also conducted to explore barriers to access and attitudes to 
vcr. These interviews were taped, transcribed and analyzed for key themes, drawing 
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on fieldwork diaries as an additional source of information (Thiede, Palmer and 
Mbatsha 2002). 
Findings about the use of clinics for general services as well as for vcr, showed that the 
two upper wealth quintiles were under represented and the second lowest was best 
represented. In specific terms, the low-income groups of people access more of the 
general services as well as go for vcr at public sector facilities than the well off. Overall, 
the findings showed that socioeconomic groups are not evenly represented in clinic 
attendance and more especially exaggerated when it comes to undergoing vcr. The 
least well-off quintiles among township population take up the services more than the 
others (Thiede, Palmer and Mbatsha 2002). 
Compared to the macro studies discussed previously, results from this specific study, 
reveal that services are not skewed in favour of the well off. This is good because a large 
proportion of these services go to those people' are who are least able to Bfford them if 
they were provided for a fee. However, one cannot conclude absolutely that disbibution 
of vcr and general clinic services at public sector facilities in township areas in Cape 
Town. South Africa is equitable because there are other factors that need to be 
considered in relation to horizontal and vertical equity before making any concrete 
decisions about whether a particular service is equitable or not 
Micro studies on benefit incidence have an added advantage over macro studies because 
they give the actual picture of what is happening specifically within a particular health 
programme, rather than giving an aggregate scenario of health services as whole. In 
addition to that, micro studies are better suited in informing policy makers on what 
needs to be done to improve the equitable disbibution of specific programmes because 
interviews with service users and focus group discussions with representatives of the 
community highlight crucial issues that are useful in improvising strategies to deal with 
particular problems. 
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As my study will focus on benefit incidence of provision of free antiretroviral drugs in 
Uganda, it will more closely follow the approach of the study on a BIA of a specific type 
of health services than the macro level studies. 
2.9 The Conceptual Framework of the study 
Based on this review of the literature, the following conceptual framework was 
developed. 
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Conceptual Framework 
Distribution of the general population 
according to Soci<reconomic groups 
Comparing between general population 
and HIV prevalence 
Distribution of HIV positive population 
according to Soci<reconomic groups 
Comparison between general 
population and ART utilization 
•.......•• 
Evaluation of equity 
according to utilization 
. 
........•.•...• ~--
,/ 
Equity 
• Horizontal 
Evaluation of equity 
according to need 
• Vertical 
Comparing between HIV prevalence 
and ART utilization 
Distribution of ART users according to 1.....-__ .. 
Soci<reconomic groups 
Derivation of benefit in monetary terms 
Cost information = average 
unit cost of providing service 
x utilization rates 
• 
• 
• 
• 
• 
• 
• 
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Factors that 
achievement of equity 
Education 
Awareness of ART 
Stigma 
Geographical location 
Cultural beliefs 
Fear of side-effects 
Distance 
influence 
The above diagram illustrates the following: 
Comparison: - Comparison will be made between socioeconomic indicators of the 
general population, the HIV positive population and users of ART. This will be done in 
combination with geographical location (Rural Vs Urban). This will enable me to assess 
the socioeconomic status of those who access ART and to what extent A comparison 
between socio-economic status distribution of HIV positive population and ART users 
will assist in evaluating equity according to need, while a comparison between socio-
economic status distribution of the general population vis-a-vis ART users will assist in 
evaluating equity according to utilization. 
Equity: - This will be evaluated in terms of horizontal equity and vertical equity 
Horizontal equity- To evaluate whether those in need of ARVS (HN positive patients) 
access them. Vertical equity- To evaluate whether priority is given to those who are HIV 
positive and who also are socioeconomically vulnerable. 
Factors influencing achievement of equity- To understand supply and demand factors 
that affect the achievement of equity. Factors to be evaluated may include education, 
awareness of ART (sensitization), stigma, geographic location, distance, income, cultural 
factors and fear of side effects. 
Cost information- In order to estimate the benefit derived from ARV s in monetary 
terms, the average unit cost of providing ART services will be obtained. This will be 
multiplied by the number of ARV users in each quintile in order to derive the 
distribution of benefits for each socioeconomic group. The costing perspective 
considered is the health system's perspective or provider's perspective. Costs accruing 
to patients will be excluded. 
40 
CHAPIER nIREE: RESEARCH METHODOLOGY 
3.0 Overview 
This chapter provides a detailed description of the methodology used to collect both 
quantitative and qualitative data, the nature and sources of data and how such data will 
be integrated for later stages in the analysis. This chapter also describes the 
methodology used to evaluate information on the socioeconomic status of those 
receiving free ARVs in relation to the socioeconomic indicators from the Uganda 
Demographic Health Survey (UDHS). Finally, the methodology for costing of the 
benefit derived from accessing free ARV s is discussed. 
3.1 Study design 
A cross sectional study design was used to assess utilization of ARV drugs for the year 
7004. Cross-sectional data.inc1uded snapshot data o( that year's utilization rat~, socio-
economic indicators and demographic characteristics of those patients receiving ARVs. 
Interviews administered in the waiting room of each facility were used to assess access 
to free ARVs by different socioeconomic groups. Information relating to knowledge, 
attitudes and barriers to access ARV s was obtained through focus group discussions, 
which were composed mainly of clinic users, staff and local community groups. 
Information regarding costs, criteria and eligibility of the ART programmes were 
obtained from key informants and these were mainly heads of ART programmes at 
selected facilities. 
3.2 Study population 
The study population included all adults accessing free ARV drugs in hospitals, primary 
health care facilities or local NGOs in Uganda Owing to the limitations imposed by 
resources, the entire population could not be studied. A sample, therefore, had to be 
drawn from the study population. My purposive sample was Kampala and Masaka 
districts. (See map on the front page). These districts were chosen as areas of the study 
due to the following facts: 
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• The research was meant to compare the benefit incidence of ARVs in urban and 
rural areas in order to assess whether accessibility of ARVs was different in roth 
settings. 
• Kampala is the capital city of Uganda thus most of the well established health 
care facilities are situated there and Masaka is one of the first districts in the rural 
areas to have an ART programme. 
• Both districts had well-established ART programmes that had been in place for 
the last two years. 1 
• These districts were accessible to the researcher within resource constraints. 
The sample comprised of four facilities selected from Kampala and one facility selected 
from Masaka, which are discussed in detail later. One of the facilities in Kampala has 
two ART departments or subunits and the facility selected in Masaka serves patients 
from a hospital and an NGO. In total therefore patients from seven facilities were 
represented roth in Kampala and Masaka. Not all facilities in one district were 
included. Due to resource· constraints, only a few were purposively selected.· These 
facilities were selected on the basis that they had in place a well-established ART 
programme. 
The inclusion criteria were: Adults arove 17 years of age, patients receiving free ARVs 
and must have been on these drugs for the past two months and patients had to be 
going to selected facilities to access the drugs. Exclusion criteria were: children, patients 
who had not yet started receiving ARVs and those patients who were visited at home by 
Community Based Organisations (CBOs). Put differently, the study was a facility-based 
interviewi therefore it excluded household surveys of those patients served by COOs-
those patients who would not come to selected facilities. 
1 The ART programmes in Uganda were initially paid for. I.e patients met the cost of 
consultation fees, laboratory fees and the drugs. The free ART programmes were introduced in 
June 2004. 
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Sample size: It was estimated that people in need of ARV in Uganda was about 120,000 
yet only 23,000 accessed free ARV s by the end of 2004. Therefore the study population 
was 120,000 adults in Uganda. A prevalence of 19 % of those accessing the drugs in 
relation to those in need was used as the estimate. A confidence interval of 95% and 
level of significance of 0.05 was used in this study. The required precision ± 5 (i.e. a 
range of 14% to 24%) was considered as an acceptable level for this study. Based on the 
above consideration, a minimum sample size of 400 patients was calculated using 
ST ATA. The intended sample size was thus ± 200 persons per district. The sample size 
for each facility was proportional to the size of the patient population as well as 
willingness to participate. Sampling was conducted over a time frame of three days per 
facility during morning and afternoon sessions. Calculation of sample size was based on 
the overall population of those in need of free ARV drugs in Uganda, irrespective of 
their geographical and physical addresses. Although the sample size was a 
representation of the entire group of those in need of ARVs in Uganda, an assumption 
was made that equal number of people would represent an urban and rural setting, 
hence results were presented separately by district 
3.3 Sampling strategy 
A multi-stage sampling strategy was used. It involved many steps before getting to the 
sampling unit who was an individual at selected facilities. The sampling frame was a list 
of facilities in Uganda that offer free ARV programmes. The strategy involved the 
following steps: -
Firstly, the study population was stratified into rural and urban regions. Two districts 
were purposively selected, one from rural and one from urban areas. Kampala district 
was selected for the urban setting while Masaka was selected for the rural setting. Using 
the sampling frame, facilities within selected districts were also purposively selected 
because the process involved the deliberate selection based on certain predefined 
criterion (Depoy and Gitlin 1994). The criterion for choosing these specific districts and 
facilities was based upon well established ART Programmes with provision of free 
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ARV s. Out of the ten facility based ART facilities identified in Kampala, four facilities 
were purposively selected, and data was collected from a hospital which had two ART 
programmes, a primary health care facility and two local NGO AIDS support centers. In 
Masaka, out of three ART facilities identified, one large NGO known as Uganda Cares 
was purposively selected. This serves patients from both Masaka regional referral 
hospital and the Uganda Cares outpatient clinic. In each facility, a systematic sampling 
of people waiting in the queue to receive ARVs was used to conduct questionnaire 
interviews. Every third person waiting in the queue was approached and asked whether 
they would be willing to be interviewed. Sampling was conducted over a time frame of 
three days per facility during morning and afternoon sessions. The sample size for each 
facility was proportional to the size of patient population as well as willingness to 
participant Purposive sampling was used to select focus group representatives and key 
informants. 
3.4 Data collection sHes 
In Kampala the selected facilities included: Nsambya HospitaL Kamwokya Christian 
Caring Community (KCCC), Mulago Infectious Disease Oinic (MIOC) and MildMay 
Centre. In Masaka, Uganda Cares was selected. 
eNsambya hospital is one of the most well recognized hospitals in Uganda. It is a private 
hospital mainly funded by Catholic organizations one of which is Catholic Relief 
services (CRS). Nsambya hospital has had an HIV / AIDS treatment center that has been 
operational since the inception of the joint United Nations Programme on HIV / AIDS 
Drug Access Initiative (UNAIDS_DAI) in 1998 (Ministry of Health 2002). Thus it is one 
of the few treatment centers in Uganda with a long standing ART programme. It has 
two main ART programmes, namely Nsambya Home Care and Prevention of Mother To 
Child Transmission (PMTCT). 
e Kamwokya Christian Caring Community is a local NGO located in one of Kampala's 
suburbs. Its ART programme just began in 2004. It is funded by PEPF AR and it gets its 
grants through CRS. It was formed with the main objective of providing free HIV / AIDS 
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treatment and care for the poorest of the poor in Kamwokya community and within a 
specified vicinity. 
• An Infectious Diseases Oinie (IOC,MULAGO) was constructed in Uganda in 2001 at 
Mulago hospital in Kampala. It is mainly funded by Pfizer. The institute's main objective 
is to improve the quality of health care to adults and children living positively with 
HN / AIDS, through the delivery of Antiretroviral therapy, clinical care, modern 
laboratory services, research, prevention programmes and training of African physicians 
and health care providers in HN care and prevention (Infectious Disease Institute, 
News Update 2(04) . 
• Mildmay center is an international non-governmental Christian organization It was 
opened officially in 1998 on Entebbe Road, Lweza - Kampala's suburb. This center was 
developed with the aim of providing and demonstrating good quality holistic, 
comprehensive, outpatient care for patients with HN / AIDS - related health problems. 
Since opening the center to patients with HN / AIDS, around' 75,000 patients attendances 
have been recorded. Mildmay International also runs a second project within Uganda, 
known as Jajja's Home. This is a day-care center and in-patient unit, which caters for 
seriously ill HN -positive children. The center's major funder is COC (Center for Disease 
Control and Prevention) (WHO 2(01) . 
• Uganda Cares is a non-governmental organization funded by a health care foundation 
in the United States. Currently, it has 6 branches in Uganda and the Masaka branch was 
the first center to provide free ARVs in 2002. The main objective of setting up this 
organization was to evaluate whether it is possible to provide free ARVs in a resource 
constrained setting (personal communication with Dr. Penninah Jutung (medical officer-
Uganda Cares- Masaka). Uganda Cares Masaka is responsible for patients from Masaka 
Regional Referral Hospital as well as the NGO's patients. 
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.. 
Although all the facilities mentioned above seem to be funded mainly by international 
organizations, some of the funds come from the government line ministry- Ministry of 
Health under the Multi-country AIDS Programme in Africa (MAP). 
3.6 Data Collection instruments and methods 
Instruments used to collect data included: Questionnaires, Focus Group discussion and 
key informant interview guidelines. To establish socioeconomic status of patients 
receiving free ARV s, facility based questionnaires asked a series of brief, closed-ended 
questions about gender, age, education, employment status, sanitary and living 
conditions and household assets. Many of these questions were taken from the Uganda 
Demographic and Health Survey (UDHS)- 2000-2001. This was to allow comparison of 
the data set from questionnaires to that from the UDHS for the analysis phase of the 
study. Some questions about knowledge around ARVs were also asked The 
questionnaires were piloted in two centers in Kampala to check whether there were 
questions that needed to be phrased differently for easy understanding. 
Questionnaires were developed in English and then translated to Luganda (main local 
language spoken both in Kampala and Masaka), for those persons who could not 
communicate in English and back translated to check the quality of translation. (See 
English version in appendix no.S). Interviews were administered by two fieldworkers 
whose choice was based on criteria that they must be university graduates and must 
have experience in data collection and research. The research assistants were trained 
prior to the commencement of the study. The training ensured that both research 
assistants understood the content of both the English and Luganda questionnaire and 
also practiced with each other in order to develop skills for time management for 
administering the questionnaire. Research assistants were also trained on ethical issues 
as discussed below in the proceeding section 
Qualitative methods were used for in-depth interviews with key informants and focus 
group discussions (FGDs) with community representatives. Five key informant 
interviews were conducted with heads of ART programmes at the selected facilities. The 
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interview guidelines for key informants consisted of about fifteen semi-structured 
questions (see appendix no.3), which were administered by the principal investigator. 
The interview guideline asked questions about criteria and eligibility as well as 
objectives underlying the provision of free ARVS. It also asked information of the 
general expenditure of the facility in question, total number of visits and costs on 
laboratory tests and provision of ARVs. Consent forms developed in English had to be 
signed prior to the interview (see appendix no.2). 
Focus group discussions were very important on soliciting information on knowledge 
and attitude towards ARV drugs as well as to understand social, economic and supply 
factors that could have been facilitating or constraining access for disadvantaged 
groups. 
The focus groups were divided in single sex groups. Females were interviewed 
independently from men. This was for the purposes of avoiding conformity because of 
the social interaction between males and females where both groups tend to "perform" 
for each other. For instance evidenCe shows greater diversitY of ideas in single sex 
groups than in those of mixed sex ( Stewart & Shamdasani, 1990). Four discussion 
groups were conducted, two groups (female and male) in each district Each focus group 
consisted of 8-10 people, and these were people with common experiences or areas of 
interest. For instance the group consisted of patients who were on antiretroviral drugs 
(ARV's), community representatives (non- users) and some health workers 
administering the drugs. These were groups that were suggested by management of 
community-based organizations as representative. One major criterion was knowledge 
and experiences about ARV services. FGDs were conducted by the principal investigator 
with the help of two research assistants. Key informant interviews and FGDs were tape-
recorded and field notes were written. 
3.5 Ethical issues 
Research assistants were trained to give a detailed explanation of the study to all 
respondents before their participation. Issues clarified included the following: 
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o The purpose of the study. 
o That participation would be on a voluntary basis. 
o That the participant is free to withdraw from the study at any time if they wish 
to. 
o To give information about the use of data collection instruments and duration of 
each interview, Assurance of confidentiality via coded identity and other means. 
o Advise on risk and harm, ensuring that the risk of harm is negligible 
o To discuss potential benefits of the study outcomes. 
o To obtain informed consent prior to the commencement of the interview. 
o The main emphasis was placed on the points below:-
eConsent form 
All participants (patients and key informants) were to be given consent forms, which 
they were free to accept or refuse to sign. There was no undue influence on the 
prospective participants. The subjects were notified of their right to refuse or withdraw 
from the study if they wished and that'their treatment would not be jeopardized in any 
way. Participants were also informed of their right to ask any questions. Consent forms 
were developed in English and also translated to Luganda. They were given to 
respondents to sign before any interviews could be conducted. (See English version 
appendix no. 4) 
eConfidentiality 
Efforts were made to ensure total confidentiality. Personal information such as one's 
identity was not obtained. Measures were taken to ensure that individuals would not be 
linked to information provided by use of codes. The study also ensured anonymity by 
not reporting any private data that identified participants. Great care was exercised to 
protect privacy and maintain confidentiality by use of a coding system. 
eBenefits versus risks 
Potential physical, social and emotional risks to participants were minimized or 
eliminated by ensuring total confidentiality. The researchers also ensured that 
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• 
questionnaires and interviews did not take a lot of participant's time off work. A 
minimum time of 10 minutes per participant was required which limited the cost of time 
that participants would invest in answering questionnaires. 
The researchers explained to the participants that the study was not meant for only 
degree purposes but also would help to improve the equitable delivery of ARV 
programmes, which would benefit the participants and the society at large. In general, 
the study would ensure that the sum of potential benefits to the participant and the 
importance of the knowledge outweighed the risk of harm to the participants. 
3.6 Nature and Sources of Data 
• Facility-based exit interviews formed the utilization data and this was purely solicited 
from patients and was recorded by use of a questionnaire. Most of the data utilization 
data described socioeconomic status of those individuals accessing free ARVs. A total of 
400 waiting room interviews were conducted, 218 in Kampala and'182 in Masaka. The 
researchers could not get equal number of participants from each district because 
Kampala has more ART centers compared to Masaka district Therefore there were 
higher chances of getting more people in Kampala than it was in Masaka district. Patient 
populations in Kampala and Masaka were comparable as the investigator ensured 
uniform baseline characteristics such as age, gender, HIV prevalence, education and 
quality of care in the selected health services . 
• There was need to collect data from the 2000/01 Ugandan Demographic health Survey 
(UDHS) on socioeconomic status of the entire population of Uganda. To assess which 
socioeconomic category each individual from the facility based questionnaires belonged, 
it was necessary to match all similar socioeconomic variables from facility based 
questionnaires with those from UDHS in order to generate an asset index - a concept 
which will be discussed later. 
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• Qualitative information from in-depth interviews and focus group discussions. FGDs 
and interviews were taped, transcribed and analyzed for key themes, drawing on 
fieldwork diaries as an additional source of information. 
• Cost data- The cost data was collected mainly from key informants of the selected 
facilities and these were mainly heads of the ART department Information collected 
comprised of: an estimate of the general total expenditure of each facility per year, total 
number of visits at each facility per year and annual estimate of total cost on ARV drugs 
for each facility. All selected facilities including hospitals have independently-run ART 
programmes, thus these facilities (or AIDS units within the facilities for which separate 
expenditure records were maintained) exclusively treat HIV I AIDS related illnesses. In 
view of this, total annual cost of expenditure on laboratory for each facility (or AIDS 
unit) was included in the general total expenditure. However, ARV drugs were not 
included in the general total expenditure because they were provided in kind. Therefore 
the information collected on ARV drugs in each facility, included number of patients on 
each drug combination and their market prices. These were multiplied to get estimates 
of total annual costs of ARV drugs in each facility. The costing was financial in the sense 
that it considered private costs incurred by the government They did not reflect any 
opportunity cost of any resources, thus indirect costs were excluded. A provider's 
perspective was considered because the study aimed at establishing the amount of ART 
public subsidy that goes to each wealth quintile in monetary terms . 
• Socioeconomic correlates of HIV infection in Uganda were obtained from literature as 
well from the Uganda Sero-behavioural Survey and the HIV I AIDS Surveillance Report 
Data on asset index of HIV prevalence in Uganda was not available. 
3.7 Data analysis 
Entering, checldng and deaning of Data: Data was entered manually from 
questionnaires into a master spreadsheet Data was checked and cleaned by a system of 
double entries into twin spreadsheets for each questionnaire by separate members of the 
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research team. After data entry completion these spreadsheets were compared and 
cross-checked. 
Software used in analysis: SfATA and EPIDATA software packages were used, in 
addition to standard Microsoft office packages (Microsoft Word and Microsoft Excel) to 
process and analyze the data. EPIDATA was used to enter the data while STATA was 
used to analyze the data. 
Quality control (Validity and reliability of results) 
The interview setting and conduct was comparable to avoid any differing responses. 
Fixed and closed rooms were used to avoid noise and other distractions and also to 
ensure privacy and confidentiality. 
Face validity was assessed through the use of a mini-pilot study. Ten questionnaires 
were administered first in two facilities in Kampala before the main study began. Any 
problems with the"draft questionnaire such as unclear questions were revised after the 
pilot Content validity was accounted for by clarity of definition and terms. 
Standardizing the questionnaire and other interview guidelines and ensuring that both 
questionnaires in local language and English had the same meaning accounted for 
reliability. All research assistants were trained to ensure that they were of the same 
mind and ways of administering the questionnaire and interviews were similar in all 
aspects. In addition, constant supervision was provided by the principal investigator. 
3.8 Benefit incidence: Calculation of Asset index 
A factor analysis to create an asset index for the benefit Incidence was used. The first 
step involved identifying socioeconomic variables that were similar from the exit-
interview questionnaire and UDHS. Data was thus extracted from both sources. 
Household characteristics and asset variables used included main source of drinking 
water, the type of toilet facility, flooring, roofing and wall material, access to electricity 
and a range of household valuables such as radio, telephone, refrigerator, lantern and 
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cupboard. Other possessions such as car/truck, bicycle, motorcycle and boat or canoe 
were also matched. 
The second step involved extracting data for Kampala district independently and for 
rural districts combined from the UDHS. This same procedure was repeated for data 
from facility-based questionnaires. The only difference was that rural districts in the 
UDHS were represented by Masaka district in the facility-based data. This was because 
the size of UDHS for Kampala was adequate enough to allow statistical analysis but 
UDHS data for Masaka was too small, so all rural districts in UDHS dataset were used. 
A principal component analysis (PCA) was run for all identified variables of the two 
data sets (Kampala and rural areas) from the UDHS independently. This generated an 
unweighted mean, standard deviation and asset factor scores for all identified variables 
for both Kampala and the rural setting. In addition, each household asset was assigned a 
factor score generated through a PCA These resulting asset scores were standardized 
and used to create' the points that defined wealth quintiles. Five quintiles were 
generated for both the UDHS Kampala data set and rural data set The quintiles were 
labeled in ascending order ranging from 1 to 5. These will be marked as: lowest, low, 
medium, high and highest for analysis purposes. 
In order to get an individual asset index score for the facility based data for the two 
districts (Kampala and Masaka), so as to place these individuals in their respective 
quintiles generated earlier from the UDHS, the following formula was employed. 
Individual 
asset score -L Value of asset variable - unweighted mean of asset x "raw" asset 
unweighted standard deviation of asset variable 
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Where value of asset variable is value assigned to a particular asset variable such as 
electricity, unweighted mean of asset variable and unweighted standard deviation of 
asset variable for either Kampala or rural areas obtained from UDHS PC::A. This depends 
on the area under consideration. II Raw" asset scores are the scoring coefficients 
generated by running the UDHS PCA. Results from this formula, generated asset index 
scores for facility-based data. Each individual was assigned a standardized score for 
each asset, where the score differed depending on whether or not the household owned 
that asset. Individuals were then ranked according to the total score of the geographical 
location in which they resided. Each individual was thus classified into appropriate 
quintiles accordingly. 
3.9 Benefit incidence costing methodology. 
• The total unit cost of providing ART service was obtained by adding unit cost of 
general expenditure to unit cost of ARVs. Unit cost of a visit at each facility was 
obtained by dividing the total expenditure of each facility (less drug 
expenditure) With total number of visits: Average unit cost of providing ARV 
drugs was obtained by estimating the total cost of ARV drugs and dividing by 
the number of people on ARVs in each facility. The annual estimate of ARV cost 
for each facility was obtained by multiplying the number of patients on each 
ARV regimen with market prices of those specified drug combinations. 
• The average benefit from government spending on ART for each facility was 
defined as the average unit cost of providing the service at each facility. 
• The distribution of benefits was derived by multiplying the average benefit by 
the number of users of the service in each quintile. 
• The resulting distribution of benefits was compared across quintiles to assess 
which socioeconomic group benefited most from government spending on ART. 
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Limitations of the study 
1. Owing to resource and time constraints, as well as the protocols put in place by 
various organizations, health workers and patients in the Focus Group Discussions 
could not be interviewed separately. The ideal would have been to interview them 
independently as these two different groups of people have power imbalances. This 
therefore could have introduced some sort of bias in the study because patients tend to 
shy away from voicing their ideas in fear that their treatment could be jeopardized. 
2. Secondly, it was not possible to get asset data for HIV prevalence in Uganda. 
Education, HIV prevalence rates and literature on the correlates of socioeconomic 
characteristics and HIV infection were thus used a proxy measure to estimate the 
socioeconomic group of those living with HIV / AIDS. If asset data for HIV infection was 
available, it would be· compared with asset data from UDHS and facility based 
questionnaire asset data. This would have enabled one to clearly tell the correlation 
between HIV infection and socioeconomic status in Uganda, which would have thus 
helped in evaluating equity according to need. 
3. A third concern is that the Demographic Health Survey in Uganda was last conducted 
in 2000/01, therefore the data are relatively old and asset ownership patterns in Uganda 
may have changed since that time. 
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CHAPI'ER. FOUR: RESEARCH RESULTS 
4.0 Introduction 
This chapter presents the objectives of the ARV programme, the type and kind of ARV 
drugs provided to patients and the criteria for eligibility to benefit from the programme. 
Demographic and initial socioeconomic characteristics of the general population, people 
living with HN / AIDS and of those in my study sample are analysed. The chapter 
further gives a description of each quintile or socioeconomic group in terms of 
household asset possession for both urban and rural settings. Findings about free ARV 
utilization by geographical location and by facility are presented. The chapter goes on to 
present the value of the benefit from ARVs in monetary terms. Finally factors that 
influence participation and those that prevent access to ARV programmes are discussed. 
This is integrated with knowledge and attitudes of users towards ARVs. 
. 4.1 Objectives for the provision of free ARVs and types of ARVs 
In order to understand the ARV-roll out policy in Uganda, it was important to find out 
the objectives pertaining to the provision of free ARVs. Interviews with key informants 
who were coordinators of government and NCO ART programmes, clearly pointed out 
that the main objective of providing free ARVs was to extend the years and improve the 
quality of life for those living with HN / AIDS. In view of this, KI(A) said "yeah It is a 
WHO initiative to provide ARVs to all those who need them in order to improve their 
quality of life and survival rates." Although, there were differing responses, all of them 
were pointing in one direction, which was mainly to provide treatment to the infected. 
However KI(E) said that not only were they targeting the infected but they were also 
concerned about the affected. He further explained that providing ARVs to the head of 
the household would have an added benefit to his/her beneficiaries because he/ she will 
live longer and thus be able to provide for his/her family. He argued that the objective 
of providing free ARV in their facility is liTo improve the quality and quantity of life of 
HIV / AIDS infected and affected. ie. the affected I mean that households could be 
affected if the bread winner is down and cannot provide for the family anymore." 
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Having established the objectives of the ARV programme in Uganda, the study went on 
to identify the type of ARV drugs offered free of charge. A question about type of ARV 
used in each programme was asked in the exit interviews with patients. About 10% of 
the respondents did not know what type of drugs they were on. Of those who knew, 
those on first line regimens and second line regimens were 75% and 15% respectively. 
The drugs were comprised of a three combination types. Of those patients on first line 
regimens, 20% were on AZT+3TC+NVP, 45% were on d4T+3TC+NVP and 10% on 
d4T+3TC+EFV. The patients on second line regimen seemed to be on the same drug 
combination which comprised of TDF+ ddI + Kaletra. Alternative names of the drugs 
mentioned above are as follows: -
AZT - Zidovudine or ZDV 
3TC - Lamivudine 
NVP - Nevirapine 
EFV - Efavirenz 
d4T - Stavudine 
TDF - Tenofovir 
ddI - Didanosine 
Kaletra -Lopinavir 
4.2 Criteria for eligibility to access free ARVs 
It is of paramount importance to understand the criteria for eligibility to access free 
ARVS in Uganda because this forms the basis against which ARV programmes are 
judged fair or not, thus the criteria for eligtbility were solicited from key informants. All 
of the interviewees (100%) said that they considered patients with a CD4 count of below 
200 and patients who had WHO stage 4 disease or advanced WHO stage 3 disease as 
eligible. In addition to the medical criteria, facility E considered social aspects like 
disclosure of HIV status to family and friends, registration with the center and distance 
from the facility - KI(E). Consent for treatment -KI(D) and inability to pay-KI(F) were 
some of the other criteria considered by facility D and facility F as reflected in box 1 
below. 
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Box 1: The criteria for eligibility of free ARVs in Uganda 
KI(D): The main things we depend on arei of course you have to be HIV positive, then 
have a WHO clinical stage 3 & 4 and the third one is to have a CD4 count of less than 
200. So those are the criteria we use! And then we want our patients to be able to came, 
to consent for treatment. We do not force them onto treatment, they have to consent 
themselves and we expect them to adhere to treatment. 
KI(E): Here we look at the medical and social criteria. In the medical, we look at the 
stage of disease, we look at the CD4 count and where available we look at the viral load. 
I.e. we consider patients who are in WHO clinical stage 3&4 and who have a CD4 count 
of below 200. We also look at disclosure especially if one has disclosed to someone that 
implies that they will be able to get good social support. This is a very important in the 
management of HIV / AIDS. We also look at the distance of where they stay. Initially we 
were looking at a radius of 3km from the center and we· are increasing to 10 or 15· km. 
There are same exceptional cases where we go beyond 15km. Another criteria we look at 
is that you should be registered at this center. 
KI(F):.The very poor who cannot afford buying the drugs, those who have never had a 
chance to buy the drugs since they started in 1999. Those who were paying before are 
not considered. Also dependant on who registered first Those who registered first get 
the opportunity. We also consider the scientific standard of WHO of CD4 count less than 
200, stage 3&4 of the disease. 
57 
4.3 Demographic and initial review of socio-economic characteristics 
This section presents demographic characteristics as well as initial socioeconomic 
characteristics of: the general population of Uganda; people living with HN / AIDS in 
Uganda; and those of patients on ARV drugs that participated. in the study. HN / AIDS 
prevalence rates for urban and rural areas are presented. as well. The demographic 
characteristics considered are age and gender and the initial socioeconomic indicators 
include: education, employment status, gender of head of household and average 
household size. Demographic characteristics and socio-economic indicators of those 
infected with HN and those accessing ARVs are important to policy makers because 
they could help in developing programmes and policies that are aimed at targeting 
particular groups with the aim of mitigating the negative effects of HN / AIDS. 
4.3.1 Demographic and initial socioeconomic characteristics of Ugandan general 
population 
Information on the demographic characteristics of the general population is obtained 
from the Uganda Demographic and Health Survey (UDHS 2000(2001). The 2000-2001 
UDHS used a household questionnaire, which elicited information on the socioeconomic 
and demographic characteristics of usual residents. In terms of gender, the data showed 
that there are slightly more women than men, with women constituting 52 % of the 
population and men constituting 48%. Results revealed that the sex composition of the 
population does not show significant variation by urban-rural residence (UDHS 2001). 
In terms of age distribution, Uganda is depicted as a country with a young population, 
with a large proportion of the population being in the younger age groups. The 
population under age 15 constitutes 52 percent of the total population. 
In regard to headship of households, nearly three in four households are headed by 
men, while one in four households are headed by women. The proportion of female-
headed households is slightly higher in urban areas than rural areas (31 percent and 27 
percent, respectively). 
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For household composition., it is reported that one in every nine households has only 
one member. However, very large households (nine persons or more) still exist in 
Uganda. Even in urban areas, which tend to have smaller household sizes than rural 
areas, 8 percent of the households have nine or more persons. In urban areas, 33 percent 
of the households have one or two members, compared with 21 percent in rural areas. 
The mean household size is larger in rural areas (4.9 persons) than in urban areas (4.2 
persons). 
As far as employment is concerned, data revealed that 73 percent of women and 63 
percent of men were employed at the time of the survey and that the employment level 
for women was higher in rural areas than in urban areas, while the reverse was true for 
men. Employment in this survey is defined as any work that one is contracted to do for 
payment in cash or kind. Employment in this survey thus implies both formal and 
informal jobs. In specific terms, among women who were employed at the time of the 
survey, 77 percent were engaged in agriculture and 23' percent were involved m 
nonagricultural activities. The percentages for men are 54 percent and 46 percent, 
respectively. The strong involvement of the population in agriculture reflects the 
predominance of the agriculture sector in the Ugandan economy. The professional, 
technical and managerial occupations, which require more skill but have higher income-
earning potential, employ only 3 percent of working women and 6 percent of working 
men. 
In terms of educational attainment, the majority of the Ugandan population seems to 
have primary level education (59.8)%, while those who have no education at all are 
21.8%. Those who have secondary level or more are the minority represented by only 
18.4%. Rural people are less educated than their urban counterparts. The report revealed 
that one in four rural women do not have an education., compared with 7 percent of 
urban women. The corresponding figures for men are 7 percent and 2 percent for rural 
and urban men respectively. This pattern is reversed for secondary or higher education. 
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Whereas only 12 percent of rural women have attended secondary or higher education, 
48 percent of urban women have at least some secondary education. 
4.3.2 Demographic & initial socioeconomic characteristics of People living with 
HIV/AiDS (PLWHAs) In Uganda. 
Information on the national HIV prevalence rates and demographic characteristics of 
PLWHAs is taken from the Uganda lllV / AIDS Surveillance report published in June 
2003 by the SID/AIDS Control Programme of the Ministry of Health and the recent 
Uganda HIV / AIDS Sero-Behavioural Survey (UHSBS) preliminary report. The 
HIV / AIDS Surveillance report is based on SID/HIV / AIDS programmatic data 
collected from surveillance activities for HIV infection, AIDS cases, SID /lllV / AIDS 
behavioural markers, sexually transmitted diseases and Tuberculosis. 
Owing to the limitation of obtaining data on the socioeconomic characteristics (asset 
ownership) of PLWHAs in Uganda, this information will serve as a proxy to compare. 
with socioeconomic characteristics of my study sample vi&-a -vis those from UDHS in 
order to evaluate access of ARVs according to need. 
HIV/AIDS prevalence rates in Uganda by geographical location 
HIV / AIDS prevalence rates were determined for urban and rural areas. In general 
terms, the findings of the report were that HIV / AIDS prevalence rates in the rural areas 
were considerably lower than those in urban areas. For instance, the distribution of 
clinical AIDS cases by District of residence as of 31st December 2002 from 1998 showed 
that total adult cases were 11,370 and 10,507 for Kampala and Masaka districts 
respectively (Ministry of Health 2003). (Data on total population in each district was not 
available; therefore HIV prevalence per district could not be calculated). In addition, 
national lllV / AIDS estimates and projections developed by the UNAIDS reference 
group on estimates, models and projections correlated with the findings. The estimates 
for HIV / AIDS prevalence were 10.01% and 3.92% for the urban and rural population 
strata respectively (Ministry of Health 2003). 
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Further, the Ministry of Health on May 2nd 2005, released preliminary results of the 
Uganda HN I AIDS Sero Behavioural Survey that indicated that 7 percent of adult men 
and women are infected with HIV in Uganda. Nationwide, prevalence is higher in urban 
areas at 10.7 percent than in rural areas at 6.4 percent (Ministry of Health 2005). The 
report further clarifies that adults living in urban areas are twice as likely to be infected 
with HIV as those in rural areas. The lowest infection rate at 2.5 percent is in the north 
west while the highest levels are in Kampala, central and north central at about 9 
percent each (Ministry Of Health 2005). 
HIVI AIDS Prevalence rates stratified by gender and age group 
A cumulative total of 56,451 adult AIDS cases are presented in the surveillance report. 
Of the 54,990 AIDS cases with sex recorded, 24,643 (44.8%) were males while 30,347 
(55.2%) were females. This pattern was consistent with estimates of new HIV infections 
which are· 28,890 and 26,650 for wOmen and men respectively as of December 2002 
(Ministry of Health 2003). The report also showed that age groups (25-29) and (30-34) 
were the most infected with HN I AIDS with 15.4 and 21.1 HIV prevalence percentages 
respectively as of December 2002. 
The recent Sero-Behavioural survey has also revealed that overall, 7.9 percent of women 
have HIV compared to 6 percent of men. For both sexes, infection levels are highest 
among those in the age groups of 30-40 and are lowest in the age group of 15-19 
(Ministry Of Health 2005). 
HIV I AIDS Prevalence rates by educational attainment 
Preliminary results of the Uganda HN I AIDS Sero-Behavioural Survey (UHSBS) 
revealed that there was no consistent pattern of HIV infection by education level. 
However, findings reveal that there is no major difference of HN infection between 
those with secondary and tertiary education and those with no education at all but HN 
infection is concentrated in those who have a primary level education. For both sexes, 
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the ~ntages of tllOS<' who have primary ~UC.l tion arc 15.5',\; tho", with S<.'U>ndary 
a.nd tL>rtiary L>uuc:ahon are 6.9% s nd lnose with no "duc"tion ilr~ 6.7%. This r~porl does 
not sl'c.'rify whkh socioeronomic class of people i~ greally affected by HIV/A1DS, 
how<,ver tho.< Uganda AIDS Commission spokesman c!nrifieo.! that initillUy. I nv infection 
was hl-avily roncmtrnlL .. t in the upper sociooconomic grouP! due \0 thei r lifestyles. I h' 
further s.1id thM textllY, infection has cut across aU groups of f'I'Ople irTt'spt...::tive of their 
weal th and l .. lucation status (Personal communica tion; Mr. Jam~ KigOl.i). 
' .3.3 Oemog"J;lhlc: .nd InitIal ao<:!o ... conomlc ~h.aracleri.nc:. of l"'''l~il'''nt. 
l1Us So!Ction presents a compMison of utili7A1Mn of the ARV proB.ammes in the fa cility 
exit interviews betw~n groups with diffe.(' nt demoe;.aphk chamcterisocs such as ag~ 
and gender as well as ini tio11 !IOCior.conomic characteristics such as edUC:.Jlion,. 
employment sta tus, hou5ehold composItion and headship as well as g~-ographical 
location. In total, 400 stud y p.uncipanls were int('rvicwi.>U. 218 W('1"l! from Kampala 
district a nd 182 from Masaka district Of \he..oo siudy parbc,pants. 'Z72 were .. ·omen 
and 128 were men as Figure I ind ica tes l~low. 
Figur~ I: Numb~rof p.1rt'dpont. on free "RY. by gcnd~r 
Nurrbe r 01 people on ARV,. by gender 
O Women 
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The gender compos ilion of parlicip~nls 
Figure t above, dearly indicates thai more women (68%) than men (32%) aCWS'> free 
ARVs. StTatifioo by geographical location, the same pattern is evidenl Figure 2 below 
confirms that even in different g,-,ographicallocations more women than men ao::ess free 
ARVS 
Figure 2: Number of I"'rtidl"'nto on AR Vs by gender . nd gwgraphiUIIcx;alion 
Number 01 pa tlenlS On ARVs by gender Ind 
geographical location 
,. 
-----'= =--===-/ 
".".. ~ 
. "'" 
mwomen 
This finding rould be explained by the fact women in Uganda pre more infected .... ;th the 
H[V virus as rompared. In men as dearly indiCilted in both the sun·eillan<;e report and 
the Scm Behavioural Survey reporl Figure 3 below however shows tha t if data from the 
St-ro Behavioural Survey report is ronsidered, thP. degree of free ARv use in the study 
sample and HtV infection in the Sem Behavioural sun·ey is not the same for both sexes. 
For example, the recent Sero Behavioural report indicated that 58.4% of those infected 
with the virus were females while 68% of those in my study sample accessing free ARVs 
were fcmali."S. On the other hand.. 4t.6% of those in the Sem behavioural report that were 
IIlV positive were men but only 32% of those in my study sample accessing the drugs 
were ~n. llU5 clearly indka~ that W<.lmen are <.If ten more vuln~able and tho!}' 
rC!lpond poslUvely t<.I II\!! callol ART t~atment than men. 
f1gun 3< P~,.., .. nt~8e of AR V u!iliutilln ond I n v I nf«lIon by 8~nd~r 
Age composition of particip~ts 
From Figure 4 ""low, one can argue that ,t '" obvinuo that HlV I AIDS aU...:111 """,,,, .. in 
their Il106t productive age_ The 30-39 and the4(1.49 ag~ groups ~ve greater IIIoCCe5S 1<.1 free 
ARVI than the rest of the age gmu~ with 46.i'5~ and 22.15% respectively 
Flgur~ 4: Num""" of p.;or1iciP<'nt. on fne ARV. by .g .. group 
Number of ARV users by age group 
'" 
" 
10.19'1" 2I).~,. »39y,. 4049y,. ~'" 60+)'0"$ 
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This find ing is clearly expl.uned by moult. from the HIV I AIDS surveillance report and 
the IIIV I AIDS Sero-Bet"wioural report wlUo;;h both confirm tha t the HtV infection t!!Vels 
are highest among the produdive age groups. As indicated previou.,ly the survdUance 
report rI .. 'Yeated that the overall mean age of ad ults with AIDS is 30.9 years (Ministry of 
I tealth 2(00). while the I ltV I AIDS Sera BehaviouraJ Survey TOC<!ntly revealed th.J.t HIV 
infechon levcl~ are higl..:-st umong thO!ie in the age IlTOup 30-4(1, However the degree of 
ARV U5e is not in proportion to n<l<ld in tI .. , differen t age groups.. "ith th()l;e in the35-39 
yea. oge group being pa.tkularly d isadvantaged. This argu"""'l is illustrated in figure 5 
betow 
Figure 5; Age di.tr ibulion of HI V ;nf«fion and ARV u~. 
ARV usa & age category 
2~" 35-39 " .. " 
age g roups 
I_ HV infection. ARI/ use J 
FigureS muSlrates that HIV infection in Uganda is concentnted in the (35-39) ase group 
at 6 1 " 'II. (this being the estimate weighted ~gainst the entire population of Uganda). 
Ho ......... er. the (30-34) age Sroup haJ greater;KCCSS to free ARV thlln the age group thai 
has the grmte§ t HIV infection.. "fill: exh:nt 10 .... hich the (35.-39) ase group has access to 
froe ARV5 is m uch lo .... er t!wn lhe need. For ill.5(ance in this as" group alone, the 
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per<('ntage of those Infected with HIV W,-'Clion is estima ted at 61.-1 % and of~, only 
21 '4 kavt' <'«1':55 to free ARV" For the o ther age groups. aCC<'ss to ARV ~ is grea ter 
than th(o lIdudl nl't"d. For instance itS i11ustralro in Figure 5 a\xlve. age groups (2)29), 
(30-3'i) and (40-4-1) kave gn'ater aC"re'l5 to fret' ARV, liS compared to their relative nero. 
In view of this. it is dear Uwt in spedfic term5 ARV u~ is not proportion 10 need. Even 
when thoe two ate groups 30-34 and 35-39 are combined as in the case of Figun- 4 above, 
it "' still dear th.,t IllV infection is conc'-'ntr~ ted in the 30-39 age group a t 70" bu t a~ 
to fnoe ARVs within thi.! age g roup is only 46.75". Thill implies WI the majority of 
people infel.1,->d w ith IIIV in this age group are not ac.:C9!iing free ARV, in proporlion to 
th,-oir nI.'I'I1 
Educational attainment of particip;lnts 
Six levels of t"-lucational attainment wert' ronsider('d. T1le:5e " 'ere repr~ted '" 
follows;· rlO;'Ver J,ct,n in school at all {no education}, prunary Iev~ education.. ~ndary 
level education, advanced high school. tertiary educoUon. induding undergra<Juate ano:! 
diploma level , master5 an<.! PHD progranunes. The frequencies aT\! ~nted in 
l'iS" .... " below 
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Considered as a .... ook>, results from tIw sample revealt>d that individuals .... ith primary 
level and :la;ondary I'd""ation ha,' .. gll'ato.'r acce5Ii to ftL.., ARV drugs in Uganda than 
the rest of groups .... ,th 45" and 3-1" respI-'ctively. Figlln' 6 also reveals that tho5e 
without education. those with advanclK1 high s<;hool 1~'VeI, tho:se with a,rtiary. 1MS1~'1'!! 
and PI !1) have th~ !~lISt occes~ of the drugs. 
ASurc 7: Nun' ...... ot porlicip.nt. On rr~~ AItV. by eduntion~lln'rl .nd geogr.phiut lo<~lion 
lOS 
, 1 
• KAMPALA 
. MA5AKA 
Strntified by geographicalloc:ation. as in Figure 1 above. still thase who howe oornpletl.od 
primary and ""-"'andary lew] hiwl' greater aCCl55 to ARVs. Ilowe'o·er. the variation occun 
In the extent to which those with primaty 1""1'1 and SoOCondary level tl'tiucation have 
...:cess to free ARVs .n dllfel1!nt g«>graplOCallocations. While the highest percentage!! of 
those who IIL'reSS free ARVs in Kampala him, au"me-d .econdary lewl ~",:ation. in 
f-',Iasaka it ios those with primary education 1b.11 have greateT access. 
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figu.e S; Comp.o,ioon ~ edu<~lion SlOI\lS for UI)IIS. 111\1 infcdion .IMI All. \I uliliza, ion 
Primary "", .. I _. 
Note: TI,e USRrlda &ro BclwlIiOurrd Survty reported HIV """",k",:c ral~ by rilUCQ lu",a' ~ i.t 
the {'trrtlllQge of po:III>lt III tildJ grC4lp l'!frcltd. Thtst data ha~ ba-II uw to adO/hilt tM 
dl;:tn'~lIIioll af the H/V wfortrd f"'PU'ulioll btluwll rrJuCllhrm.>1 groops lIS 1'tjl«ttfl In Figun 8. 
When the educational status of t'fItire population is compared 10 tha i of ARV U$t'n and 
thai of the HIV I AIDS inf"",Jed popula tion u indicaled in Figure 8 abov", il d clear thai 
the group of people m Uganda tNt ~ lICtllally g~l.Iy infecled by HIV are those " 'ith 
primary education (77.~). Ilo,,~r access 10 AKV d gn1aler among those indiviJu .. ls 
with sec:ondary l!'Yel OOUC-dlion and more. 
Educational attainmen t has been used as u proxy meil5ure for ~ioecoIlOmic slatus in 
many stlldies be<:au5e ttwy have s hown a pos llive .:orr~ta lion between education and 
income (Ainsworth and Semali 1998; Film ..... 1998; l)ehcndfee\.all998). As mentioned 
pr""iou~ly, owing 10 lack of asset d~ta for 11IV Infec tion In Ugandll, thi!t: stlldy will use 
OOu(""" l1o",,1 ~ Ild inmenl for p«>ple living with IIIV I AIDS M a proxy meil5U«, fur their 
SQCioeconmn,c status. Using the UDI [S da la llel Tabla t lind 2 below also '!'Yeal II 
pu!litive corn.'t"tion between educational attainment and ... , ... JIh 
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QulnUl .. No adIJca!ion Primary laval Ilvel& mora 
0' 
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1.0000 
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St.t .. output 1.1 dearly indicates that there i~ a positive rorrdation bMwCO'n ed uo:ational 
level and income. Although the rorrelauon "" Mt vel)' &trOng. I'\.'5ults $how !hJ,t the 
rorrelation is statistically s.gnillCllIll bec .. use p-vahw is Io,oSllIh.an O.OS, th us It Is juslified 
to use education as a pro")' measure fO<" income. Results in Table I reveal that 
individuals with hig"'" educalional 1evcls oIl"£' mo ... likely to rome from t~ higher 
inrom@groupsandvice-vers.t. For instance, the majority of mdividuals with "5<.'COndary 
",, '('I education and more" are from the highesl (OS) and high (0') Income gmups w,th 
28% and 2~" respe<:tively wlule the majority of those without education are frum the 
lowest (QI) and low (Q2) inrome groups with 50';' and 25% respec tively. Results further 
ITveitl that th05e with primal)' education in K.:unpal .. a'" mOre li).:dy to ('(Ime from the 
lowest and low·income groups as Table I clearly indicates tha t the}' al"f: lughly 
r~prescnteJ in ttw..e income groups 011 3<1% and 32% respec tively. Therefore One can 
ronclude that income incr\'~'S with increasing education. This l);Ittem i5 ,emion;OO by 
Table 2 below. which ...... ·eals rnon,>or Ie" the 1Olml' general paltern m the rural :!ICttmg. 
rseCOndaryleve 
Oulntiles No educMlon P,imary level & mo,e 
0' 
"" ". 
,. 
0' .
"" "''' 0 3 ,,. 
'" '" 
'" ". 
,,. 
'1% 
0' 
" "" "" Tot. 1 
''''' 
",,. 
''''''' 
SUla "ulpul 2.1. A stala outpul corr .. btion beI ... ·...,n ~du<~lionaJ aliain"",nl and .. ,~. lth 
q .. inlil ~~ in a ru ,.lldt;n&-
I hv l 06 01 ru(al -. 
- -
... _---_ . .. _ .. -...... _ ... . 
0.2(61 1.0000 
O.DOOO 
Slala OUtput 2.1 still confunu a po"ltive rorrcl~ tion betwt'(!n lodU(ilti<m and ;I1<;OUle in 
the rural ,.etting and resu lts abo reveal that the correlation is 5t.:1 tisticaUy 5ignmcan! 
beouse I)-val ..... ~ 1\'55 than 0.<5. TabLe 2 illustratt.", th.lt in the rural $l;'tting.. individuals 
with no edUCiltioo. come from the lowest quint;]e (29%). the low qulntile (22%) and 
middle quintil" (23") and they are I,,~t re l1'r\'''l'ntro iII the hlghest quintilc (5" ). 
Indivit.luals with primary Loducation are almost l'VcnJ~' distribu ted aCross alL irocOUle 
groups bu t tho!5e wi th H.5eC()ndary level education lind mont are highly ,epresented in 
the highest mcome group al 47% and in the high quinti]e at 21 " And leASt represented in 
the lowL'S1 quinti]" at 7%. 
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Using information from Tables I and 2. one can conclude that individuals ,,~th the 
lughest levels of HIV infections i.e thooe with primary level education al'<' from the 
lowest and low income {;ro u~ in Kampilla while the same group of people is almost 
evenly distributed across aU quintiles in rural areas, 
l'articip.mI'S household headship and composition 
In the normal Ugandan setting as indirnted from the UDHS, men have always head~>d 
households in all asP<"'=ts. The proportion of female-headed hou5eholds is small 
compilred to male-headP.d households.lhis pilltern is not true for study pilrtkipilnts. 
1ne headship of households of participilnts was different for diff"rcnt geo{;"'phical 
locations. Whereas mol'<' of the pilrlidpants' households were headed by men in 
Kampala (53.2%) Uliln women (46.8%), the reverse was true for rural areas. In Masaka. 
SO.S % of women compared to 49.5% of men headcd Ihe home. This therefore implies 
that households in the rural areas are in poor conditions as compared to th~ ones from 
urban areas as Cohen (1996) argues that the poorest households arc often female headed. 
In terms of homehold composition, results revealed that the household she of 
p.trticipilnu was larr,e for both urban and ru ral areas. Huwever, the ~verage houscllold 
size WaS larger in Masaka district (7.0 persons) as compared to (6.1 persons) in Kampala 
district. 
rarl idpant's employment status 
Both in Kampala ami r.tasaka the f".'I'Ccnl<lge of the ARV participo:lnts who wert> 001 
employed were much hi{;her Utan Uta! of Ihose who were employed. The employed in 
Kampala district,. we", only 30. 2 'X. compared to 6\1.8% who were not employed, In 
Masaka district, only 13,2% were employed and 66.8% were not employed. It was 
interesting Utat in Kampala "",re Women than m= were employed. Of the 65 
mdlViduals who were employed at the time of the survey, '1:1 were men while 38 were 
women. 'n-.e kinds of jobs of those employed in Kampal.1 were mainly white cotlar jobs 
and UIC~ in.:luded : coordin.1tor, invi!Stigator, land survey, manager, nurse, officer, 
reVen ue assistant secretary, s upervisor. ~acl-oer. ad visor and business owners, f)\ue-
coilM jobs included: shop attendant. cMl)t!nler. rtUlid . l.!Iund ry ~ttendant. t."liIor. 
mechanic and driver_ The whIte-collar jobs were mainly d one by mm wlule the non-
white collar jobs were done by women. I:or insbnc~. 74 '" of men had whit@-collar;abs 
while only 24% had non-white collar jobs. On the other h.lnd. 42'- of women had white 
rollar jobs compared to 58'- with non-white col~1r jobs. In Masaka d istrict. more men 
than "'ornen Werf' employed. Out of the 24 employed. 14 participants were men and ]0 
were women. In Masakll districl, the $arT\!! percentage of men had flIual CharlCfl of 
either doing a white-collar job or non-while ,ollar job (50'%), lOOse doing wh,le-<oIlar 
jobI5 were teachers, enginet'rs. priests and army oI'flCers "nd those doing non-while col[ar 
jobs were mainly f<lrmers, fishermen. dea~ and dm"en. The wome-n III lIo{asab 
m"inly d id informal work as compared to formal wor!.... Of the 10 women emplo~ 
only 2 (20%) had fo...-w worl<. One was a cashier and the other one was 11 nurse. The res t 
SO '" wert! fMrners, vend~, shop attendants and waitresses. With this iwld 01' data. 0Ilf' 
can a rgue lha l lowetnploymenl rall!5 could be either as It resul t 01' discrinunation agains t 
those inf«ted ,,-ith HIV I AIDS or because the unemployed are more likely to attend 
public or NCO fadlil1eS. On.! other poisible factor IS that AIDS related illnesses affected 
flt'Ople's ability to continue working d ue to physical ""eaknes6 as evidenced from FGDs 
Other ('Vidence h.u soo...TI thai the eptdelIOC ha5 caused employment insecuritoes and 
dikrimin.ltion In the labour fon:e especially whm organ;;,,a liom subjecl prOSJ'f!(:tlve 
en'plo)'tflto mandatooy HIV screening lests before Tl'CTUitment and those found to be 
Infecled with HIV are denied employml'.nl (UAC 2004) . 
..... O.scripclon of !lou •• hold ... et owner.hlp In urban/noral selling and by 
weallh qulnllt ••. 
Since tim study kI$ ou lto judge flIulty on a iMlCioeconomic and geographical basis, it is 
nec:essary 10 give it brief dE'S(ti pUon of how househollJ assel ownership differs in urban 
and rural selting and in terms of wealth quintiles, D.11<1 used i~ exlrn<;ted from the 
Uganda Demogr~phic Health Survey 2000/1. 
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It is clear that urban asset ownership is different from that one in the rural setting. From 
the data presented in Table 3 and Table 4 more than half of the households in Uganda 
own a radio; urban households are more likely than rural households to have a radio. 
Only about 6 percent of households own a television and about 4 percent own a 
telephone. Refrigerators are also uncommon. These assets are very common in the 
urban areas compared to the rural areas. Bicycles are more common in rural areas than 
in urban areas, while cars and motorcycles are almost exclusively owned by urban 
households. This therefore implies that urban households are more likely than rural 
households to have access to information and health care. 
Information on housing characteristics including access to electricity, source of drinking 
water, type of sanitation facility and construction materials of dwelling reflects aspect of 
environmental health. According to UDHS 2~2001, nine percent of households in 
Uganda have access to electricity. Access to electricity is much higher in urban areas (44 
percent) than in rural areas (2 percent). 
Data shows that open wells are still a major source of drinking water and only one in 
nine households has access to piped water, mainly from a public tap (UDHS 2()()()"2001). 
The percentage of households with access to piped water is much higher in the urban 
areas (63 percent) compared to the rural areas (2 percent). 
Most households (79 percent) in Uganda, use traditional pit latrines; this is true in both 
urban and rural areas. Flush toilets are less common in the rural areas than in urban 
areas. The type of toilet facility has implications for the household's health status. For 
instance households without a proper toilet facility are exposed to the risk of diseases 
like dysentery, diarrhoea and typhoid fever. 
The type of material used for the floors may be viewed as an indicator of the quality of 
hOUSing (an income dimension) as well as indicator of health risk. Some floor materials 
like earth, sand and cow dung, pose a health problem since they can act as breeding 
grounds for pests and may be a source of dust. In general, rural households have poorer 
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quality floors than urban households. Ninety percent of rural households have earth or 
dung floors, while 73 percent of the urban areas have floors made from cement, tiles or 
polished wood (UDHS 2000-2(01). This kind of information therefore has implications 
for the rural households, as it is dear that rural households are at a higher risk of poor 
health status as compared to urban households. 
Table 3: Percentages of asset possession in different quintiles in an urban setting. 
KAMPALA 
Q1 Q2 Q3 Q4 
ave carltruck 0.0% 0.0% 1.9% 1.7% 
ave motorcycle 0.9% 5.6% 5.7% 5.2% 
9.5% 7.1% 16.0% 6.0% 
ave telephone 0.0% 0.8% 5.7% 26.7% 
ave fridge 0.0% 0.8% 4.7% 20.7% 
ave television 0.0% 2.4% 31.1% 66.4% 
ave radio 56.9% 83.3% 91.5% 94.8% 
Have electricity 6.9% 29.4% 62.3% 87.9% 
ave piped water in residence 0.0% 0.0% 0.0% 0.0% 
ave public stand piped water 77.6% 74.6% 77.4% 86.2% 
ave flush toilet 0.0% 1.6% 1.9% 8.6% 
ave traditional pit latrine 96.6% 96.8% 85.8% 75.0% 
ave earth sand floor 50.9% 8.7% 4.7% 0.0% 
ave cement floor 24.1% 54.0% 63.2% 79.0% 
ave ceramic floor 0.0% 0.0% 0.0% 0.0% 
ave cement block walls 1.7% 6.3% 4.7% 6.9% 
ave mud-pole walls 50.9% 4.8% 0.9% 0.0% 
Have burnt-mud walls 14.7% 10.3% 10.4% 5.2% 
ave thatched roof 0.0% 0.0% 0.0% 0.0% 
ave iron sheet roof 99.1% 99.2% 99.1% 96.6% 
ave tiled roof 0.0% 0.0% 0.0% 0.9% 
ave asbestos roof 0.0% 0.0% 0.9% 1.7% 
The five quintiles described below are labeled in ascending order from lowest to highest 
socioeconomic groups. These are represented as follows: Q1-lowest, Q2- low, Q3-
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middle, Q4-high and Q5-highest Below in Tables 3 and 4 a description of asset 
possession in terms of percentage ownership in different wealth quintiles is presented in 
an urban and rural setting respectively. 
Table 3 above represents the percentage of those households in different wealth 
quintiles that possess the specified asset or item in Kampala district 
Data from table 3 indicates that on average in an urban setting, individua1s/households 
from the highest quintiles possess more cars/trucks and motorcycles compared to the 
rest of the wealth quintiles. They also possess a good number of bicycles. Possession of 
telephones, refrigerators, televisions, radios and electricity is also highly associated with 
the highest income group. Piped water in residence, as a source of drinking water is 
exclUSively associated with the highest socioeconomic group and public tap water is less 
common to this quintile compared to the rest of the income groups. The type of toilet 
facility is mainly flush toilet and houses from the highest quintile have cement floors, 
cement block walls and iron sheets, tiles or asbestos roofs. . 
On the other hand, none of the households from the lowest quintile possesses 
cars/trucks and only 0.9% of households in this quintile possess motorcycles. On 
average, at least 9.5% of households in the lowest income group use bicycles as a mode 
of transport None of the households in the lowest income group owns a telephone, 
refrigerator or television, however, at least about 57% of households in this quintile own 
a radio. Households in this income group hardly have electricity and the main source of 
drinking water is a public tap. The toilet facility is mainly traditional pit latrine and the 
houses are mainly built with earth/sand floors with few exceptions of cement floors. 
The main wall materials are mud-pole and burnt-mud and the roofing materials are iron 
sheets. 
Quintile groups low, middle and high mainly use motorcycles and bicycles as a means 
of transport It is surprising that the low and middle-income groups have more 
motorcycles and bicycles than the high income group. However in terms of household 
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durable goods, ownership of a telephone, refrigerator, television and radio increases 
with increasing wealth. For instance the highest percentages of households from the 
high socioeconomic group own the above mentioned goods followed by the middle 
quintile and lastly the low quintile. Having electricity is more associated with high and 
middle-income groups (87.9% and 623%) than it is with the low-income group, which 
has only 29.4% households with electricity. The main source of drinking water for the 
three quintiles is a public tap. Traditional pit latrine is the main toilet facility but 
households with this facility decrease with increasing income. For instance, more 
households in low (96.8%) and middle-income groups (85.8%) compared to the high 
quintile (75%) have a traditional pit latrine. Housing characteristics of the three income 
groups are as follows: 
The type of floor is mainly cement for all the three income groups but some houses in 
low and middle groups have earth/sand floors. Wall materials are mainly burnt-mud 
for low and middle quintiles and cement blocks for high-income group. Few households 
in low and middle-income groups have cement blocks while few households in high-
income groups have burnt-mud walls. The main roofing material for all three income 
groups is iron sheets. 
In conclusion therefore, data indicates that, in an urban setting, households from the 
highest socioeconomic group compared to other quintiles, are more advantaged in terms 
of access to information and health care because they have an efficient means of 
communication, transport as well as better standards of living. Higher ownership of 
household durable goods and assets also suggest that these households have better 
illness coping strategies than their other counterparts. On the other hand, the lowest 
socioeconomic group is more vulnerable than the rest of the income groups as far as 
health status is concerned. 
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Table 4: Percentages of asset possession in different quintiles in a rural setting. 
RURAL 
Variable Q1 Q2 Q3 Q4 
ave car/truck 0.00% 0.00% 0.00% 0.00% 0.600A 
ave motorcycle 0.00% 0.00% 0.00% 0.65% 9.08° 
ave bicycle 15.90% 41.54% 31.46% 55.29% 
ave telephone 0.00% 0.00% 0.00% 0.00% 
ave fridge 0.00% 0.00% 0.00% 0.00% 1.69 
ave television 0.00% 0.00% 0.10% 0.00% 8.61 
ave radio 4.30% 39.71% 40.04% 65.95% 84.64° 
ave electricity 0.00% 0.00% 0.38% 1.12% 9.64 
ave piped water in residence 0.00% 0.00% 0.00% 0.00% 0.56 
ave piped public tap water 0.09% 0.64% 1.62% 1.68% 
ave open well in residence. 0.00% 0.00% 0.00% 0.09% 0.09 
ave open public well. 30.68~ 22.06% 31.84% 41.15% 24.72° 
ave flush toilet 0.28% 0.55% 0.48% 0.47% 0.56° 
ave traditional pit latrine 57.06% 73.90% 86.08% 92.70% 92.98° 
ave earth sand floor 76.43% 57.72% 72.07% 69.13% 41.01 
ave cement floor 0.00% 0.00% 0.00% 0.00% 32.02 
ave ceramic floor 0.00% 0.00% 0.00% 0.00% 0.09 
ave cement block walls 0.00% 0.00% 0.00% 0.09% 2.62 
ave mud-pole walls 88.49% 61.95% 79.03% 70.63% 25.84 
ave burnt-mud walls 0.56% 6.43% 6.39% 11.88% 12.45 
ave thatched roof 99.81% 88.05% 27.93% 10.29% 
ave iron sheet roof 0.00% 10.85% 71.31% 89.06% 97.94 
ave tiled roof 0.00% 0.00% 0.00% 0.00% 0.37 
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In the rural setting, households in the lowest, low and middle quintiles have neither 
cars/trucks nor motorcycles. Of the households in the high quintile, only 0.65% of 
households have motorcycles. In rural areas, posseSSion of cars/trucks and motorcycles 
are rare even in the highest quintile. Data in Table 4 above suggests that the major mode 
of transport in rural areas for all the income-groups is by bicycles. Possession of bicycles 
is more associated with low, high and highest quintiles as compared to lowest and 
middle-income groups. 
In terms of household durables, possession of a telephone and refrigerator is exclusively 
associated with the highest socioeconomic group, although households with these items 
are very few (281 % and 1.69%) respectively. Possession of television is also almost 
exclusive to the highest quintile (8.61 %) with just an exception of one person in the 
middle quintile with a television. Possession of a radio applies to all income groups but 
the degree of possession increases with increasing wealth. For instance, households in 
the lowest quintile who have radios are only 4.3% compared to those in low quintile 
(39.71 %), middle (40.04%), high (65.95%) and highest (84.64%). None of the households 
in the lowest and low-income groups have electricity. It is relatively uncommon in the 
middle and high quintiles but relatively high in the highest socioeconomic group. 
The main source of drinking water in rural areas common to all quintiles is open public 
well although piped public tap water is common in the highest quintile. Traditional pit 
latrine is the most common toilet facility to all income groups. In addition, most 
households in all income groups have earth/ sand floors but a significant number of 
houses in the highest quintile have cement floors (32%). Mud-pole is the main wall 
material in the lowest, low, middle and high-income groups but it is less common in the 
highest socioeconomic group. 
Unlike in urban areas where none of the households is thatch-roofed, the majority of 
households in the lowest and low socioeconomic groups are thatch-roofed. As much as 
some households from middle, high and highest quintiles are thatch-roofed, the 
majority of these households have iron sheets as the main roofing material. 
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One can conclude therefore income groups in rural households differ from those in 
urban households in all aspects and households from the highest socioeconomic group 
still have an added advantage over other income groups in terms of health status. In 
addition, it is clear from both Tables 3 and 4 that households from the lowest 
socioeconomic group in the rural setting are much more disadvantaged than their urban 
counterparts in terms of asset possession and living conditions. This makes them a more 
vulnerable socioeconomic group in terms of health status as well as in access to health 
care. 
4.5 Asset Index results from Principal Component Analysis (PCA) 
This section presents results of ARV utilization by different quintiles of socio-economic 
groups. Utilization is presented in terms of geographical location (Urban Vs Rural), 
gender and facility. 
4.5.1 Utilization of ARV by Geographicallocation. 
It is important to compare utilization of ARV programmes in different geographical 
locations and across wealth quinti1es. This comparison forms part of the benefit 
incidence of ARVs in terms of urban and rural setting. Results from this comparison 
enables one to judge whether access in the two geographical locations is different and if 
so, it gives a clear foundation on which to judge equity on a geographical and 
socioeconomic basis. 
79 
Figure 9: Percentage distribution of people on ARVs by geographical location and wealth 
quintiles 
/ r-------~--------~--------~--------~------~. 
Q1 (Lowest) Q2(Iow) Q3(MddIe) Q4(Hgh) Q5(Hghest) 
• Kampala mlMasaka 
As indicated in Figure 9 above, the distribution of ARV utilization is different in the two 
geographical locations. Overall, the findings show that socioeconomic groups are not 
evenly represented in free ARV utilization, and this pattern is exaggerated in Masaka 
district Whereas distribution is concentrated in two extreme ends in Q1 and Q5 in 
Kampala with 25.7% and 36.2% respectively, ARV utilization in Masaka follows an 
ascending pattern from lowest to highest quintiles. Put differently, ARV utilization in 
Masaka increases with increasing wealth, however it is more skewed to the two topmost 
quintiles 4 and 5 with 30.2% and 48.9% respectively. 
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4.5.2 Utilization of free ARVs by gender and wealth quintiles 
Table 5: Number (%) of patients on ARVs by gender and wealth quintiles 
~ampala Masaka 
Qulntiles Female Male Female 
I 
Male 
Q1 (Lowest asset score) 40 (25.9) 16(25.0) 3 (2.5) . 
Q2 (low asset score) 14 (9.1) 8 (12.5) 5 (4.3) 3 (4.7) 
Q3 (Middle asset score) 20 (13.0) 8(12.5) 19 (16.1) 8 (12.5) 
Q4 (High asset score) 28 (18.2) 5 (7.8) 32 (27.1) 23(35.9) 
Q5 (Highest asset score) 52 (33.8) 27(42.2) 59 (50) 30 (46.9) 
Total 154 (100) 64 (100) 118 (100) 64 (100) 
From Table 5 above, it is interesting to note that the pattern of ART utilization by 
gender is similar to that for the overall geographical location pattern. Both women and 
men in the lowest and highest quintiles (Q1 and Q5) in Kampala and both sexes in the 
middle, high and highest quintiles in Masaka have greater access to ARVs than those 
from the rest of the groups. The proportionality of ARV access however differs for 
different gender groups. In all instances utilization of ARVs is skewed in favour of 
women in both districts. Another point to note is that utilization of ARVs from the 
lowest and low quintiles is very low for both men and women in Masaka district. In fact, 
utilization of ARV for men in Masaka is nil in the lowest quintile. 
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4.5.3 Utilization by facility. 
Table 6: Number (%) of patients on ARVs in different health facilities by wealth quintile. 
Kampala Masaka 
Facility A Facility B FacllltyC FacllltyE FacilltyF FacilityD FacllltyG 
Q1 23 (31.9) 4 (14.8) 8 (34.8) 14 (31.8) 7 (13.5) 2 (1.5) 1(2.0) 
Q2 8 (11.1) 1(3.7) 2 (8.7) 5(11.4) 6 (11.5) 6 (4.6) 2 (5.9) 
Q3 10 (13.9) 2 (7.4) 4(17.4) 3 (6.8) 9 (17.3) 20 (15.3) 7 (13.7) 
Q4 10 (13.9) 5 (18.5) 3 (13.0) 11(25) 4 (7.7) 44 (33.6) 11(21.6) 
Q5 21(29.2) 15 (55.6) 6 (26.1) 11(25) 26 (50) 59 (45) 30 (58.8) 
Total 72 (100) 27 (100) 23 (100) 44 (100) 52 (100) 131 (100) 51 (100) 
Table 6 above indicates that access to free ARVs in facilities A, C and E is skewed to the 
lowest and highest socioeconomic groups (Q! and Q5) but more inclined to the lowest 
quintile, while in facility B, F, D and G distribution is skewed in favoUr of the highest 
socioeconomic group (Q5). It is interesting to note that in general, the socioeconomic 
group II low" (Q2) has the least utilization of ARV compared to the rest of the groups. It 
is important to note however, that in facilities D and G, distribution follows a particular 
pattern, with ascending frequencies from lowest to highest socioeconomic groups. 
4.6 Cost and Benefit Incidence 
In order to determine how much public subsidy is provided by either the government or 
donors for ART in each facility, total general expenditure (excluding medicines) for each 
facility was divided by the total number of visits to get general average unit cost per 
facility. This was added to the average unit cost of ARV drugs for each facility as shown 
in Table 7 below. 
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Table 7: Average unit cost of providing ART service in different facilities for the year 2004. 
Facility A Facility B Facility C Facility E FacilltyF Facility D&G 
Total 
Expenditure 
USO) 2,976,000.00 172,414.00 342,618 499,435.2C 3,000,000.00 
1N0. of Visits 44,35" 4,665 5,000 43,45S 28,800 
peneraI averagE 
~tcost 67.1C 36.% 68.52 11.49 104.17 
Cost of ARV 
drugs 685,283.2(] 116,928 416,184.97 449,426.sa 640,000 
No. of patients 2,42a 174 600 45(] 800 
Unit cost 01 282.24 672.00 693.64 998.73 800.00 
ARVs 
Total unit cost 
of providing 349.3 709.0 762.2 1010~ ~ 
ART 
As indicated in Table 7, there are diverse ranges of general expenditure unit costs as well 
as unit costs of ARV drugs for each facility. The variations in the unit cost of general 
expenditure are explained by the fact that different facilities have different general 
expenditure as well as number of visits. Some facilities are small NGOs and therefore 
have small expenditure while others are big NGOs and hospitals and thus have big 
expenditures. The differences in expenditure also reflect different staff mixes, as salaries 
are the largest component of health expenditure. Higher cost facilities are more likely to 
have larger numbers of doctors while low cost facilities have few doctors and a higher 
proportion of nurses. This influences quality of care and thus has a bearing on the 
general expenditure of different facilities. The variations are more distinct particularly 
for facilities E and F. Facility F is a large NGO with a wide range of different 
professionals i.e more doctors, physicians, specialists and nurses but Facility E is a small 
NGO with few health workers. Another point to note is that while Facility F has a big 
general expenditure it is not overcrowded, it is clear from Table 7 that this facility has 
fewer number of visits as compared to facility E and yet facility E has a much smaller 
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611,871.89 
11,500 
53.21 
360,()(I(] 
1200 
300.00 
353.2 
expenditure compared to facility F. This explains why there are distinct variations in the 
general average unit cost between the two facilities. 
The variations in the unit cost of ARV s in different facilities are explained by the fact 
that different facilities have different numbers of people on different drug combinations 
and these drug combinations have different market prices. For instance some facilities 
have more people on first-line regimens while others have more people on second-line 
regimens. Second-line regimens are more expensive than first-line regimens. For 
example one drug combination on first line regimen i.e d4T+3TC+NVP goes for US$15 
per dose on the Ugandan market while a second line drug regimen i.e 
TDF+ddI+Kaletra goes for USD$115.6 per dose. Facilities A and D&G have a higher 
proportion of patients on first line regimens. For instance, 94.7% of patients in Facility A 
are on first-line regimen while 86% of patients in Facilities 0 &G are on first line 
regimens and most of the drugs used in these facilities are generic drugs. On the other 
hand Facilities B, C, E and F have a relatively high proportion of their patients on second 
line regimens and thoSe on first-line regimens aie on branded drugs, which are equally 
expensive. For example 25% of patients in facility E are on second-line drugs and the 
majority of those on first-line drugs are on the branded drug combination 
d4T+3TC+EFVwhich is about US$50 on the Ugandan market The variations in unit cost 
of ARV s in different facilities are thus explained by these facts. 
4.6.1: Benefit of ART users In different wealth qulntlles. 
The average unit cost of providing ART obtained in Table 7 was multiplied by 
utilization (number of ART users in each quintile for each facility) to obtain monetary 
benefit by each quintile (socioeconOmic group) of the specified facility as indicated in 
Table 8 below. This is useful because values in monetary terms act as a measure of 
benefit that accrues to each socioeconomic group. 
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Table 8: Facility monetary benefit (USO) by wealth quintiles 
Qulntlles A B C E F D G Total benefit 
Q1 
Q2 
Q3 
Q4 
Q5 
8,034.85 2,835.84 6,097.32 14,143.05 6,329.17 706.41 353.21 38.499.85 
2,794.73 708.96 1,524.33 5,051.09 5,425.00 2,119.24 706.41 18,329.76 
3.493.41 1,417.92 3,048.66 3,030.65 8,137.50 7,064.13 2,472.44 28.664.72 
3,493.41 3,544.80 2.286.50 11.112.40 3,616.67 15,541.08 3,885.27 43,480.11 
7,336.17 10,634.39 4,572.99 : 11,112.40 . 23,508.33 20,839.17 10,596.19 88.599.63 
In general terms, individuals from the highest quintile have the greatest benefit of ARVs 
as compared to other groups because from Table 8, this quintile alone has monetary 
benefit worth USD$ 88,559.63. The second highest benefit (USD$ 43,480.11) accrues to 
the high socioeconomic group and this is fonowed by the lowest quintile with benefit 
worth USD$ 38,499.85. The low and middle quintiles have the least amount of benefit 
worth USD$18,329.76 and USD$ 28,664.72 respectively. In specific terms facilities B, F, D 
. . 
and G have the greatest benefit accruing to the highest socioeconomic groups while 
facilities A, C and E have the greatest benefit accruing to the lowest quintile. This 
implies that the ART public subsidy in facilities A, C and E are wen targeted to poor 
while the reverse is true for facilities B, F, D and G. Findings from this model clearly 
indicate that in general, the ART public subsidy in Uganda is pro-rich. In other words, 
the ART programme in Uganda is not well targeted to the poor and indeed favours 
those who are better off. Although facilities A, C and E seem to target the lowest 
quintile, these facilities also have more benefit accruing to the highest socioeconomic 
than in any of the other quintiles, particularly the low and middle classes. 
If monetary benefit per person on free ARV for each quintile is calculated the pattern of 
benefit is somewhat different as indicated in Table 9 below. 
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Table 9: ART monetary Benefit per person in each quintile 
Quintiles Total number of Total annual monetary Annual monetary benefit 
people benefit (USD) per person (USD) 
Ql 59 38,499.85 652.54 
Q2 30 18,329.76 610.99 
Q3 55 28,664.72 521.18 
Q4 I 88 43,480.11 494.09 
Q5 168 88,599.63 527.38 
Results from Table 9 indicate that when monetary benefit per person is calculated, the 
two lower quintiles have a larger public ART subsidy compared to the rest of the 
quintiles. The variations are not very distinct though. This information does not mean 
that the public subsidy is well targeted to the poor. There could be other factors that 
influenced such a distribution of the ART subsidy, which will be discussed later. 
There are a range of factors that influence the pattern of free ARVs distribution, that is 
why it is important to understand supply and demand factors that affect the 
achievement of equity. In view of this, social, economic and supply factors that increase 
or constrain access for the disadvantaged groups were solicited from focus group 
discussions. It was also necessary to find out the knowledge and attitude that people 
had towards ARV s because this could have encouraged or constrained accessibility of 
ARVs. 
4.7 Social, economic and supply factors that increase or constrain access for 
the disadvantaged groups. 
In this section, knowledge and attitude towards ARVs, factors that encourage 
accessibility of ARVs and factors that constrain accessibility are presented. 
4.7.1 Knowledge and attitude of ARVs 
Firstly, the facility based questionnaire asked about the sources of information about 
provision of free ARV drugs. The majority of the participants responded that they heard 
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about it either from clinic personneL community health workers or family and friends. 
These were represented by 29.2 %,36 % and 22.8% respectively. Other media sources 
such as newspapers, leaflets and television were not a common source of information 
about ARVs. However, to some extent, radios played a role in conveying the message. 
One can therefore argue that either sensitization of ARVs through the media is still 
inadequate or that probably many people who need such information do not have access 
to the media due to financial constraints. It is evident however from the UDHS that the 
majority of Ugandans possess radios- one probable reason as to why radios played a 
major role in conveying the ARV messages. 
In Focus Group Discussions (FGDs), respondents were asked to talk about what they 
knew about antiretroviral drugs for HIV / AIDS. In the female group in Kampala, all 
respondents acknowledged that ARVs are good and helpful Most of the respondents 
said that the drugs are useful in prolonging life (Respondent 1) and giving people new 
hope to plan ahead (Respondent 6). Another major theme that emerged from the 
women's FGD discussions in Kampala was that ARVs restore energy and strength, 
hence people who had stopped working due to HIV / AIDS related illnesses are able to 
go back and do their usual work (Respondent 8). In other words, ARVs improve quality 
of life. Other issues raised were that ARVs give appetite, thus those who had suffered 
physical wasting as a result of the AIDS disease, gain weight and get back into shape 
and are no longer being stigmatized (Respondent 9). Below are some of the quotes 
supporting the above arguments. 
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Box 2: Knowledge and attitude towards ARV drugs 
Respondent 1: 1"This drug is good because it helps in extending people's life, when 
people take them it increases energy because if someone was to die in one year, by 
taking the drug she can live for (pauses a bit) five or ten years depending on individuals. 
Kale (okay) these drugs do not heal completely but they give energy so that people can 
live longer." 
Respondent 6: "Kale (okay) Me I would say that this drug help in giving people future 
plan ehh, if someone is taking this drug ehh .. , at first people did not have hope, they 
used to think about dying all the time but when one is on treatment, they have hope 
and are able to plan" 
Respondent 8: liMe the good. I know about this drug is that if one's baselikale (White 
blood cells) had been reduced by the virus, and she is being attacked by opportunistic 
diseases all the time, when she takes these drugs, the. white blood cells are enet:gized, 
the patient gets enough energy and also one of the drugs gives appetite like these ladies 
who take the drugs have testified, so you find that those who had lost weight, lost 
energy, it helps them regain their energy and go back to do his usual work and live 
longer." 
Respondent 9: "This drug is good especially for women, not only women but men too 
(Laughter in the background) because people are no longer being stigmatized. Those 
who used to feel the stigma because their bodies looked horrible, after taking the drug, 
their bodies go back to shape, they are renewed so this reduces on the stigma. The drug 
has worked really well." 
In the FGDs for male respondents in Kampala, like their female counterparts confirmed 
that ARV drugs were essentiaL particularly in improving people's quality of life. The 
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majority of the respondents reported that ARV had reduced the incidence of 
opportunistic infections and had thus enabled people to stay healthier and live longer. 
They emphasized the fact that ARVs reduce HIV viral load and increase CD4 count thus 
improving quality and quantity of life (Respondent 4). Other respondents said that 
ARVs help people to regain strength and also give people a new window of hope. In 
other words, those people who were bedridden as a result of HIV / AIDS related 
illnesses, go back to find jobs and sustain their families (Respondent 3). Below are 
responses illustrating these views. 
A continuation of knowledge and attitude towards ARV drugs 
Respondent 4: "what I know about this drug. When someone starts using the drug, it has 
many functions. It suppresses the virus, the virus is paralyzed and it can no longer multiply 
at the rate it used to before the antiretroviral drugs. Also the viral load decreases and with 
time the viral load decreases until the virus can hardly be detected in the body. Even the CD4, 
which had gone down, increase to the level of that of a normal person. This therefore reduces 
the opportunistic diseases that were so common and a person is able to live longer. This does 
not mean that the person is cured completely but their life expectancy is extended". 
Respondent 3: ''This drug is very useful because it has helped patients. I am one of the people 
who monitors patients in their homes. Ever since they started taking these drugs, there has 
been great improvement. Many people have gone back to look for work/jobs, others have 
regained strength and others look very good and feel good about themselves". 
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In Masaka, the women's group was mainly composed of ARV users. Uke their Kampala 
counterparts, the ladies emphasized the fact that ARVs had improved their quality of 
life and restored them to their full capacity of going back to work and lead a normal life. 
For instance here are the words of Respondent 4: II This drug has helped us a lot 
because we were at the verge of death but now we have regained life. I never used to eat 
and walk, ever since I started on these drugs, I am able to eat well, I have energy and do 
my work properly and I also look good physically. In fact people ask me II ehh as you 
look different now". I am sure it is this drug that has made the difference." Most of them 
reported that before starting ARVs, they were very ill and could not plan for their 
children but with the use of ARVs, many of them have been able to educate their 
children and provide for their basic needs. Quoting from Respondent 5: II ••• since I 
started on these drugs, ... I have also been able to work and pay for my children fees ... " 
Some other women also said that ARV reduce occurrence of opportunistic diseases and 
prolong life. For instance, Respondent 5: III have no words I can use about this drug: I 
first of all thank all the health workers because I came here when one of my side was 
paralyzed, but ever since I started taking these drugs, now when you see me you can't 
believe that I had gotten paralyzed, so please go ahead and give us more drugs so that 
we stay alive longer and look after our children as Uganda Cares is helping us. n 
The FGD for men in Masaka reported that ARVs enhanced energy and restored people 
to their normal lives. Respondent 2 stated, ~ drug has helped us a lot because they 
have restored us to back to our original state. It has improved our quality of life and has 
given us the energy to go to our normal duties, which we used to fulfill before we were 
infected with the virus", They also emphasized that ARVs improved quantity and 
quality of life and appetite (Respondent 1) "Before these drugs, I never used to eat I had 
no appetite, but since I started taking these drugs, now I have regained my appetite, I 
eat well. I even have strength and I can now ride a bicycle, something that I could not do 
when I was ill before taking this medicine." Another factor raised was that ARVs 
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increase CD4 count. Respondent 6: uIt increases CD4 count; I came when my CD4 was 
139 but now I am going to 250". 
All in all, the major themes that emerged from all the four FGDS about knowledge and 
attitude towards ARV for both women and men were that ARVs: 
• Extend life expectancy by reducing viral load and increasing CD4 count 
• Improve quality of life by reducing opportunistic infections 
.Give strength and energy 
.Give hope and new plans to people living with HIV / AIDS 
• increase productivity 
• give appetite thus help in regaining weight 
4.7.2 Factors that promote accessibility of ARVs 
Owing to the pattern of ARV utilization, it is necessary to discuss some of the factorS 
that promote accessibility of ARV drugs. These factors emerged from focus group 
discussions held both in Kampala and Masaka as well as from exit interviews with 
patients. The major themes that emerged in the FGDs in both districts were 
II sensitization" and "testimonies." In Kampala in the women's group respondent 7 said 
"The sensitization that we volunteers did, encouraged more people to come for ARVs. 
We also need to go on sensitizing the public because there are still people who believe 
that those drugs are not good. Another factor is testimonies. When people see that their 
colleagues have recovered well, they come and say "I also need to be tested and I would 
also need drugs". It is interesting that men respondents from Kampala also said that 
sensitization and testimonies were major contributing factors to accessing ARVs. 
Quoting Respondent 3: uSensitization has played a big role, especially when people 
realize that there is hope to live longer. Every body is yearning for life, so many people 
are encouraged to come." In addition to sensitization and testimonies, some 
respondents in the men's group in Kampala said that personalized service also 
encouraged people to access ARVs. In this regard Respondent 4 argued, "Clients on 
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drugs are witnesses to fellow patients. A1s0 when we do home care visits, the way 
clients are handled, personal touch and confidentiality, has given people 
encouragement" In the men's group in Masaka Respondent 4 said II Also programmes 
on the radio have encouraged people to come for counseling and testing which has thus 
resulted in people accessing ARVs. More to that, testimonies of before and after the 
drugs have played a big role in encouraging people to come for drugs." In the women's 
group in Masaka the same themes emerged However, in addition to sensitization and 
testimonies, Respondent 7 said that provision of food and transport by CBOs and also 
provision of free ARV drugs played a major role in increasing accessibility of ARVS: 
"First of all, community based organizations (CBOs) have helped a lot in transport costs 
and providing food Sensitization have also helped a lot although it is still very low, but 
in villages where such sensitization has taken place, we see many people coming to get 
the drugs. Another factor is when people recover, they are testimonies to the rest of the 
society. A1s0 the fact that these drugs are given free of charge, has encouraged many 
people to come to centers where such services are offered." It is interesting to note that 
patients from facility exit interviews generated more or less the Same responses as FGDs. 
The facility exit questionnaire asked respondents about the factors that could have 
facilitated them to be on the ARV programme. Only 138 out 400 responded to the 
question. Of the 138, 40 people said that it was due to the testimonies from their 
colleagues, 54 said that counseling played a major role in encouraging them, 15 said that 
because the drugs were free, 20 said that their health status was very poor due to 
HN I AIDS related illnesses and 9 said that it was due to the desire to live longer. 
4.7.3 Factors that discourage accessibility of ARVs. 
Questions about the factors that discourage accessibility of free ARVs were asked both 
in facility exit interviews and FGDS. The facility exit questionnaire asked about the 
factors that constrain some people from accessing the drugs. All 400 participants 
responded to the question. Of the 400, 28% responded that the major constraint was lack 
of money for transport costs and food, 16% said that the bureaucracy involved hindered 
people from accessing ARVs. The patients argued that there are many long processes 
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and procedures involved before one can actually access the drugs. Other factors raised 
were stigma (8 %) and lack of sensitization (12%). In additi~ many people (25%) argued 
that free drugs are still provided on a small scale in Uganda and therefore not everyone 
who needs ARVs has access to them. Some other people (11 %) said that many patients 
are told that they are not yet eligible for the drugs. Put differently, these patients meant 
that some people who still had a high CD4 count could not access the drugs. It is 
interesting that some responses given in the facility based questionnaire tallied with 
those from FGDs. 
The FGDs, asked respondents to give their views about factors they thought hindered 
accessibility of ARVs". The major responses that emerged were that - many people 
lacked adequate sensitization. For example, some people were unaware that there are 
free ARVs being offered at particular facilities. Others feared side effects of the drug 
while other people still experienced stigma from the public. Some other factors that 
discouraged people from accessing ARVs were distance, for example some patients 
stayed far from the centers where such'drugs were provided and in many centers one of 
the criteria for accessibility was that, patients had to be staying within a specified 
distance radius. Many respondents especially from Masaka districts reported that 
transport costs were a major hindrance. Some also said that ARVs give appetite and yet 
they lack the money to buy enough food. Other factors included cultural and religious 
beliefs and lack of disclosure to spouses. 
It is interesting to note that both gender groups in the different geographical locations 
came up with similar responses. Below are some of the quotes for each factor mentioned 
above. 
Sensitization 
Women's group- Kampala 
Respondent 1: '1<ale (okay) many people would need the drug but the majority have not 
yet been sensitized or educated about ARVs. Some other people tell their colleagues that 
ahh that drug was brought to do what? To kill us! In other words, people would want to 
get the drug but they still lack being sensitized, about how this drug works and what 
93 
good things are in these drugs. Such kinds of things, kale (okay) even if they wanted it, 
they have not yet known it in detail". 
Men's Group-Kampala 
Respondent 1: "More to that we lack support from the government while sensitizing 
people. The media does not facilitate us in sensitizing the public. So many people do not 
know that even at this center we have free ARVS". 
Men's Group- Masaka 
Respondent 5: ULack of sensitization in the villages." 
Women's group -Masaka 
Respondent 7: "Another factor is the belief about the ARVs in the village is still very 
bad. For reasons that people believe that these drugs kill, they burn. Many people will 
go and say the drug has terrible side effects, so if there is no sensitization going on, 
many people will get discouraged". 
Stigma 
Men's Group- Kampala 
Respondent 6: "People are still ignorant, they get false information about the drugs. 
Another factor is stigma. Many people do not want to be seen here at the center because 
they do not want people to think that they have AIDS" . 
Men's Group-Masaka 
Respondent 6:" There is still stigma; people do not want others to know that they come 
to the center to access drugs, ... The most hindering factor however, is the stigma 
associated with HIV / AIDS" . 
Women's group- Masaka 
Respondent 6: "Another factor is stigma. Many people do not want to be known that 
they come to centers to access drugs". 
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Cultural and Religious beliefs 
Respondent 1: (Man- Kampala) "Another major factor that has been a hindrance to 
some people are traditional healers. They tell our patients that " endagala e1yo tilikola, 
elyaffe lyeIikola nyo" meaning (That medicine (ARVs) does not work, ours is the best), 
Oients come and report! Saying 1/ you people tell us that this drug works yet our 
traditional doctors tell us it does not work at all." So you can see the dilemma we are 
facing. The traditional healers of course want a market so they will try to jeopardize our 
efforts, not all of them though but some." 
Respondent 2: (Woman- Kampala) "Others would need them, but the majority of the 
people got saved meaning (Christian conversion), so when they go to their pastors, they 
tell them ' you are taking the drug for nothing, for we have prayed for you and laid 
hands on you for healing, you are healed!'. So this hinders them from taking the drugs 
believing that the way I have been prayed for, I am healed. They stop taking the drugs 
when in actual sense they need the drugs." 
Side effects! appetite 
Respondent 5: (Woman- Kampala). "This drug, I am talking from experience as one 
who is on it, this drug brings a lot of appetite!( Stressing the point), you feel that you 
want to eat all the time. In fact I regret why I started it (Laughter from background) in 
fact I am requesting the government to help everybody who is on these drugs. Me I 
usually disturb health workers even those who come home for monitoring, know me, I 
feel hungry all the time, I really need help!" (Stresses the point) 
Respondent 5: (man-Kampala) "Our is society is still poor. People fear taking the drug 
especially when they know that ARVS give appetite, and yet they do not have enough 
money to buy all the food they would need So poverty also hinders access to these 
drugs". 
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Lack of disclosure 
Respondent 3: (Man- Kampala) "Disclosure is still a problem., especially women fear to 
disclose to their husbands and yet one of the criteria for couples to be on this drugs is 
that they have to disclose to their partners. Therefore you find that such a factor 
discourages people from accessing drugs". 
Respondent 9: (Woman -Kampala) "some other people who have failed to access the 
drugs, okay, because in our secretariat, we usually advise patients that if both of you are 
sick, it is best that both wife and husband start on the drugs, but in most cases, women 
come and their husbands stay at home. Also with disclosing, some people do not like to 
do what? To show their wives or husbands that they are on these drugs. Therefore 
women fear that their husbands will chase them away from home especially when they 
refuse to fulfill their marital obligation because they are on drugs and their husbands are 
not. So you find that most women will say that" how will I take these drugs alone if my 
husband is not taking them, and yet you tell us that it is good that both of us need to be 
taking these drugs to be on the safe side". . 
Distance 
Respondent 6: (Woman-Kampala) "Maybe among those who have not been able to 
access the drug, there is a fact that someone from Fort Portal (one of the districts in 
Uganda), who was being directed here by friend I relative that we at KCCC give free 
ARVS. We cannot give drugs to this person and hel she goes back to Fort Portal without 
any close mOnitoring, so those find that have not got the drugs. Also those who need 
them are still fearful about the drugs (Pauses abit) due to their side effects, especially 
when they see those who have developed side effects, or because of wrong rumors". 
Transport Costs 
Respondent 2: (Man -Masaka) "what discourages people from accessing these drugs 
are lack of ability to come to the centers due to transport costs". 
96 
Respondent 4: (Woman-Masaka) Irsanage ( my friends) I will also say that transport 
costs are a big problem. Some of us walk long distances due to lack of transport fees. 
This factor has hindered so many people from coming to the center to pick drugs. In fact 
today I do not have transport and I am worried on how I am going to go back". 
Having analysed information from FGDs, one can conclude that not only do supply 
factors influence the achievement of equity of free ARV drugs in Uganda but also 
demand factors play quite a big role in the distribution of these drugs. Therefore policy 
makers should look at both factors in order to formulate policies that are aimed at 
achieving equity in the distribution of health resources including ART. 
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CHAPTER. FIVE: DISCUSSION OF RESEARCH RESULTS 
5.0 Introduction 
This chapter will discuss results in a more integrated way. The main emphasis will be 
placed on the findings of socioeconomic status vis -a vis ARV utilization It is also in this 
chapter that equity on a geographical and socioeconomic basis will be judged in relation 
to horizontal and vertical equity as well as according to the /I priority view" of egalitarian 
and the maximin principle of social justice. Benefit in monetary terms will also be 
discussed on a socioeconomic basis and judged in the light of equity definitions and 
concepts. 
5.1 The free ART policy in Uganda and what it involves 
The main objective of providing free ARVs as elicited from key informant interviews is 
to improve the quality and length of lives for those living with HIV / AIDS and also 
those affected by the, effects of HIV / AIDS. This is a "3x5" WHO initiative and it also 
consistent with goal 2a of The Revised National Strategic Framework (NSF) for 
HIV / AIDS Activities in Uganda Goal 2a of NSF is to mitigate the health effects of 
HIV / AIDS and improve the quality of life of PLWHAs with the main objective of 
increasing and expanding access to ART and opportunistic infection care (UAC 20(4). 
Findings from the study reveal that the majority of the HIV positive Ugandans on free 
ARVs are on first line regimen. This is because the free ARV roll-out policy began only 
around June 2004 in Uganda and according to WHO recommendations, a standard 
combination of drugs known as first-line should be given to those who have just started 
on the ARV treatment This explains the reason why the majority of ARV users are 
mainly on first line regimens. 
It is also clear that the main criteria for eligibility to access the free ARVs in Uganda is 
based on the WHO recommendation guideline that in a resource-limited setting, starting 
treatment should depend on: 
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• WHO stage IV disease regardless of CD4 count 
• WHO stage III disease taking into account if the person has a CD4 count less than 350 
• WHO stage I or II disease with CD4 count less than 200 
This medical eligibility is necessary but as Macklin (2004) argues it is not sufficient 
condition for ARV treatment The threshold of CD4 count less than 200 in limited 
resource settings as set by WHO is just a condition that must be met before proceeding 
to other criteria for selecting individuals or groups to receive ARVs. Selecting 
individuals with social support as a basis of eligibility to access free ARVs and giving 
priority to those who registered first with particular centers could lead to discrimination 
against unmarried individuals or those who lack social support systems and those who 
are in most urgent of the drugs (the sickest) but who did not register with the specified 
centers early enough. 
5.3 The Characteristics of those on ARV 
5.3.1 Utilization by gender 
Utilization of free ART by women has been considerable. Findings revealed that more 
women than men access ARVs both in an urban and rural setting. One reason for this 
finding is that, according to the Uganda HIV / AIDS surveillance report (Ministry of 
Health 2003) and the HIV / AIDS Sero Behavioural survey (Ministry of Health 2005), 
women are more infected by the virus than males. This finding is consistent with other 
studies in Central and East Africa that have found a higher percentage of women than 
men infected with HIV (Barongo etall992; Berkley etall990). However results reveal 
that the ratio of women to men on ARVs is much higher than the ratio of infection. In 
other words results revealed that 58.4% of women in Uganda are infected with 
HIV / AIDS but 68% of those who access free ARVs are women compared to 41.6% of 
men infected with only 32% of those accessing ARVs being men. The explanation to 
these findings can be obtained from FGDs which revealed that women are more likely to 
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go for voluntary counseling and testing and hence consent to ARV treabnent than their 
male counterparts .. 
Based on the priority view of egalitarian and the maximin principle of social justice, one 
can argue that delivery of ART in Uganda is equitable from the perspective of gender 
because utilization according to need is addressed. A justification for this argument is 
that women who are more infected with HN virus have greater access to the ART 
programme than men. In addition there are some factors, which make women a 
vulnerable group of people that must be considered as a priority for free ART rollout 
For instance, literature has revealed that women usually bear the burden of caring for 
the sick and orphans to the extent that they usually forego productive activities 
including employment in order to fulfill these duties. Many other women are stripped of 
their property and discriminated against when they are widowed. Some surveys such as 
the HIV / AIDS Surveillance study in Uganda revealed that female children are more 
likely than male children to be taken out of school to care for the sick or dying parents 
. and other relatives. Further, there is increased pressUre among girls to engage in casual 
sex especially with older partners as a survival strategy (UAC 20(4). Moreover some of 
these women are mothers who need to prevent HIV transmission to their unborn 
children and who need to live longer to care for their children. 
5.3.2 Utilization by Age group 
Results from the study also indicate that the age groups 30-39 and 40-49 have greater 
access to free ARVs than the rest of the age groups. This finding could be as a result of 
the much higher rates of HN infection in the 30-39 age group. The recent Uganda 
HN / AIDS Sero Behavioural survey report indicates that for both sexes, HIV infection is 
concentrated in the age group of 30-39 (Ministry of Health 2005). However if five 
interval age groups are considered, HIV infection is concentrated in the 35-39 age group 
at 61.4% but access to free ARVs in this age group is only 21%. If a ten-interval age 
group is considered ie (30-39), 70% of individuals in this age group are infected but only 
46.75% in the same group have access to the drugs. This age group constitutes the 
largest and most productive segment of the labour force and has the largest HIV 
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infection rates. Inadequate ARV access by this age group will therefore have 
implications for the labour force supply as well as the Ugandan economy in general. It 
could be considered unfair that the age group mostly infected by ffiV / AIDS epidemic 
and which" constitutes the Ugandan labour force is not accessing free ARVs in 
proportion to their need. However priority should not be given to the more productive 
members of society purely due to their financial worth, rather, need should be 
considered as priority to access. Doing otherwise would violate ethical principles of 
human rights which emphasize that everyone is entitled to the enjoyment of the highest 
attainable standard of physical and mental health irrespective of their social worth 
(Article 25, paragraph I, the Universal declaration of human rights). Furthermore, 
considering those members of society who constitute the labour force would lead to 
maximization of the overall societal monetary benefit (efficiency) but may ignore 
distributional goals of the egalitarian principle of social justice which emphasizes equal 
opportunities to access health care services. Policy makers should therefore prioritize 
access of free ARV s to the 30-39 age group not based on their financial worth but 
according to their need. 
5.3.3 Utilization by educational level 
As discussed previously, many of those accessing free ARVs currently in Uganda are not 
illiterate. Findings reveal that in both rural and urban areas, the majority of those 
accessing free ARVs have either attained a primary or secondary level education. In 
addition there are also those with advanced high school, tertiary education and even 
those with masters and PHD holders. In fact those without any education at all are an 
insignificant percentage (7%), compared to those with some education (93%). Although 
many studies, from Central and Eastern Africa in the late 1980s and early 1990's showed 
a positive correlation between ffiV infection and socioeconomic status, as measured by 
schooling, this finding was not consistent with the recent survey done in Uganda 
Findings from the recent Uganda ffiV / AIDS Sero- behavioral survey revealed that the 
degree of HIV infection is higher among individuals with primary level education 
(15.5%) and almost similar among those with no education (6.7%) and those with 
secondary level education or more (6.9%). When ffiV infection and ARV utilization are 
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compared in terms of educational status as indicated in Figure 8, it is concerning that 
individuals with "secondary level education and more" who have a much lower degree 
of HIV infection than those with primary education have greater access to free ARVs. In 
addition, although individuals with "no education" and" secondary level education and 
morel! have more or less the same degree of HIV infection, the extent to which these two 
groups have access to ARVs is very unfair. Those with secondary level education are 
about 7 times more likely to access free ARVs in Uganda than those with no education 
and yet the degree of HIV infection in the two educational statuses is quite similar. 
Based on horizontal and vertical equity, it is clear that free ARV distribution in Uganda 
is not equitable for the following reasons: 
Firstly, if free ARV distribution is judged according to horizontal equity, it is clear that 
these drugs in Uganda are not distributed according to equal treatment for equal need. 
This is justified by the fact that individuals with "no education" have the same need as 
those with 'secondary level and more" education and' yet they are not getting equal 
treatment in terms of free ARV utilization. In other words, the two groups are not 
getting equal opportunity to access the drugs. 
Secondly, in terms of vertical equity, distribution of free ARV drugs in Uganda is not 
based on unequal treatment for unequal need. One would expect that individuals with 
primary level education who bear a heavier burden of HIV infection would have more 
access to the drugs than their counterparts. Instead it is those with a secondary level 
education with a lesser burden of HIV infection that have greater access. In addition, 
priority is not given to those who are equally in need (i.e those with no education) and 
those who are also socioeconomically vulnerable. 
5.3.4 Household headship. composition and Employment status 
The household composition of Kampala and Masaka sample of people who access free 
ARVs is much larger than the average household size of the general population of 
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Uganda. According to the 2000-01 UDHS, the mean household size for rural and urban 
areas are 4.9 and 4.2 persons respectively while the mean household size for ARV users 
is 6.1 persons for Kampala and 7.0 persons for Masaka. The fact that the mean 
household sizes for those accessing free ARVs are larger than the mean household sizes 
for 1x>th urban and rural areas in the general population may have implications on the 
living conditions and consumption levels of ARV users, which may transcend into poor 
health status. 
As far as household headship is concerned, the UDHS revealed that on average, male-
headed households are more than female-headed households and that the proportion of 
female-headed households is slightly higher in urban areas than rural areas. However, 
results from the study revealed that female-headed households among ARV users are 
more in rural areas than in urban areas. Since results revealed that women participants 
were more disadvantaged than men in terms of employment opportunities in rural 
areas, this composition will have implications for the income of these households and on 
their coping strategies. ART distribution in rural areas'should be targeted to wOmen 
who are the breadwinners in this community in order to enable them cope with the 
negative economic impact of HIV / AIDS. As evidenced in the Masaka FGDs, many 
women confirmed that ARVs had increased their productivity and has thus helped them 
to cater for their families. Respondent 6 (woman-Masaka) was quoted as saying liMe 
what I have seen is that we have been able to plan for our children. Before, when we 
were down with sickness, we had left them in a bad situation, but I have been able to 
build my house which had fallen down, I have also been able to work and pay for my 
children fees, I even have one who is going to Makerere! (meaning university) but if had 
not got this life back, I could not have been able to do all this. Okay the drug has helped 
us to live longer and plan for children ". 
Although the UDHS revealed that employment rates in Uganda were high at the time of 
the survey, it was evident that many of those accessing free ARVs were unemployed. 
Further, participants in Masaka were less employed than those in Kampala, Rural areas 
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should thus be considered as areas with people who are economically worse off and 
least disadvantaged. 
Overall, most of the beneficiaries of the free ART programme have no steady income. 
On average, as far as employment is concerned, free ART distribution in Uganda is to 
some extent fair because it is targeted to the unemployed who do not have the ability to 
pay for the ARV drugs. 
5.4 Benefit incidence analysis of ARVs 
In this section, evaluation of the benefit incidence of free ARVs in Uganda will mainly 
focus on socioeconomic status highlighting a few differences about ARV utilization on a 
geographical and facility basis. Benefit in monetary value will also be discussed in the 
light of socioeconomic status. 
5.4.1 Utilization of ARV by geographical location &: socio-economic status 
Both the Uganda HN / AIDS Sero behavioural survey and the HN / AIDS Surveillance 
reports reveal that urban residents bear a heavier burden of HN infection than their 
rural counterparts. However, clear equity judgments cannot be made on a geographical 
basis based on my study sample because the total number of people in both districts 
who access free ARVs in relation to need is not known. In this case equity on a 
geographical basis will be judged from the perspective of wealth quintiles and only 
differences in the ARV utilization pattern in both districts will be discussed. 
As previously mentioned, there is currently no asset data for HN infection in Uganda. 
Therefore it is not possible to directly compare the general population with HN 
infection and ARV utilization in terms of asset ownership. However a comparison 
between the general population and ART users revealed that ARV utilization in 
Kampala was high in the lowest and the highest quintiles while in Masaka it was 
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skewed to the topmost quintiles (the high and highest) socioeconomic groups. In both 
districts, the low and middle socioeconomic classes had the least utilization of ARVs. 
While the pattern of utilization is different in the two districts, it is evident that on 
average in both districts, the free ARVs are mainly accessed by the individuals from the 
highest socioeconomic group. The variation exists in the extent to which accessibility 
accrues to the highest socioeconomic groups. While ARV utilization in Masaka increases 
with increasing wealth, in Kampala, at least the lowest socioeconomic group is also 
catered for. Without HIV infection asset data, exact "need" in each quintile is not 
known. 
Literature shows that initially HIV infection was concentrated amongst richer groups 
but it now cuts across all socioeconomic groups (Burtely etall994; Carr etall994; 
Parker 1996). This line of argument is supported by Uganda AIDS commission's public-
relations officer who said that HIV infection in Uganda was initially higher among the 
richer groups due to their lifestyles but today it cuts across all socioeconomic groups. 
Further, the recent Sero Behavioural Survey in Uganda has revealed that HIV infection 
is higher among individuals with a primary level education and almost similar among 
individuals with "no education" and those with "secondary level education and more". 
Since data on educational status of HIV infection is available, it is correlated with asset 
quintiles in order to determine HIV infection by socioeconomic groups as indicated in 
Table 1 and Table 2 of the results chapter. 
Based on the notion that education is a proxy measure for socioeconomic status, it is 
clear that in Kampal~ individuals with the highest levels of HIV infection and who also 
have primary level education are from the lowest and low-income groups. However 
access to free ARVs in Kampala is not proportional to need. This is because individuals 
in the highest quintile have greater access to the drugs (36.2%) and only 25.7% and 
10.1% of individuals from the lowest and low quintiles respectively who have the 
greatest need, have access to free ARVs. This implies that distribution of free ARVs is 
not according to equal treatment for equal need thus horizontal equity is still not 
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achieved in Kampala district On one hand one can argue that in Kampala district there 
is some equity as far as the maximin principle of social justice and vertical equity are 
concerned. This is because the most financially disadvantaged (the lowest quintile) are 
served. However, the degree to which these individuals and those from the low-income 
group are served is not relative to their need. If need was to be addressed in Kampala, 
one would expect the pattern of ARV utilization to decrease with increasing wealth as 
indicated in the primary level education column in Table 1. Instead free ARV utilization 
in Kampala is skewed to the highest and lowest quintiles but follow an ascending order 
across the low, middle and high quintiles. Vertical equity in Kampala is also not 
achieved because those who are more socio-economically vulnerable (lowest and low) 
quintiles and who also have enormous need of free ARVs do not have greater access to 
them. 
In Masaka, HIV infection is likely to be evenly distributed across all socioeconomic 
groups as suggested in Table 2. Therefore for need to be addressed, one would have 
expected the pattern of ARV utilization to follow the same trena. It is surprising though 
that it is not the case. As discussed previously, ARV utilization follows an ascending 
pattern across wealth quintiles, increasing with increasing wealth. In view of this, 
distribution of ARV use in Masaka is judged inequitable for the following reasons. 
Firstly, distribution of ARV use is not proportional to relative need instead it is skewed 
to the high and highest quintiles and not across quintiles, as it should be. Thus 
horizontal equity is not being achieved in Masaka because current distribution of ARV 
use is not according to equal treatment for equal need. 
Secondly, it is clear from the results section in Tables 3 and 4 that individuals from the 
lowest socioeconomic group are both economically disadvantaged and vulnerable in 
terms of health status. Moreover individuals from the lowest quintile in rural areas are 
much more disadvantaged than their urban counterparts in terms of asset possession 
and living conditions that influence health status. Yet individuals from this group in 
Masaka who are least able to afford ARV drugs and able to cope with the HIV / AIDS 
106 
effects are the ones that are underserved. In terms of vertical equity, distribution of ARV 
use in Masaka is not equitable because there is no additional measure to promote use of 
those who are HN infected and who are also socioeconomically vulnerable. In addition;. 
priority is not given to the least financially advantaged individuals from the lowest 
quintile thus ART distnbution is judged unfair according to the maximin principle of 
social justice. 
In general terms, current distribution of ARV use is inequitable in both Kampala and 
Masaka districts because not only do the highest quintile benefit more than other 
income-groups but also individuals who bear the heavier burden of HIV infection are 
not served in proportion to their relative need in both districts, particularly in Masaka 
district. In view of this and according to the "priority view" of egalitarian, it is clear that 
distribution of ARV use is not according to need, thus it is judged inequitable. 
5.4.2 ART Utilization by Facility 
Facilities A, C and E seem to target the poorest in the community. This explains why the 
distribution of ARV s is skewed to the lowest socioeconomic groups in these facilities. 
However, in the same facilities, the richest quintile also benefit from the distribution of 
free ARVs, while individuals from low, middle and high socioeconomic classes are 
underserved. Basing on vertical equity, facilities A, C and E are judged to achieve some 
equity because distribution of free ARV use is more skewed to those unable to pay for 
the drugs and who have a similar need as individuals from the high and highest 
quintiles. However these facilities suffer the weakness of not targeting individuals from 
the low who bear a heavy burden of HIV infection and middle-income groups who have 
about the same need. (See earlier discussion on the correlation between education and 
asset quintiles). 
Distribution of free ARV use in facilities B, F, D and G is judged inequitable for the 
following reasons: 
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Firstly, in these facilities, free ARV distribution is skewed to the better-off quintiles (high 
and highest) than to the rest of the income groups. Yet HIV infection is concentrated 
amongst individuals with primary education who are represented more in the low 
quintile and about the same in the lowest, middle and high quintiles. Individuals from 
the highest quintile do not bear as much burden as individuals from the low, lowest and 
middle income-groups yet they have greater access to free ARVs than the rest of the 
groups. In this case facilities B, F, D and G are judged unfair as far as horizontal equity 
and the priority view of egalitarian are concerned. 
Secondly, facilities B, F, D and G do not promote free ARV use by the socio-
economically vulnerable (individuals from the lowest and low quintiles) who are least 
able to pay for the drugs and who have more need of the free ARV drugs than their 
better-off counterparts. Therefore, in view of vertical equity and maximin principle of 
social justice, these facilities are judged unfair. 
5.4.4 Benefit Incidence Analysis of ART users In different wealth qulntlles 
Overall, average government spending on ART in Uganda favors those who are better 
off in terms of wealth and asset endowment as compared to their worse-off 
counterparts. Findings from the study clearly indicate that individuals from the highest 
and high socioeconomic groups get a larger proportion of government's ART subsidy 
than the rest of the socioeconomic groups. This finding is consistent with many macro 
BIA studies of the social sector spending including health, education and basic 
infrastructure, which, revealed that government subsidies were not well targeted to the 
poor but favoured those who were better off (Demery 2000; Castro-Leal et.all999; Sahn 
and Younger 1992,2000; Ajwad and Wodon 2002). On the other hand, results from my 
study contradict those of a micro BIA study done by Thiede, Palmer and Mbatsha (2002) 
in South Africa, which revealed that it is the least well off who actually have greater 
access to government vcr subsidy and other general services at the public facilities. 
This finding could have been as a result of the fact that in South Africa, the richest 
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groups prefer private care as opposed to public care (Castro-Leal etal 1999). As far as 
findings of my study are concerned, ARV distribution is Uganda is not equitable 
because those who are more likely to suffer exclusion of access to health care and who 
are the poor are continually being excluded from accessing life sustaining ARV drugs. It 
is also clear that HN infection is currently relatively high among individuals from the 
low socioeconomic group. Yet this groups with the greatest need is underserved in 
terms of total public ART subsidy. Therefore it is obvious that distribution of free ARV 
use in Uganda is currently inequitable because not only is the public subsidy not well 
targeted to the financially worse off and most disadvantaged but it is also not well 
targeted to those who bear the heavier burden of the HN infection. For example the 
total benefit to the highest quintile (Q5) is more than double (USD$ 88,599) compared to 
the total benefit that accrues to the lowest quintile (Q1), which is worth (USD$ 38,499). It 
is also about five times more than benefit that accrues to the low-income group (Q2-
USD$18,329.76) and three times more than the benefit that accrues to the middle-income 
group (Q3-USD$ 28,664.72). Although monetary benefit per person reveals that two 
lower quintiles have a larger public ARt subsidy in Table 9 of the' results chapter, this 
information does not indicate that the poor get a large share of the subsidy. For instance 
the high monetary benefit per person in the two lower income groups could be that the 
majority of the people in the lowest (Q1) and low (Q2) are on second-line drug regimens, 
which may be related to compliance issues. In other words the poor could have failed to 
comply with first-line drugs due to difficulties in regular accessing their monthly supply 
of ARVs and could have thus developed resistance to them. As a result they could have 
been put on the high cost second-line regimens. Another possible reason could be that 
higher cost facilities are the ones targeting the poorest of the poor, thus influencing the 
monetary benefit per person. This is an area that needs to be further investigated. It is 
still clear however, that people from the highest quintile (Q5) benefit most from the ART 
public subsidy in terms of total ART resource allocation and in the number of people 
that have access to free ARVs in Uganda. 
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According to the Maximin principle of social justice and vertical equity, one would 
argue that in general terms, ARV distribution in Uganda is not equitable because there is 
no evidence of additional measures taken to promote use of free ARV by the worst off in 
terms of wealth endowments as well as the severity of need except for a few facilities. 
Indeed, the poor who are least able to cope with social and economic consequences of 
HIV / AIDS are the ones not actually being targeted in this case. It is unfair to note that 
poor households, which have few, if any financial or other assets, are being socially and 
politically marginalized. As much as the non-poor also find their resources diminished 
by their experience of HIV infection, they stand a better chance of coping with the 
epidemic because of their initial asset endowments as compared to the poor. Studies by 
Ainsworth and Semali (1998) also reveal that adult members of poor households are 
more likely than those in better-off households to die from causes other than AIDS, 
while AIDS death occur across economic spectrum. This means that in Uganda, as in 
other low-income countries, in order to make the largest contribution to mitigating the 
impact of AIDS, programmes should focus on helping households with the fewest 
resources. 
According to horizontal equity and the "priority view" of the egalitarian principle of 
social justice, it is still arguable that the ART public subsidy is unfair because it not well 
targeted to those in most need of them. For instance on average, distribution of free ARV 
use is not proportional to relative need. It is clear that HIV infection occurs across all 
socioeconomic groups in Uganda but free ARV use is skewed to particular income 
groups. 
Although results revealed that in specific terms ART monetary benefit per person is 
higher among individuals from the two lower quintiles, there could be other factors 
influencing the results, which need to be further investigated. It is clear that in absolute 
terms individuals from the higher quintiles benefit most from the ART public subsidy in 
terms of total resources and in number of people. 
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CHAPTER. SIX: CONCLUSIONS AND POllCY RECOMMENDATIONS. 
6.0 Conclusions 
This paper set out to answer the question: /I Which groups of people in Uganda benefit 
from the provision of free ARV programmes in relation to socioeconomic status, gender 
and geographical location; what are the implications of such benefits; and is current 
provision of ARVs equitable?" 
The investigation has established that women have substantial benefit of free ART 
relative to men and the age groups 30-39 and 40-49 have the greatest access to ART 
although access of these drugs is not proportion to relative need in both perspectives. In 
addition, those with primary and secondary level education, the unemployed and from 
large household size have greater access to ARVs. It was clear that HN infection in 
Uganda is greater among individuals with primary education but those with secondary 
level education and more have greater access to free ARVs. Further, results indicate that 
on average, the non-poor or the highest socioeconomic group has the greatest access to 
free ARVs in Uganda compared to the rest of the groups. This finding is more 
exaggerated in the rural areas compared to urban areas. In urban areas, the lowest 
socioeconomic group benefits after the highest socioeconomic group has benefited. 
Further, based on the correlates between education and wealth quintiles the 
investigation established that the distribution of free ARV use in Uganda is not in line 
with need both in Kampala and Masaka. The degree to which individuals from different 
socioeconomic groups access free ARVs is not in proportion to the need. The benefit 
incidence analysis model confirmed that the government ART subsidy is pro-rich. It is 
not well targeted to the poor and indeed favours the better off in society. The poor only 
benefit after the non-poor have benefited. In addition, the public subsidy is not well 
targeted according to need. In this regard, free ART distribution in Uganda is judged 
unfair from the perspective of vertical and horizontal equity as well as in the light of the 
maximin principle of social justice and the /I priority view" of the egalitarian approach 
because the financially worst-off and least disadvantaged are being excluded from 
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accessing free ARVs and these drugs are not well targeted according to the severity of 
need. 
In summary therefore, this investigation has established that: 
• There is need for improving vertical and horizontal equity in ARV targeting and 
provision in Uganda. 
• There is need for improving resource distribution in favour of the poor, the less 
educated and least advantaged both socially and economically as well as 
according to need. 
• There is need for carrying out research to more clearly establish the 
socioeconomic characteristics e.g. in terms of asset possession of those who are 
infected with HN / AIDS. Further investigation needs to be carried out in this 
area to enable a proper asset index comparison with the UDHS and ART users, 
on which dearer equity judgments can be based. 
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6.1 Policy Recommendations 
In the face of limited resources to provide free ARVs to all those who need them in 
Uganda, the quality and length of lives of PLWHAs could be improved through a more 
equitable allocation of the limited ARVs. This should be in line with human rights, laws 
and ethical principles, which provide guidance on expanding access to ART in a just and 
equitable manner. The human right to life, health" equality and non-discrimination 
obliges states to provide HIV-re1ated treatment and care without discrimination to all 
those who need it (WHO/UN 2004). Towards this goal therefore, governments and 
donors should develop practical and sustainable strategies and plans that include 
timetables and benchmarks as part of their commitment to the progressive realization of 
the right to health, including the right to ART and other aspects of care for people with 
HIV / AIDS. The goal of universal access means that cost and or socioeconomic status 
must not be a barrier 'to accessing treatment and care, and particular efforts should be 
made to enable the poor to gain access to treatment Strategies should be developed to 
provide ART free mainly to those who cannot afford it and those who are in greater 
need of it In the light of this study, the following issues need to be addressed in order to 
at least achieve a fair distribution of ART in Uganda. 
Firstly, analysts and policy makers need to establish the socioeconomic characteristics of 
those mostly infected with HIV in terms of asset endowment These are important 
because: 
• Information on the socioeconomic characteristics of those most likely to be 
infected can improve the targeting and effectiveness of programmes aimed at 
prevention as well as care and treatment of HIV / AIDS. 
• The characteristics of those infected with HIV affect the economic impact of 
AIDS epidemic on households and the economy, including the distribution of 
skills in the labour force and the demand and ability to pay for curative 
medical care. 
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• The socioeconomic characteristics of individuals infected with HIV and who 
die from AIDS are also important in developing programmes to assist 
households and communities in coping with the epidemic, 
After establishing the socioeconomic characteristics, policy makers should develop 
a standard against which to measure accessibility of ARVs according to ability to 
pay as well as according to need. As much as it is quite difficult to have clear 
standards against which equity is accessed, efforts should be directed to ensure 
access to ART for people who risk exclusion because of economic, social, 
geographical or other barriers as stipulated in the "3x511 WHO initiatives, In this 
regard, policy makers should improvise strategies that will address issues 
pertaining to social, economic and supply factors that constrain accessibility of the 
socially and financially least advantaged in society. This can be achieved by doing 
the following: 
• Firstly, govern:ment should increase availability of more free ARVs 'as findings 
from the service users indicated that lack of enough drugs hindered many from 
accessing them. The government should also shorten the bureaucracy involved in 
accessing these drugs. HIV patients are already psychologically affected by the 
epidemic; subjecting them to long processes and procedures make many people 
shun the ARV drugs . 
• The government should expand the availability of ARVs by taking these services 
to the rural settings and nearer to the people. In fact, efforts to provide free ARVs 
in rural communities should be prioritized especially towards the poorest of the 
poor. Put differently, the government can facilitate those hindered by transport 
costs by building more centers at grass root levels, or they could employ, train and 
facilitate more community based volunteers to go deep in the communities and 
reach those who are not able to come to the few scattered ART centers, 
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• The government should also widely sensitize the public about ARV programmes 
by increasing awareness of these programmes in the mass media as findings in this 
study reveal that currently, mass media is not one of the major ways contributing 
to the ART awareness in Uganda. For example the government should create 
awareness about availability of free ARVs and at which centers they are provided 
as well the good aspects of these drugs. The government should for example 
educate the public that ARVs improve quality of life and extend life of people 
living with HIV / AIDS. Further, given that most Ugandans have access to radios 
(as opposed to TVs and newspapers), this method of communication should be 
prioritized. 
• National campaigns aimed at mitigating HN stigma should be staged in all sub-
counties and at grass-root community levels. This can be achieved by improving 
the mechanism of spreading the gospel of the good about ART (Testimonies). 
People on these drugs who have experienced positive outcomes from ART should 
be given a platform on which to voice their views. 
• The government should not only offer ARV treatment but it should provide 
basic care, such as food to those who cannot afford to buy it. This will reduce 
discouragement of people who fear to take the drugs due to their side effect of 
increasing appetite. 
• Lessons can be learnt from facilities that have managed to achieve some degree 
of equity and these can be applied in other settings. For instance, looking in detail 
at the facilities that are explicitly targeting the poorest and identifying what is 
making them successful can help in deriving guidelines on how to reach 
disadvantaged groups more effectively. 
• The government should ensure that the ART public subsidy is targeted to 
groups who are least able to afford ARV drugs as well those who have greater 
need of them. This can be achieved through designing a resource allocation 
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process in such a way that distributes health care resources in a fair/jUst way 
within each society. Targeting of the public subsidy according to need will only be 
successful if stakeholders in the ART programme in Uganda first establish the 
HIV / AIDS socioeconomic correlates in terms of asset ownership and in relation to 
the UDHS. However, according to this study, I would recommend that ART 
stakeholders in Uganda should target or prioritize the following groups in order to 
achieve some equity in relation to need: 
• Target individuals from the 30-39 age groups where HIV infection is 
mostly concentrated. 
• Target more people in the lowest and low quintiles in Kampala but 
have an even distribution of ARV drugs in rural areas. 
• Target individuals who have attained primary level education 
• Encourage more men to go for Voluntary Counseling and Testing and 
thus to consent to ARV drugs. 
• The government should develop toolS for constantly monitOring the 
programme's public subsidy to ensure that it is well targeted according to the set 
priorities and groups. This can be achieved by use of anonymous score asset cards, 
which can be assessed biannually or annually. i.e these cards can be designed in 
such a way as to assess the socioeconomic status ( in terms of asset ownership} of 
those accessing free ARVs. There is a need to indicate to patients that the 
information they provide will not affect their continued access to ARV s so as to 
increase the likelihood of obtaining accurate information. 
As long as provision of free ARVs is sti.11 on a small scale in Uganda, there is a need 
to set priorities for accessibility of these drugs and to target them in such a way 
that they will reach the least advantaged groups and those in need of them if 
equity is to be achieved. The rationale for choices of target groups and other 
priorities should be "reasonable" in the sense that it appeals to reasqns and 
principles that are accepted as relevant by the stakeholders (Daniels and Sabin 
2002). Whatever options are selected for setting priorities and whichever ethical 
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principles are chosen as most equitable for Uganda, those responsible for making 
decisions should take into consideration all relevant ethical and equity principles 
to ensure that all human rights obligations are respected, protected and fulfilled 
(Macklin 20(4). 
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Appendix 1: Letter of request to stakeholders 
Heads of Institutions where facility-based interviews will be conducted 
(Note: Each letter will be headed individually, not collectively as appears below) 
The medical Superintendent! Head of Aids support organization, Uganda / Ministry of 
Health-Uganda 
Dear Sir/madam, 
RE: REQUEST TO CONDucr A STUDY ON BENEFIT INCIDENCE OF FREW 
SUDSIDIZED ARV DRUGS IN UGANDA 
My name is Rosette ISyomuhangi, a student at pte University of Cape T?wn in South 
Africa. I am pursing a master's programme in Public health., concentrating in health 
economics. 
I wish to conduct a study on the benefit incidence of free provision of antiretroviral 
drugs in Uganda. This is in fulfillment of the requirements contributing toward the 
award of Master of Public Health. However, the study will have the added advantage of 
informing policy makers about key issues regarding the equitable distribution of the 
programme. 
This letter therefore seeks your permission to let me access your facility as well as the 
patients that access the drugs from your facility. 
You are assured that the information solicited for will be on voluntary basis and will be 
treated with complete confidentiality. Persons responsible for the study will only access 
completed questionnaires. Protection of identity, no names or personal information will 
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be obtained from the participants. Participants also have the right to withdraw from the 
study whenever they wish to. 
The study findings will be made available to you on completion of the research. 
Attached, please find the study protocol. 
Thanking you in advance. 
Yours faithfully, 
Rosette Kyomuhangi 
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Appendix 2: A letter of consent for key informants 
This study, which you are being requested to participate in, is about who benefits from 
freel subsidized antiretroviral drugs in Uganda. The information being volunteered will 
be treated as confidential. Your participation is entirely voluntary and you have the 
right to withdraw from the process of the interview whenever you wish to. The 
information provided will only be accessible to the researchers and no personal 
information will be required from you. 
The study is for purposes of my masters programme but it will contribute to the 
generation of knowledge base for policy makers by suggesting tools for constant 
monitoring the programmes' benefit incidence as well as to derive guidelines on how to 
reach disadvantaged groups more effectively. 
Declaration 
I have read and understood the nature of the study in which I am participating. I 
therefore agree! do not agree to participate. I also give I not give permission for this 
interview to be taped by the interviewer 
Signature of respondent 
Date: 
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Appendix 3 :Key informant interview schedule 
I.Please describe the ARV programmes you are involved in? 
2.Are the ARV drugs provided free or on a subsidized basis? 
3.When were each of these programmes initiated? 
4.What are the objectives underlying the provision of free or subsidized ARV drugs? 
S.What are the criteria for eligibility to access free ARVs? 
6.Are these ARV programmes aimed at individuals or households? 
7.What groups of people are these ARV programmes mainly targeting? 
8.What is the monthly cost of ARV drugs per patient to your organization and if not 
made available free of charge 9.what is the monthly cost to patients? 
10.Do you believe those eligible for free / subsidized ARVs are accessing them? 
If not, what are the barriers? 
11.How do you monitor who is accessing the drugs and if you are meeting the target 
group? 
1~.Can you give me an estimate of the general total. expenditure of your fa~ty per 
year? 
13. What would you consider to be the total number of visits per year? 
14.What is the estimate of total expenditure on ARV drugs per year ? 
IS. What are the total cost of expenditure on laboratory test per year? 
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Appendix 4:Informed consent form for study participants 
I am a student at the University of Cape Town (UC!) in South Africa. I am conducting a 
study to evaluate who benefits from free antiretroviral drugs in Uganda. This is in 
fulfillment of the requirements contributing toward the award of Masters of Public 
Health. However, the study will have the added advantage of contributing to the 
generation of knowledge to policy makers who may in turn improve the health services 
you are receiving. A feed back of research findings will also be provided to you. 
You are assured that the information to be volunteered will be treated as confidential 
and will in no way impact on the treatment you receive at this facility. Completed 
questionnaires will only be accessible to persons responsible for the study and they will 
be destroyed immediately after data analysis. No names or any other personal 
information will be requested of you. You have the right to choose or choose not to 
participate in the study, and as a participant, you have the right to withdraw from the 
pro-;ess of the study whenever you wish to. 
Verbal consent Would you like to participate in this study? Yes / No 
Signature of participant __________ _ 
Date: ___________ __ 
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Appendix 5: Questionnaire 
SECI10NA 
Reference Number: ______ _ 
Name of facility: 
Location: (Area, town) 
PLEASE INDICA1E BY TICKING 1HE APPROPRIA1E ANSWER WHERE 
APPUCABLE. 
Socio- economic and demographic characteristics of respondents 
Gender 
I:~LE I~ 
What is your age? ____ _ 
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3a) What is the highest level of school you completed? Please tick appropriate box 
00= never been in school (no education) 
01-(17= primary level education 
51-54= Secondary level education 
SS-56= Advanced high school level 
Above 56= Tertiary education. including undergraduate and diploma level 
Higher advanced learning = masters and PHD programmes 
3b) if aged less than 2S years: Are you still in school? 
YES 
NO 
4. Where do you live? _____ _ 
5. How long do you travel to reach this clinic/ hospital / facility? 
Less than 15 min 1 
15-30 minutes 2 
ehour 3 
Over one hour 4 
Do you travel by public or private means? 
Private 1 
Public 2 
If public how much does it cost you to travel here? ____ _ 
o 
o 
o 
o 
o 
o 
6. For the last 6 months, how many times have you utilized this programme? ___ _ 
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7a. Are you employed? 
Yes 1 Go to questions 7b and 7c 
No 2 Go to questionS 
7b. If yes, where do you work? ____ _ 
7c. What is your position there ? _____ Go to question 11 
S.In the past 7 days have you had any work for pay? 
Yes Go to question S 
No Skip to question 9 
9. What type of work was it? _________ go to 12 
10. When was the last time that you worked for money? 
Within the last month 1 
Within the last 3 months 2 
Over six months ago 3 
11. In the past 7 days have you had money available from other sources than work? 
Yes 1 Go to question 13 
No 2 Skip to question 14 
12. What were the sources ___ _ 
13. What is the number of people living in the household? __ _ 
14. Who heads the household? Male or female 
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15. What is the main source of drinking water for members of your household? 
IPiped ~ ~ Outside !Public taF 
~ In residence 1 residence ~ ;3 
pPenwell ~ ~ n yard/plot~ Outside yard ~ 
~ 
fProtected well p In yardl plo* Outside yard ~ 
Borehole ~ ~n yard/plot~ Putside yard 2 
~pring water 5 
Rain water {) 
Tanker truck water 7 
River, canal 018 
surface water 
Bottled water 9 
Water from gravity 10 
flow scheme 
16. What kind of toilet facility does your household have? 
Flush toilet (own) 1 
Flush toilet (shared with other household) 2 
Traditional pit toiletl latrine 3 
Ventilated improved pit latrine 4 
No facility I Bushl Field 5 
Other: Please specify 6 
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17. Please indicate by ticking if your household has: 
Electricity EL 
Radio RD 
Television TV 
Telephone (fixed) /(mobile) PH 
Refrigerator FR 
Lantern LN 
Cupboard CB 
18. What is the principal flooring material in your house? 
Earth/ dirt/ sandI dung 1 
Cement 2 
Vinyl or asphalt tile 3 
Ceramic tiles 4 
Parquet or polished wood 5 
Other, please specify 6 
19. What is the main material in the walls? 
Thatched 11 
Mud and pole !2 
Un burnt bricks 3 
Burnt bricks with mud 4 
Burnt bricks with cement 5 
Timber 6 
Cement blocks, bricks, concrete walls 7 
Stone 8 
,...d. 
, please specify 9 
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20. What is the principal roofing material in your house? 
Thatched 1 
Iron sheets 2 
Asbestos 3 
Tiles 4 
Tin 5 
Cement 6 
Other, please specify 7 
21. Does any member of your household own ... 
Abicyde BK 
A motorcycle or motor scooter 
A car or truck 
22. What do you use for lighting? 
Electricity 
Biogas 
Kerosene 
Charcoal 
Dung 
Others please specify 
MB 
CA 
BO 
DK 
EL 
BIO 
KR 
CH 
DG 
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23.Now let us talk about the household and what it can afford. Wauld you say that 
people in your household often, sometimes, seldom or never go hungry? 
Often 1 
Sometimes 2 
Seldom 3 
4 
139 
SECfIONB 
ANTIRETROVIRAL DRUGS 
24. From what sources did you know about provision of free ARVs? 
Friends/ family FF 
Posters at clinic PC 
Newspapers NP 
Leaflets LL 
Oinic personnel HW 
Community health worker/health CHW 
educator 
Radio RP 
TV TV 
Other, please 
specify 
25. How did you qualify to be on this programme? ___________ _ 
26. When did you start receiving ARV drugs on this programme? _____ _ 
27. Which drugs are you receiving? ___ _ 
28. How many times in a month are you entitled to the drugs? 
Once a week 1 
Once in a fortnight 2 
Once a month 3 
29. Are you the only person in your household accessing the drugs? 
Yes 1 Skip toqn 31 
No 2 Gotoqn30 
140 
30. How many other people are accessing free ARVs? ___ _ 
31. Are you the only one who needs these drugs in the household? 
I~: I~ 1:::32 
32. What are the factors that could be constraining accessibility of these drugs for 
members of your household that need them __________ ? 
33.What benefits do you get from these programmes? _________ _ 
34. Do you incur any costs in accessing these drugs? 
I Gotoqn35 
Skip to 36 
35. What are the costs? 
Consultation fee CF 
Payment for drugs DC 
Laboratory test fees LT 
Other costs, please specify 
36.What factors would you consider to have facilitated you to be on this programme? 
37. Do you think every body that needs these drugs gets access to them? 
I~ I End 
38. What factors do you think constrain some people from accessing the drugs? 
141 
Appendix 6: Focus Group discussion Guidelines (community) 
Representative community within selected area will participate in focus group 
discussions, which will be conducted in single-sex groups. To ensure, representation 2 
groups in each region will be selected, one will comprise only males and the other will 
comprise females. The reason for such a separation of gender is that, females may not 
feel free to discuss some issues in presence of males and vice-versa. 
I will give a brief introduction about the research project, and myself then obtain verbal 
consent from all participants. 
Questions 
1.Can you tell me what you know about antiretroviral drugs for HIV / AIDS? 
2.What benefits do you think are derived from antiretroviral drugs? 
3.Do you know whether ARVs are provided free ~r at a low cost in any facip.ty in your 
community? 
4.Do you know who is eligible to access free or low cost ARVs? 
S.Which groups of people would you think benefit more from such health services? 
Why? 
6.Do you think everyone who needs to use these ARVs get access to them? 
7.What factors would encourage or discourage people from accessing antiretroviral 
drugs? 
a.How do you think provision of ARVs should be made more accessible to ordinary 
people? 
Appendix 7: Extra notes for literature review 
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2.2 How different countries in Africa are affected by the HIV / AIDS scourge 
National HIV prevalence rates vary greatly between individual countries. There is 
empirical evidence that in some African countries, the epidemic is still growing while 
others face an increasing danger of explosive growth. For instance, literature states that 
there was a sharp rise in HIV prevalence among pregnant women in Cameroon (more 
than doubling to over 11 %) among those aged 20-24 between 1998 and 2000. In Somalia 
and Gambia, the prevalence is estimated to be under 2% of the adult population while in 
South Africa and Zambia around 20% of the adult population is infected (Avert 2004). 
In four Southern African countries, evidence clearly shows that the national adult HIV 
prevalence rates have risen more than was expected and now exceed 24% in some of 
these countries like Botswana (37.3%), Swaziland (38.8%), Lesotho (28.9%) and 
Zimbabwe (24.6%) (USAID 2002). 
West Africa on the other hand is relatively less infected although in some countries the 
prevalence rates are creeping up. In West and Central Africa HIV prevalence is 
estimated to exceed 5% in a number of countries including Cameroon (6.9%), Central 
African Republic (13.5%), Cote d'Ivoire (7.0%) and Nigeria (5.4%) (USAID 2002). 
HIV infection in East Africa varies between adult prevalence rates of 2.7% in Eritrea to 
8.8% in Tanzania. In Uganda the countrywide prevalence among the adult population 
has declined and is estimated at 4.1 % 
(Avert 2004). 
Over and above personal suffering of those infected with HIV / AIDS in Sub-Saharan 
Africa, HIV threatens to devastate whole communities, impeding progress towards a 
healthier and more productive future of the citizens of the most affected countries. 
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A general overview of the impact of HIV & AIDS in Africa 
In addition, the effect of HIV / AIDS on households is very severe. Many families have 
lost income earners and families of those that die have to find money to pay for their 
funerals. Many of those who die have surviving partners who are infected and in need 
of care. As a result HIV / AIDS strips family assets, further impoverishing those at the 
margins of existence. As parents die, they leave behind children who struggle to survive 
without parental care. This scourge of HIV / AIDS eventually dissolves households as 
parents die and children are sent to relatives for care and upbringing. Countries that are 
heavily affected by the HIV epidemic are facing increasing health care expenditure, 
which is far beyond what their economies can sustain. This is due to the fact that as the 
epidemic matures so does the demand for care of those living with HIV / AIDS. 
HIV / AIDS has the potential to create severe economic impacts in many African 
countries. In terms of laboUr supply, the loss of young adults in their most prOductive 
years affects overall economic output In addition, if AIDS is more prevalent among the 
economic elite, then the impact is even larger than the absolute number of the AIDS 
deaths (Stover and Bollinger1999). In terms of costs, the direct costs include expenditure 
on medical care, drugs and funeral expenses and indirect costs include lost time due to 
illnesses, recruitment and training costs to replace workers and care of orphans. If such 
costs are financed out of savings, a reduction in investment could lead to a significant 
reduction in economic growth. The economic effects of AIDS are first felt by individuals 
and their families and then it spills over to the firms and businesses and eventually to 
the macro-economy. In fact, a World Bank study of the economic impacts of AIDS in 
Africa concluded that the macroeconomic effects could be significant (Over 1992). 
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2.5.1 When to start treatment 
WHO recommends that before anyone starts treatment in a resource-limited setting, a 
basic clinical assessment should be carried out This should include: documentation of 
past medical history, identification of current and past HN -related illnesses, 
identification of other medical conditions that might influence the timing and choice of 
ART and current symptoms and physical signs of other medical conditions such as TB 
and pregnancy (Avert 2005). Once this assessment has been carried out, it will be known 
which stage of HN disease the person has. WHO has a method of describing people 
with HN as being at different stages of HN infection, according to the different clinical 
symptoms they may have. 
WHO recommends that all people who have WHO stage N disease, should start 
treatment However, making a decision on whether other people should start depends 
on what laboratory tests are available and in particular whether the person's CD4 cell 
count is known. A CD4 test measures the number of CD4 or T -helper cells in a person's 
blOod. The more CD4 cells there are per millimeter of 1:)lood, the stronger is the :i:rimtune 
system, and the stronger the immune system, the better the body can fight illnesses 
(WHO 20(3). WHO recommends that a person should start treatment when one is in 
WHO stage IV disease regardless of CD4 count, WHO stage III disease taking into 
account if the person has a CD4 count less than 350 and WHO stage I and II disease with 
a CD4 count less than 200 (WHO 2003). 
Antiretroviral therapy needs to be changed for two main reasons, namely side effects 
and treatment failure. The drug combinations are known to often cause side effects. It is 
reported that some people only experience mild side effects and find them easily 
manageable but for some people the side effects are so severe that they have to consider 
alternative drugs. The second reason for changing treatment is when the drugs have 
failed to work and are not slowing down the reproduction of the virus in the body. The 
WHO definition of treatment failure depends on whether a CD4 test is available. If a 
CD4 test is available, then treatment failure is said to occur if CD4 count has returned to 
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the level that it was before treatment started, or if there has been a 50% fall of CD4 count 
while the person has been on therapy. 
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